PHYTOCHEMICALS
June 1, 2022SEX HORMONE BINDING GLOBULIN
August 3, 2022- Stem cell therapy in perspective
- Adult Stem cell therapy in perspective
- Stem cell therapy for human neurodegenerative disorders–how to make it work
- Stable benefit of embryonic Stem cell therapy in myocardial infarction
- Stem–cell therapy for diabetes mellitus
- New prospects for human Stem–cell therapy in the nervous syStem
- Neural Stem cell therapy for neurological diseases: dreams and reality
- Stem cell therapy in a caprine model of osteoarthritis
- Stem cell therapy and gene transfer for regeneration
- Adult Stem cell therapy for the heart
- Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans
- Nonmyeloablative Stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of …
- Mesenchymal Stem cell therapy in joint disease
- The effect of neural embryonic Stem cell therapy in a rat model of cavernosal nerve injury
- Stem–cell therapy for amyotrophic lateral sclerosis
- Potential of hematopoietic Stem cell therapy in hepatology: a critical review
- Becoming immortal: Combining cloning and Stem–cell therapy
- 28. Embryonic and adult Stem cell therapy
- Dentin regeneration by dental pulp Stem cell therapy with recombinant human bone morphogenetic protein 2
- Stem cell and precursor cell therapy
- Stem cell therapy for ischemic heart disease
- Intervertebral disc cell therapy for regeneration: mesenchymal Stem cell implantation in rat intervertebral discs
- Stem cell therapy for ocular disorders
- Potential Stem cell therapy and application in neurotrauma
- Stem cell therapy of the liver—fusion or fiction?
- Stem cell therapy for diabetes: do we need to make beta cells?
- Stem cell therapy for myocardial repair: is it arrhythmogenic?
- Neural Stem cell therapy in the aging brain: pitfalls and possibilities
- Stem cell therapy for urinary incontinence
- Stem–cell therapy for renal diseases
- Stem cell therapy forcerebral palsy
- Genetically engineered Stem cell therapy for tissue regeneration
- Emerging neuroprotective strategies for Alzheimer’s disease: dietary restriction, telomerase activation, and Stem cell therapy
- Hematopoietic Stem cell therapy for type 1 diabetes: induction of tolerance and islet cell neogenesis
- In utero Stem cell therapy.
- Stem cell therapy for Parkinson’s disease: where do we stand?
- Stem cell therapy for the infarcted heart (“cellular cardiomyoplasty”)
- Monitoring Stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agents
- Stem cell therapy for muscular dystrophy
- Stem cell therapy in ischemic heart disease
- Adult Stem cell therapy for heart failure
- Stem–cell therapy for myocardial diseases
- Stem cell therapy for the heart
- Stem cell therapy of cardiac disease: an update
- Applications of magnetic resonance imaging for cardiac Stem cell therapy
- The origin and development of the immune syStem with a view to Stem cell therapy
- Stem cell origin of cancer and differentiation therapy
- Novel approaches to allogeneic Stem cell therapy
- Autologous bone marrow-derived Stem cell therapy in combination with TMLR. A novel therapeutic option for endstage coronary heart disease: report on 2 cases.
- Immune ablation and Stem–cell therapy in autoimmune disease-Clinical experience
- Stem–cell therapy for amyotrophic lateral sclerosis
- Stem cell therapy for neurodegenerative diseases: the issue of transdifferentiation
- Hematopoietic Stem cell therapy of autoimmune diseases.
- Three-dimensional approach to Stem cell therapy
- Editorial Stem cell therapy in human ALS
- Stem cell therapy in utero
- Human embryonic Stem cell therapy
- Stem cell plasticity: the growing potential of cellular therapy
- Pancreatic islet and Stem cell transplantation: new strategies in cell therapy of diabetes mellitus.
- Cardiovascular disease: potential impact of Stem cell therapy
- From Stem cells to beta cells: new strategies in cell therapy of diabetes mellitus
- Additional Stem cell therapy for graft failure after allogeneic bone marrow transplantation
- Stem cell therapy for ALS: Hope and Reality A discussion paper from the Executive of the European ALS Consortium
- Allogeneic cell therapy for patients who relapse after autologous Stem cell transplantation
- Stem cell plasticity or fusion: two approaches to targeted cell therapy
- Augmentation of virus-specific immunity after hematopoietic Stem cell transplantation by adoptive T-cell therapy
- Stem cell therapy for myocardial infarction
- Stem cell therapy in acute myocardial infarction
- Stem cell therapy for neurological disease and injury.
- Correction of ADA-SCID by Stem cell gene therapy combined with nonmyeloablative conditioning
- Stem cell therapy for urinary incontinence and pelvic floor disorders: a novel approach
- Bone-marrow Stem cells as a source for cell therapy
- Stem–cell therapy: what dose should we use?
- Stem‐cell plasticity and therapy for injuries of the peripheral nervous syStem
- Public Stem cell banks: considerations of justice in Stem cell research and therapy
- Hematopoietic Stem cell compartment: acute and late effects of radiation therapy and chemotherapy
- Immune ablation and Stem–cell therapy in autoimmune disease: experimental basis for autologous Stem–cell transplantation
- Stem cells for cell therapy in Parkinson’s disease
- Dendritic-cell therapy after non-myeloablative Stem–cell transplantation for renal-cell carcinoma
- Nuclear transplantation, embryonic Stem cells and the potential for cell therapy
- Mylotarg™(gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received Stem cell transplantation
- cell therapy: Stem cell transplantation, gene therapy, and cellular immunotherapy
- Comparison of high-dose therapy and autologous Stem–cell transplantation with conventional therapy for Hodgkin’s disease induction failure: a case-control study
- Autologous Stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn’s disease: a new cell-based therapy
- Current status and perspectives of Stem cell therapy for the treatment of diabetes mellitus
- Neural Stem cells in the developing central nervous syStem: implications for cell therapy through transplantation
- Nuclear transplantation, embryonic Stem cells, and the potential for cell therapy
- Exogenously regulated Stem cell-mediated gene therapy for bone regeneration
- The potential for Stem cell therapy in cystic fibrosis.
- High-dose therapy with autologous Stem cell transplantation in patients with peripheral T cell lymphomas
- Neuroreplacement therapy and Stem cell biology under disease conditions
- Stem cell gene therapy for chronic renal failure
- In utero hematopoietic Stem cell therapy
- Embryonic Stem cell therapy in experimental stroke: host-dependent malignant transformation
- Adoptive cellular therapy for early cytomegalovirus infection after allogeneic Stem–cell transplantation with virus-specific T-cell lines
- Prostate Stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate
- Influenza infections after hematopoietic Stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy
- Music therapy for mood disturbance during hospitalization for autologous Stem cell transplantation: a randomized controlled trial
- The potential of marrow stromal cells in Stem cell therapy
- cell therapy using human embryonic Stem cells
- Impact on survival of high-dose therapy with autologous Stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population …
- High-dose therapy and autologous peripheral blood Stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential …
- High‐dose therapy with autologous haemopoietic Stem cell support for Waldenström’s macroglobulinaemia
- A new concept of Stem cell disorders and their new therapy
- … response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic Stem cell transplantation. Myeloma Subcommittee of the …
- Autologous peripheral hematopoietic Stem cell transplantation restores hematopoietic function following marrow ablative therapy
- Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous Stem cell transplantation for relapsed B cell lymphomas
- A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic Stem cell transplantation
- Paradigms of adult Stem cell therapy for type 1 diabetes in mice
- CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic Stem–cell transplantation
- … ablation and Stem–cell therapy in autoimmune disease Immunological reconstitution after high-dose immunosuppression and haematopoietic Stem–cell …
- Rituximab and ICE as second-line therapy before autologous Stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
- Heal thyself: Potential applicability of Stem cell therapy in the management of heart disease
- Stem cell therapy for autoimmune disease: overview of concepts from the Snowbird 2002 tolerance and tissue regeneration meeting
- The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and nonmyeloablative allogeneic Stem cell transplantation
- High-dose immunosuppressive therapy and autologous peripheral blood Stem cell transplantation for severe multiple sclerosis
- … impact of cytomegalovirus serostatus of donor and recipient before hematopoietic Stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy
- Innovative approaches of adoptive immune cell therapy in paediatric recipients of haematopoietic Stem cell transplantation
- Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic Stem cell transplantation: risk factors, correlation with DNA …
- Prognostic factors for survival and response after high‐dose therapy and autologous Stem cell transplantation in syStemic AL amyloidosis: a report on 21 patients
- Parainfluenza virus infections after hematopoietic Stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
- High-dose therapy and autologous peripheral blood Stem cell transplantation for patients with lymphoma
- Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy
- 486: Stem cell therapy in Treatment of Urinary Incontinence: First Clinical Results
- Mesenchymal Stem–cell therapy in a regulated environment
- therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous Stem cell transplantation
- Stem cell therapy in scleroderma
- High-dose therapy and autologous blood Stem cell transplantation in POEMS syndrome
- First-line therapy with thalidomide and dexamethasone in preparation for autologous Stem cell transplantation for multiple myeloma
- Intensive therapy with peripheral Stem cell transplantation in 16 patients with mantle cell lymphoma
- Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic Stem cell transplantation: Presented in …
- Infectious complications after allogeneic Stem cell transplantation: epidemiology and interventional therapy strategies
- Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and Stem–cell rescue: results of the Chicago Pilot II Study
- Viral interleukin-10–engineered autologous hematopoietic Stem cell therapy: a novel gene therapy approach to prevent graft rejection
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of multiple myeloma: an evidence-based review
- Thoracic transplantation and Stem cell therapy
- High-dose therapy with Stem cell transplantation for mantle cell lymphoma: results and prognostic factors, a single center experience
- P75. Feasibility of Stem cell therapy for intervertebral disc degeneration
- Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic Stem cell transplantation: a phase …
- Imatinib mesylate therapy for relapse after allogeneic Stem cell transplantation for chronic myelogenous leukemia
- High-dose therapy and autologous Stem cell transplantation for multiple myeloma poorly responsive to initial therapy
- Prognostic factors for survival after high-dose therapy and autologous Stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients …
- Should immunoglobulin therapy be used in allogeneic Stem–cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial
- Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood Stem cell support
- Relationship between spermatogonial Stem cell survival and testis function after cytotoxic therapy.
- High-dose melphalan, etoposide, total-body irradiation, and autologous Stem–cell reconstitution as consolidation therapy for high-risk Ewing’s sarcoma does not …
- High-dose therapy and autologous Stem–cell transplantation for adult patients with Hodgkin’s disease who do not enter remission after induction chemotherapy: results …
- The role of high-dose therapy and autologous hematopoietic Stem cell transplantation for mantle cell lymphoma
- Stem cell strategies for neuroreplacement therapy in Alzheimer’s disease
- Immune reconstitution to cytomegalovirus after allogeneic hematopoietic Stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
- High-dose intravenous melphalan and autologous Stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of …
- Blood Stem cell transplantation as therapy for primary syStemic amyloidosis (AL)
- … dose therapy and autologous Stem–cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients …
- Endocrine complications of high‐dose therapy with Stem cell transplantation
- A human umbilical cord Stem cell rescue therapy in a murine model of toxic liver injury
- High-dose therapy and autologous haematopoietic Stem–cell transplantation for HIV-1-associated lymphoma
- Hematopoietic Stem cell transplantation: a new therapy for autoimmune disease
- Implications of long-term survival in acute Stem cell leukemia of childhood treated with composite cyclic therapy
- … and autologous peripheral-blood Stem–cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy
- Pluripotent Stem cells–model of embryonic development, tool for gene targeting, and basis of cell therapy
- Sequential chemotherapy regimens followed by high-dose therapy with Stem cell transplantation in mantle cell lymphoma: an update of a prospective study
- Adult Burkitt’s and Burkitt-like non-Hodgkin’s lymphoma–outcome for patients treated with high-dose therapy and autologous Stem–cell transplantation in first remission …
- Hematopoietic Stem cell gene therapy: selecting only the best
- … reconstitution after autologous hematopoietic Stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications
- … followed by high-dose therapy with Stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell …
- High-dose therapy and autologous Stem–cell support for chemosensitive transformed low-grade follicular non-Hodgkin’s lymphoma: a case-matched study from the …
- Hormonal replacement therapy after Stem cell transplantation
- High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic Stem cell transplantation for relapsed follicular non-Hodgkin …
- Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and Stem cell rescue
- Myeloablative therapy with blood Stem cell transplantation is effective in mantle cell lymphoma.
- Temporary corneal Stem cell dysfunction after radiation therapy.
- Early autologous Stem–cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin’s lymphoma: an Italian …
- Therapeutic Effects of Massage therapy and Healing Touch on Caregivers of Patients Undergoing Autologous Hematopoietic Stem cell Transplant.
- Progress toward vector design for hematopoietic Stem cell gene therapy
- Embryonic and adult Stem cells as a source for cell therapy in Parkinson’s disease
- High-dose therapy followed by autologous hematopoietic Stem–cell infusion for patients with multiple myeloma.
- … relapsed or refractory Hodgkin’s disease treated with high-dose chemotherapy and Stem cell rescue at the time of maximal response to conventional salvage therapy …
- cell-replacement therapy with Stem cells in neurodegenerative diseases
- Retroviral Stem cell gene therapy
- Mesenchymal Stem cells: cell biology and potential use in therapy
- High-dose therapy followed by autologous peripheral-blood Stem–cell transplantation for patients with Hodgkin’s disease and non-Hodgkin’s lymphoma using …
- Human pancreatic Stem cell and diabetes cell therapy
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin’s lymphoma: an evidence …
- Current antiviral strategies for controlling cytomegalovirus in hematopoietic Stem cell transplant recipients: prevention and therapy
- Risk to the coronary arteries of intracoronary Stem cell infusion and G-CSF cytokine therapy.
- High-dose therapy and autologous Stem cell rescue for patients with Hodgkin’s disease in first relapse after chemotherapy: results from the EBMT
- Therapeutic cloning and Stem cell therapy
- Stem cells in cardiovascular disease: from cell biology to clinical therapy
- … emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with Stem cell …
- … photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic Stem cell …
- Haematopoietic Stem cell transplantation and gene therapy in the fetus: ready for clinical use?
- High-dose therapy plus autologous hematopoietic Stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV …
- … -emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic Stem cell transplantation: a single …
- Stem cell transplantation therapy: controversy over ethical issues and clinical relevance.
- Adult Stem cell technology-prospects for cell based therapy in regenerative medicine
- High-dose chemotherapy followed by autologous Stem cell transplantation as first-line therapy in aggressive non-Hodgkin’s lymphoma: a meta-analysis
- Second malignancy following high-dose therapy and autologous Stem cell transplantation: incidence and risk factor analysis
- Epstein-Barr virus (EBV) reactivation in allogeneic Stem–cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy
- Myeloablative radiochemotherapy followed by autologous peripheral blood Stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of …
- High-dose therapy with autologous Stem–cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the …
- High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow Stem cell transplant recipients
- Hematopoietic Stem cell gene therapy: progress toward therapeutic targets
- Stem cell biology and gene therapy
- High-dose therapy with autologous Stem cell rescue for pediatric sarcomas
- … lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic Stem cell transplantation for severe …
- Parainfluenza virus type 3 infections in hematopoetic Stem cell transplant recipients: response to ribavirin therapy
- 10 Current status of Stem cell therapy and prospects for gene therapy for the disorders of globin synthesis
- Hematopoietic Stem cell gene therapy
- Stem cell Gene therapy for the β‐Chain Hemoglobinopathies: Problems and Progressa
- Hematopoietic Stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapy [see comments]
- High-dose consolidation therapy with autologous Stem cell rescue in stage IV breast cancer.
- High-dose therapy/autologous Stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission
- Stem cell therapy and research
- High-dose immunoablative therapy with hematopoietic Stem cell support in the treatment of severe autoimmune disease: current status and future direction
- High-dose chemotherapy (HDC) and autologous hematopoietic Stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma
- High-dose consolidation therapy with autologous Stem–cell rescue in stage IV breast cancer: follow-up report.
- Toward Epidermal Stem cell-Mediated ex Vivo Gene therapy of Junctional Epidermolysis Bullosa
- Mesenchymal Stem cells from the bone marrow stroma: basic biology and potential for cell therapy
- High-dose multimodality therapy with autologous Stem–cell support for stage IIIB breast carcinoma.
- … load in plasma allows for fast and accurate prediction of response to therapy of Epstein–Barr virus‐associated lymphoproliferative disease after allogeneic Stem cell …
- Single agent dexamethasone for pre-Stem cell transplant induction therapy for multiple myeloma
- Efficacy of high-dose therapy and autologous hematopoietic Stem cell transplantation for non-Hodgkin’s lymphoma in adults 60 years of age and older
- Arsenic Trioxide (Trisenox®) therapy for Acute Promyelocytic Leukemia in the Setting of Hematopoietic Stem cell Transplantation
- Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic Stem cell transplantation: a pilot study
- Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and Stem cell …
- … high-dose cyclophosphamide without Stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease
- High dose therapy and autologous Stem cell transplantation for human immunodeficiency virus‐associated non‐Hodgkin lymphoma in the era of highly active …
- Autologous peripheral blood Stem cell transplantation after high dose therapy in patients with advanced lymphomas.
- Hematopoietic Stem cell gene therapy: a current overview.
- Muscle-derived Stem cells: characterization and potential for cell-mediated therapy
- Immunotherapy with rituximab following high-dose therapy and autologous Stem–cell transplantation for mantle cell lymphoma
- Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA‐identical hematopoietic Stem cell …
- … with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood Stem cell transplantation in elderly …
- therapy with imatinib mesylate (Glivec) preceding allogeneic Stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute …
- High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood Stem cell support in unresectable osteosarcoma
- Benefit of aggressive multimodality therapy with autologous Stem cell support for intra-abdominal desmoplastic small round cell tumor
- Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic Stem cell transplantation
- Stem–cell therapy for myocardial diseases
- Cytokine production during myeloablative and reduced intensity therapy before allogeneic Stem cell transplantation
- High risk of therapy-related leukemia after BEAM chemotherapy and autologous Stem cell transplantation for previously treated lymphomas is mainly related to primary …
- Diamond-Blackfan anemia in Japan: clinical outcomes of prednisolone therapy and hematopoietic Stem cell transplantation
- Results of high-dose therapy and autologous bone marrow/Stem cell transplantation during remission in poor-risk intermediate-and high-grade lymphoma …
- Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic Stem cell …
- High-dose therapy in lymphomas: a review of the current status of allogeneic and autologous Stem cell transplantation in Hodgkin’s disease and non-Hodgkin’s …
- Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic Stem cell transplantation
- Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous Stem cell transplant
- Stem cell gene therapy, position effects and chromatin insulators
- Role for high-dose therapy with autologous hematopoietic Stem cell support in Waldenstrom’s macroglobulinemia
- The hematopoietic Stem cell therapy for exploration of deep space
- … mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic Stem cell transplantation: a prospective …
- … determinant (CD) 34+ cell dose on the cost and consequences of peripheral blood Stem cell transplantation for non-Hodgkin’s lymphoma patients in front-line therapy
- Sequential high-dose therapy and autologous Stem cell transplantation for treatment of mantle cell lymphoma
- High-dose therapy and autologous Stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive …
- Adult mesenchymal Stem cells: characterization, differentiation, and application in cell and gene therapy
- Evaluation of the risk of therapy-related MDS/AML after autologous Stem cell transplantation
- Intensification of therapy using hematopoietic Stem‐cell support for high‐risk neuroblastoma
- Strategies for hematopoietic Stem cell gene therapy: insights from computer simulation studies
- A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic Stem cell transplantation
- Stem cell defects after cytoreductive therapy in man.
- … with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or Stem cell rescue therapy
- Myeloma cell contamination of peripheral blood Stem cell grafts in patients with multiple myeloma treated by high-dose therapy.
- Embryonic Stem cell grafting: the therapy of the future?
- Transabdominal first trimester embryofetoscopy as a potential approach to early in utero Stem cell transplantation and gene therapy
- Single center experience of a new intensive induction therapy for Ewing’s family of tumors: feasibility, toxicity, and Stem cell mobilization properties
- Pre-emptive therapy with rituximab for prevention of Epstein–Barr virus-associated lymphoproliferative disease after hematopoietic Stem cell transplantation
- High-dose therapy and autologous Stem cell transplantation in relapsing cutaneous lymphoma
- Peripheral blood Stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study
- … (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral Stem cell …
- Where next with Stem–cell-supported high-dose therapy for breast cancer?
- Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high‐dose therapy and peripheral blood Stem cell transplantation
- Lymphoid development and function in X-linked severe combined immunodeficiency mice after Stem cell gene therapy
- Consolidation therapy with autologous Stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three …
- Analysis of feasibility of myeloablative therapy and autologous peripheral Stem cell (PBSC) transplantation in the elderly: an interim report
- Embryonic Stem cells in vitro-prospects for cell and developmental biology, embryotoxicology and cell therapy
- Peripheral blood Stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood …
- An update on the role of high-dose therapy with autologous or allogeneic Stem cell transplantation in mantle cell lymphoma
- Hematopoietic Stem cell transplantation for cancer therapy
- Hematopoietic Stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid …
- Hematopoietic Stem cell gene therapy of murine protoporphyria by methylguanine-DNA-methyltransferase-mediated in vivo drug selection
- Superiority of double over single autologous Stem cell transplantation as first-line therapy for multiple myeloma.
- … (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic Stem cell …
- Twelve years experience with high-dose therapy and autologous Stem cell transplantation for high-risk Hodgkin’s disease patients in first remission after MOPP/ABVD …
- Salvage therapy with thalidomide in multiple myeloma patients relapsing after autologous peripheral blood Stem cell transplantation
- The role of autologous Stem cell reconstitution in intensive therapy for resistant neoplasms
- Nonmyeloablative therapy and allogeneic hematopoietic Stem cell transplantation
- Decitabine with allogeneic peripheral blood Stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study
- Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous Stem cell transplantation for salvage therapy in B-NHL
- The place of high-dose therapy with haemopoietic Stem cell transplantation in relapsed and refractory Hodgkin’s disease
- siRNAs, ribozymes and RNA decoys in modeling Stem cell-based gene therapy for HIV/AIDS.
- Clinically‐based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic Stem cell …
- Embryonic Stem cell research and therapy: the need for a common European legal framework
- … high-dose chemotherapy with granulocyte colony-stimulating factor and autologous Stem–cell transplantation support as first-line therapy in high-risk diffuse large-cell …
- Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood Stem cell transplantation …
- Marginal benefit/disadvantage of granulocyte colony-stimulating factor therapy after autologous blood Stem cell transplantation in children: results of a prospective …
- Nutritional support of the patient receiving high-dose therapy with hematopoietic Stem cell support
- … Stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with α/β hepatosplenic T-cell …
- … boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high‐risk allogeneic hematopoietic Stem cell transplantation. Scedosporiasis and …
- Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic Stem cell transplantation
- … long‐term hematologic recovery despite a marked quantitative defect in the Stem cell compartment of patients with aplastic anemia after immunosuppressive therapy
- Lack of emergence of cytomegalovirus UL97 mutations conferring ganciclovir (GCV) resistance following preemptive GCV therapy in allogeneic Stem cell transplant …
- Potential use of human Stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias
- Effectiveness of high‐dose MCNU therapy and hematopoietic Stem cell autografts treatment of childhood acute leukemia/lymphoma with high‐risk features
- Interleukin-2 therapy after bone marrow or Stem cell transplantation for hematologic malignancies.
- Cytokines: value-added products in hematopoietic Stem cell gene therapy
- … of Multiple Myeloma and Breast Cancer cells by TH9402‐mediated Photodynamic therapy: Implication for Clinical Ex Vivo Purging of Autologous Stem cell …
- Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic Stem cell transplantation
- Autologous Stem cell transplantation for AL amyloidosis: a standard therapy?
- A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood Stem cell transplantation in adults
- Hematopoietic Stem cell gene therapy: towards clinically significant gene transfer efficiency.
- Minimal residual disease–based role of imatinib as a first-line interim therapy prior to allogeneic Stem cell transplantation in Philadelphia chromosome–positive acute …
- Search for a cure for idiopathic pulmonary fibrosis: is Stem cell therapy a light at the end of a long tunnel?
- Stem cell Transplantationfor Leukemias Following Myelodysplastic Syndromesor Secondaryto Cytotoxic therapy
- Hematopoietic Stem cell–based gene therapy for acquired immunodeficiency syndrome: efficient transduction and expression of RevM10 in myeloid cells in vivo and …
- Stem cell therapy (Aastrom Biosciences Inc).
- High-dose chemotherapy with Stem cell rescue as initial therapy for anaplastic oligodendroglioma
- Directed mobilization of endogenous neural progenitor cells: the intersection of Stem cell biology and gene therapy.
- High‐dose intravenous methotrexate followed by autologous Stem cell transplantation as a potentially effective therapy for neurolymphomatosis
- 6The role of haematopoietic Stem cell-supported myeloablative therapy for the management of multiple myeloma
- Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood Stem cell transplantation
- Early intensive therapy with autologous Stem cell transplantation in advanced Hodgkin’s disease: retrospective analysis of 158 cases from the French registry
- Ultrasound-guided Stem cell sampling from the early ovine fetus for prenatal ex vivo gene therapy
- Hematopoietic Stem cell therapy for multiple sclerosis
- The remission status before and the PCR status after high-dose therapy with peripheral blood Stem cell support are prognostic factors for relapse-free survival in …
- Hematopoietic Stem cell gene replacement therapy
- … by non-myeloablative allogeneic Stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation
- Peripheral blood Stem cell transplantation after high-dose therapy in patients with malignant lymphoma: a retrospective comparison with autologous bone marrow …
- Stem cell therapy for intervertebral disc diseases in vitro and in vivo feasibility study
- The leukemogenic risk of integrating retroviral vectors in hematopoietic Stem cell gene therapy applications.
- Functional organization of the hematopoietic Stem cell compartment: implications for cancer and its therapy.
- The importance of CD34+/CD33− cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood Stem cell rescue
- … suppression and autologous hematopoietic Stem cell transplantation in severe Crohn’s disease refractory to immunosuppressive and immunomodulator therapy
- Micro-injection-mediated hematopoietic Stem cell gene therapy.
- Early allogeneic blood Stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid …
- Fetal immune suppression as adjunctive therapy for in utero hematopoietic Stem cell transplantation in nonhuman primates
- Development of a modified selective amplifier gene for hematopoietic Stem cell gene therapy
- Embryonic Stem cells: a promising tool for cell replacement therapy
- Clinical benefits of granulocyte colony-stimulating factor therapy after hematopoietic Stem cell transplant in children: results of a prospective randomized trial
- Value of autologous Stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS …
- Late infectious complications after high-dose therapy and autologous blood Stem cell transplantation
- Stem cell gene therapy: a breakthrough combination magnified by therapeutic Stem cell homing
- Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous Stem cell transplantation
- Peripheral blood Stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin’s lymphoma
- Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after Stem cell transplantation: effective monitoring of CMV infection by quantitative …
- Highly active antiretroviral therapy corrects hematopoiesis in HIV-1 infected patients: interest for peripheral blood Stem cell-based gene therapy
- Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood Stem cell transplantation for lymphoma
- Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic Stem cell transplantation
- Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood Stem cell transplant when started soon after engraftment
- Bone marrow Stem cell gene therapy of arylsulfatase A-deficient mice, using an arylsulfatase A mutant that is hypersecreted from retrovirally transduced donor-type …
- Front-line high-dose therapy with autologous Stem cell transplantation for high risk Hodgkin’s disease: comparison with combined-modality therapy
- Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical Stem cell transplantation
- Plasticity of skeletal muscle differentiation generating Stem cell-like phenotype: Possible application to cell therapy for muscular diseases
- The Hematopoietic Stem cell therapy for Exploration of Space
- Selective expansion of transduced cells for hematopoietic Stem cell gene therapy
- Progress towards hematopoietic Stem cell gene therapy.
- Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic Stem cell …
- When to harvest peripheral-blood Stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in …
- Globin gene transfer for the treatment of severe hemoglobinopathies: a paradigm for Stem cell‐based gene therapy
- Autologous blood Stem cell transplantation as therapy for autoimmune diseases
- High‐dose therapy/Stem cell support: Comparison of mice and humans
- High‐dose therapy with Stem cell rescue for pediatric solid tumors: Rationale and results
- Transfusion therapy in the patient undergoing hematopoietic Stem cell transplantation
- Long-term follow-up on a patient with incomplete POEMS syndrome undergoing high-dose therapy and autologous blood Stem cell transplantation
- Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic Stem cell transplantation
- Multivalent anti-CCR5 ribozymes for Stem cell-based HIV type 1 gene therapy
- Renal dysfunction during high-dose cisplatin therapy and autologous hematopoietic Stem cell transplantation: effect of aminoglycoside therapy
- High-dose therapy with Stem–cell transplantation in the malignant lymphomas.
- … Stem and progenitor cells from acid sphingomyelinase-deficient mice: implications for Niemann-Pick disease gene therapy and the development of improved Stem cell …
- Treatment of mantle-cell lymphomas with the VAD+/− chiorambucil regimen with or without subsequent high-dose therapy and peripheral blood Stem–cell …
- … Stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: does platelet contamination of peripheral blood mobilized Stem cell grafts …
- High-dose therapy and autologous peripheral Stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone …
- … of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood Stem cell …
- Technology evaluation: Stem–cell therapy, Aastrom Biosciences Inc.
- … colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic Stem cell transplantation for lymphoid …
- The present role of bone marrow and Stem cell transplantation in the therapy of children with acute leukemia.
- Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H. 82 with autologous Stem cell support and cyclosporin A
- Stem cell transplantation and gene therapy for HIV-related lymphomas
- High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood Stem cell support in the adjuvant therapy of high-risk breast cancer: a practical …
- High-dose therapy and Stem cell transplantation in follicular lymphoma
- Allogeneic hematopoietic Stem–cell transplantation: the next generation of therapy for metastatic renal cell cancer
- … for cytomegalovirus disease in patients receiving polymerase chain reaction–based preemptive antiviral therapy after allogeneic Stem cell transplantation depends on …
- Autologous peripheral blood Stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in outcome
- Retroviral vector design studies toward hematopoietic Stem cell gene therapy for mucopolysaccharidosis type I
- Adult Stem cells and their importance in cell therapy.
- A novel sub-population of bone marrow–derived myocardial Stem cells: potential autologous cell therapy in myocardial infarction
- Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and Stem cell transplant
- Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic Stem cell transplantation
- High dose therapy and autologous Stem cell transplantation in follicular non-Hodgkin’s lymphoma
- Multidisciplinary therapy including high-dose chemotherapy followed by peripheral blood Stem cell transplantation for invasive thymoma
- High dose therapy and autologous hematopoietic Stem cell transplantation in poor risk solid tumors of childhood.
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin’s lymphoma
- Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and Stem cell rescue. A feasibility study
- … carboplatin and interleukin-2 (IL-2) activated autologous Stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma–a …
- Filgrastim‐induced Stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging
- The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and Stem cell gene therapy for AIDS
- Intensive therapy and autologous Stem cell transplantation for Hodgkin’s disease in first relapse after combination chemotherapy
- Stem cell-based gene therapy
- Stem–cell depletion and grid therapy
- Adult Stem cell therapy: Imagining Futures in cell Biology
- Long-term survival in primary plasma cell leukemia after therapy with VAD, autologous blood Stem cell transplantation and interferon-alpha
- … of autologous Stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy
- Consolidation therapy with autologous blood Stem cell transplantation in a patient with primary plasma cell leukaemia
- … therapy for remission in myeloma with Intron A following high-dose melphalan and either an autologous bone marrow transplantation or peripheral Stem cell rescue.
- Intermediate‐dose melphalan (IDM) combined with G‐CSF (filgrastim) is an effective and safe induction therapy for autologous Stem cell transplantation in multiple …
- … therapy for Hodgkin’s disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous Stem …
- Stem cell therapy: medical advance or moral challenge?
- Experience with liposomal Amphotericin‐B in 60 patients undergoing high‐dose therapy and bone marrow or peripheral blood Stem cell transplantation
- In utero hematopoietic Stem cell transplantation: a caprine model for prenatal therapy in inherited metabolic diseases
- … non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral Stem–cell transplantation: changing the natural history with monoclonal antibody therapy
- Future cure of hearing disorders? Gene therapy and Stem cell implantation are possible new therapeutic alternatives
- Thiotepa and cyclophosphamide with Stem cell rescue for consolidation therapy for children with high-risk neuroblastoma: a phase I/II study of the Pediatric Blood and …
- High‐dose therapy and autologous blood Stem cell transplantation in multiple myeloma: Preliminary results of a randomized trial involving 167 patients
- Interferon-α therapy following autologous peripheral blood Stem cell transplantation for adult T cell leukemia/lymphoma
- Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood Stem–cell support as front-line therapy
- Hematopoietic Stem cell gene therapy for Niemann–Pick disease and other lysosomal storage diseases
- Neural Stem cells are uniquely suited for cell replacement and gene therapy in the CNS
- Stem cell component therapy: supplementation of unmanipulated marrow with CD34 enriched peripheral blood Stem cells
- Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood Stem cell support is an effective adjuvant treatment for high-risk primary breast …
- Donor chimerism and Stem cell function in a murine congenic transplantation model after low-dose radiation conditioning: effects of a retroviral-mediated gene transfer …
- Stem cell therapy for severe autoimmune diseases
- … use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic Stem cell transplantation as consolidation therapy for high-risk …
- Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic Stem cell transplantation
- … survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with Stem cell transplantation: a retrospective …
- therapy-related myelodysplastic syndrome after autologous Stem cell transplantation for breast cancer
- … significance of the detection of tumour cells in peripheral blood Stem cell collections in stage II and III breast cancer patients treated with high-dose therapy
- Male germ line Stem cells: from cell biology to cell therapy?
- High dose therapy with autologous Stem cell transplantation for solitary bone plasmacytoma complicated by local relapse or isolated distant recurrence
- Cytomegalovirus following Stem cell transplantation: from pharmacologic to immunologic therapy
- High-dose therapy followed by Stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin’s lymphoma
- High-dose therapy and autologous Stem cell rescue for poor risk and refractory lymphoma: a single centre experience of 123 patients.
- The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic Stem cell transplantation for patients with chronic myelogenous …
- Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood Stem cell transplantation
- … of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood Stem cell …
- High-dose therapy with Stem cell support in solid tumors
- cell sources and support programs for Stem cell research and cell-based therapy in the USA
- Immune ablation and Stem–cell therapy in autoimmune disease Introduction
- Current status in intrauterine fetal Stem cell therapy
- … exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: implications for the ex vivo purging of autologous haematopoietic Stem cell …
- Allogeneic Stem cell–Derived “Repair Unit” therapy and the Barriers to Clinical Deployment
- Autologous Stem cell therapy for syStemic vasculitis
- Diabetes therapy boosts Stem–cell campaign
- Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood Stem cell transplantation when started soon after …
- A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood Stem cell transplantation as initial therapy for patients with high-risk non …
- Stem–cell gene therapy moves toward approval: an NIH advisory committee gives the nod to a new strategy for genetic therapy based on a rare type of blood cell
- Dog leukocyte antigen-haploidentical Stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model
- The case for and against high-dose therapy with Stem cell rescue for early poor prognosis Hodgkin’s disease in first remission
- Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-positive leukemia patient receiving myeloablative chemotherapy and autologous Stem cell …
- Neural Stem cells–a versatile tool for cell replacement and gene therapy in the central nervous syStem: Section Editor: Roderick R McInnes e‐mail: mcinnes@ sickkids …
- Cidofovir for cytomegalovirus-preemptive therapy in Stem cell transplant recipients
- Autologous Stem cell Transplantation as First Line therapy in Peripheral T cell Lymphomas. Update of a Prospective Multicenter Study.
- 1432: The Effect of Neural Embryonic Stem cell therapy in a Rat Model of Cavernous Nerve Injury
- In vitro T lymphopoiesis: a model syStem for Stem cell gene therapy for AIDS
- Immune therapy for EBV infections after hemopoietic Stem–cell transplant
- Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous Stem cell support
- High‐dose therapy with peripheral blood Stem cell transplantation results in a significant reduction of the haemopoietic progenitor cell compartment
- … ‐dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood Stem cell …
- Autologous Stem cell transplantation as adjuvant treatment vs no further therapy for poor-risk Hodgkin’s disease in first complete remission after MOPP/ABVD
- Autologous blood Stem cell transplantation for acute myeloblastic leukemia in first complete remission. Intensification therapy before transplantation does not prolong …
- High-dose therapy with peripheral blood Stem cell transplantation for patients with relapsed or refractory Hodgkin’s disease: long-term outcome and prognostic factors
- … antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through Stem cell factor/granulocyte-macrophage …
- A human pluripotent Stem cell in the blood of adults: towards a new cellular therapy for tissue repair
- PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous Stem cell transplantation is a prognostic factor for event-free survival …
- … /nonlymphoid antigen+ acute leukemias: immunologic and karyotypic monitoring during therapy and at relapse suggests the transformation of a bipotential Stem cell.
- High dose therapy followed by autologous peripheral blood Stem cell transplantation as a first line treatment for multiple myeloma: a Korean Multicenter Study
- Neural Stem cell therapy
- Circulating hematopoietic Stem cell populations in human fetuses: implications for fetal gene therapy and alterations with in utero red cell transfusion
- … -associated pulmonary alveolar proteinosis as two hereditary diseases of childhood which are potentially curable by Stem cell gene therapy but require different …
- … of interferon tolerance after autologous bone marrow or peripheral blood Stem cell transplants for myeloma patients who have responded to induction therapy
- … suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous Stem cell …
- Tandem high-dose therapy followed by autologous Stem–cell transplantation for refractory or relapsed high grade non-Hodgkin’s lymphoma with poor prognosis …
- Efficacy and toxicity of sequential high-dose therapy with peripheral blood Stem cell support in patients with high-risk breast cancer.
- Hematopoietic Stem cell gene therapy: progress and prospects
- Purging of contaminating breast cancer cells from hematopoietic Stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation
- … cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood Stem cell harvests and bone marrow after therapy
- Embryonic Stem cell therapy: Progress and Perspectives
- High-dose combined alkylating agent therapy with autologous Stem cell support and chest radiotherapy for limited small-cell lung cancer
- Allogenic Stem cell transplantation as salvage therapy for patients relapsing after autologous transplantation: experience from a single institution
- Development of gene therapy for hematopoietic Stem cell using viral vectors
- Stem cell therapy: prospects and
- Toxic megacolon: a life-threatening complication of high-dose therapy and autologous Stem cell transplantation among patients with AL amyloidosis
- Blood Stem cell transplantation and gene therapy of cancer
- MESENCHYMAL Stem cell therapy IN GROWTH PLATE CARTILAGE INJURY
- Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic Stem cell transplantation
- Repetitive low-dose radiation therapy for acute Stem–cell leukemia
- Modeling human hematopoietic Stem cell gene therapy in nonhuman primates.
- The role of high-dose therapy with hematopoietic Stem cell rescue in low-grade non-Hodgkin’s lymphoma
- Intensified daunorubicin in induction therapy and autologous peripheral blood Stem cell transplantation in postremission therapy (Double-7 protocol) for adult acute …
- Mobilization of peripheral blood Stem cells (PBSCs) after etoposide, adriamycin and cisplatin therapy, and a multimodal cell therapy approach with PBSCs in …
- High-dose chemotherapy and autologous Stem cell support followed by post-transplant doxorubicin and taxol as initial therapy for metastatic breast cancer …
- Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous Stem cell support in patients …
- Survival after high-dose therapy with autologous Stem cell support
- Stem–cell researchers offer possible therapy for diabetes
- Hematopoietic Stem cell gene therapy for inherited bone marrow disorders: past accomplishments and continued challenges
- ESHAP+/− Rituximab as Salvage therapy for Relapsed Lymphoma Prior to Stem cell Transplant: Single Institution Experience.
- Stem cell (CFU-S) inhibitory peptides: Biological properties and application of pEEDCK as hemoprotector in cytostatic tumor therapy
- High-dose therapy and autologous Stem cell transplantation for high-risk Hodgkin’s lymphoma: a single center experience
- Outcome after Second Autologous Stem cell Transplantation as Salvage therapy in Patients with Relapsed Multiple Myeloma.
- Complications after high dose therapy and autologous Stem cell transplantation. Retrospective study of an unselected patient sample
- Feasibility of using autologous transplantation to evaluate hematopoietic Stem cell-based gene therapy strategies in transgenic mouse models of human …
- … in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood Stem cell …
- Pulmonary infiltrates after cytokine therapy for Stem cell transplantation: massive deposition of eosinophil major basic protein detected by immunohistochemistry
- Hematopoietic Stem cell therapy.
- THE ETHICS OF Stem cell therapy
- High-dose therapy with autologous bone marrow Stem cell support in primary and metastatic human breast cancer
- Hematopoietic Stem cell autografts in support of myeloablative therapy for multiple myeloma
- The third conference on hematopoietic Stem cell gene therapy: biology and technology
- Survival Following Etanercept therapy for the Treatment of Idiopathic Pneumonia Syndrome Post Allogeneic Stem cell Transplantation.
- Excellent disease eradication by myeloablative therapy and Stem–cell transplantation in patients with acute myelogenous leukemia
- Phase I/II trials of autologous peripheral blood Stem cell transplantation in autoimmune diseases resistant to conventional therapy: preliminary results from the …
- NOVEL CLINICAL CONCEPTS ON Stem cell therapy: 336
- Monoclonal antibody therapy with autologous peripheral blood Stem cell transplantation for non-Hodgkin’s lymphoma
- Lamivudine therapy for acute hepatitis B infection following peripheral blood Stem cell transplantation
- The addition of topotecan to carboplatin and paclitaxel as first-line therapy for advanced ovarian cancer; is it possible only with peripheral blood Stem cell support?
- … high dose therapy and autologous Stem cell transplantation versus conventional therapy for patients with advanced Hodgkin’s disease responding to first line therapy
- Results of a Multi-Center Randomized Phase II Trial of Thalidomide and Prednisone Maintenance therapy for Multiple Myeloma Following Autologous Stem cell …
- Mesenchymal and nonhematopoietic Stem–cell therapy
- Neurosurgical Stem cell therapy
- A Stem cell therapy for stroke
- Embryonic Stem cell lines for regenerative therapy and pharmaceutical research
- Effect of prior therapy and bone marrow metastases on progenitor cell content of blood Stem cell harvests in breast cancer patients
- … by campath mab t cell depleted Stem cell allograftP14. Stem cell treatment in inflammatory myopathies: proposals for patient selectionP15. Autologous Stem cell …
- ALLOGENEIC Stem cell therapy FOR JOINT DISEASE
- … Foundations. Note: A. Hultquist is presently at the Department of Stem cell Biology, Strategic Center for Stem cell Research and Gene therapy, Lund University, S …
- High-dose chemotherapy and autologous Stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer.
- Early infectious complications after high-dose therapy and autologous blood Stem cell transplantation
- High dose therapy and autologous hemopoietic Stem cell transplantation in rheumatoid arthritis–the feasibility of phase III trials.
- Adjuvant high-dose therapy with peripheral blood Stem cell support for patients with high-risk breast cancer
- High-dose therapy and autologous Stem cell transplantation in relapsed and refractory Hodgkin’s disease: outcome based on a prognostic model
- Rituximab given after high dose therapy and autologous Stem cell transplantation induces durable clearance of minimal residual disease in about half of the …
- Becoming Immortal: Combining Cloning and Stem‐cell therapy
- A Setback for Stem cell therapy?
- Safety and efficacy of Stem cell mobilization under imatinib therapy
- Stem cell therapy for Ischemic Heart Disease: A Status Report
- Repetitive cycles of cytoreductive therapy followed by Stem cell autografting for nonlymphoblastic transformation of chronic granulocytic leukaemia
- Intrauterine Stem cell therapy
- Embryonic and Adult Stem cell therapy.(Abstracts)
- Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous Stem cell transplantation to improve outcome in …
- Stem cell therapy in the Mouse Heart
- Good manufacturing practice production of human Stem cells for somatic cell and gene therapy
- Use of capecitabine as first-line therapy in patients with metastatic breast cancer relapsing after high-dose chemotherapy and autologous Stem cell support
- Stem cell therapy for Alzheimer’s Disease
- Mobilized versus non-mobilized peripheral Stem cell transplantation after high dose therapy for low grade nonhodgkin lymphoma: Effect on failure-free survival
- Cytapheresis—The Next 25 Years: Stem cell therapy
- COMBINATION GENE AND Stem cell therapy FOR MS: PROMISE OR FANTASY?
- Stem cell therapy for Ischemic Heart Disease: A Status Report
- Costs of high-dose salvage therapy and blood Stem cell transplantation for resistant-relapsed malignant lymphomas in a southern Italian hospital
- Stem cell therapy for ACS: The Possibility of Myocardial Regeneration
- Stem cell biology and gene therapy
- One strategy for cell and gene therapy: harnessing the power of adult Stem cells to repair tissues
- Stem cell therapy in diabetes mellitus: Dream or reality
- Intensified myeloablative therapy and autologous Stem–cell transplantation for patients with AML: single center experience
- Adoptive cellular therapy for Cytomegalovirus Following Allogeneic Stem cell Transplantation: Toxicity and Efficacy.
- Future treatment options for Parkinsonism: Stem cell therapy
- How far away is the Stem cell therapy from the glaucoma management. A ten-year review
- High-Dose therapy and Stem cell Transplantation
- Potential Use of Stem cell therapy for Traumatic Brain Injury
- Reduced Intensity Conditioning therapy Using Campath-1H Is Successful for Stem cell Transplantation in Non-Malignant Disorders.
- Adult Mesenchymal Stem cell therapy in Joint Injury and Disease
- Autologous Stem cell Transplantation and cell therapy for Acute Leukemia
- Stem cell transplantation after salvage therapy with high-dose cytarabine and amsacrine in adults with high-risk leukaemia
- Single cell DNA analysis: possibilities, methods, implications in relation to Stem cell therapy
- Stem cell transplantation and gene therapy in utero
- Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with Stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial
- Twelve cases of malignant hematopathy treated by combined therapy of hematopoietic Stem cell transplantation and Chinese herbal medicine
- Ethics of Stem cell therapy and genetic engineering on human tissue
- Observation on Stem cell therapy of far advanded skin trauma of guinea pig
- Stem cell therapy for diseases in the nervous syStem-A potential for regeneration of inner ear
- Understanding endocrine development of the human beta cell: guiding Stem cell therapy for Type 1 Diabetes
- Radiation therapy after high-dose chemotherapy with peripheral blood Stem cell support for high-risk breast cancer
- Quadruple therapy with CsA, MTX, MMF and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic Stem cell transplantation
- RELAPSE AFTER AUTOLOGOUS Stem cell therapy (ASCT) IN A PATIENT WITH SYStemIC LUPUS ERYTHEMATOSUS (SLE)
- High dose therapy with Stem cell support for breast cancer: the jury is still out
- cell therapy: Stem cell transplantation, gene therapy, and cellular immunotherapy: Edited by George Mortsyn and Wiliam Sheridan (New York: Cambridge University …
- Allogeneic cell therapy (act) after relapse from autologous Stem cell transplantation (autosct)
- Ceftazidime and ciprofloxacin as empiric therapy in febrile neutropenic patients undergoing hematopoietic Stem cell transplantation
- Muscle derived Stem cell-based cell therapy in urology
- … Stem cell harvests have no impact on 5 year outcomes for breast cancer patients with 4–9 positive nodes treated with adjuvant high-dose therapy and Stem …
- Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood Stem cells with a low CD34+ cell content
- Research for corresponding dental therapy for patients undergoing bone marrow and peripheral blood Stem–cell transplantation.
- Autologous Stem cell transplantation (ASCT) as consolidation therapy for patients with low-intermediate (LI) risk diffuse large B-cell lymphoma (DLBCL) and …
- … with seven-drug induction therapy and intensive consolidation with or without autologous Stem cell transplantation followed by maintenance therapy. Experience of a …
- Disease‐or therapy‐related bone marrow damage cannot be overcome by changes in Stem cell source or dose in allogeneic transplantation
- The effects of Stem cell factor and granulocyte colony stimulating factor therapy on the activity of the neutrophil NADPH oxidase enzyme syStem.
- Idarubicin or Mitoxantrone, VP-16, and Cytarabine for Induction/Consolidation therapy Followed by Autologous Stem cell Transplantation in Elderly Patients with …
- Mending a broken heart: animal studies helped lay the groundwork for Stem cell therapy.(Hot Papers)
- Neoadjuvant therapy with high dose chemotherapy via isolated pelvic intra-abdominal perfusion with bone marrow Stem cell support for advanced endometrial cancer
- Current Trends and Prospect of cell therapy using Hematopoietic Stem cells
- Willenbacher W, et al.: Somatic Risk Factors for Intermediate and Long-Term Sequelae after Hematological Stem cell therapy Predictive for Feasibility of a …
- therapy of highly malignant non-Hodgkin lymphoma with high-dose chemotherapy and Stem cell transplantation
- Establishment of juvenile and tolerant immune syStems in patients with autoimmune diseases treated with immunoablation and autologous Stem cell therapy
- Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal Stem cells for cell and gene therapy
- Stem cell therapy for treatment of central nervous syStem pathology in α-mannosidosis guinea pigs.
- Early and late toxicity of involved-field radiation therapy in conjunction with high-dose chemotherapy and Stem cell rescue
- Sequential High‐Dose Alkylating therapy and Stem cell Support for High‐Risk Stage III Breast Cancer
- Adoptive therapy with monocyte‐derived macrophages in the setting of high‐dose chemotherapy and peripheral blood Stem cell transplantation
- Catheter Interventions in Congenital Heart Disease—Part I Guest Editor, Horst Sievert Applications of Magnetic Resonance Imaging for Cardiac Stem cell therapy.
- Sequential high-dose therapy of adult acute lymphoblastic leukemia: role of maintenance chemotherapy after peripheral blood Stem cell transplantation in first …
- Hematologic toxic reaction to radiation therapy adjuvant to autologous peripheral blood Stem cell transplantation for recurrent or refractory Hodgkin disease
- … therapy with UVADEX® for the Prevention of Acute GVHD in Patients Undergoing Standard Myeloablative Conditioning and Allogeneic Hematopoietic Stem cell …
- High-dose therapy of cancer with CD34 positive cells as Stem cell support
- Hematopoietic chimerism following immunoablative therapy for non-malignant disorders-out-patient Stem cell transplantation
- Prospective Multicenter Trial Comparing Repeated Immunosuppressive therapy (IST) with Stem cell Transplantation (SCT) from an Alternative Donor as a Second …
- Autologus Stem cell transplantation as postremission therapy for acute myeloid leukemia. Risk factors at diagnosis can predict the outcome
- Myeloablative Chemotherapy and Peripheral Blood Stem cell Transplantation vs. Consolidation therapy of Acute Myelogenous Leukemia in First Remission
- … Heart Function after the Combined Treatment of Patients Undergoing Coronary Artery Bypass Grafting through Stem cell therapy and Transmyocardial Laser …
- Treatment of non-Hodgkin’s lymphoma with high-dose therapy and hematopoietic Stem cell support.
- KINETIC MODELING OF THE MOLECULAR PROBE 18F-FHBG FOR IMPROVED PET REPORTER GENE IMAGING OF Stem cell therapy
- Feasibility of a Stem cell Gene therapy Approach with Nonmyeloablative Conditioning in Patients with HIV-1 Infection.
- High-dose therapy with peripheral blood Stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive …
- Rituximab, Fludarabin and Cyclophosphamide Followed by High Dose therapy with Autologous Stem cell Rescue Leads to High Molecular Remission Rate …
- High dosage therapy with Stem cell transplantation in neuroendocrine carcinoma
- High dose chemotherapy and Stem cell support for poor risk and recurrent nonseminomatous germ cell cancer: initial experience with sequential therapy
- Hepatocyte growth factor modified human umbilical cord mesenchymal Stem cell therapy promotes remyelination after intracerebral hemorrhage in rats
- Wednesday, September 22, 2004: Plenary Session PL1: Stem cell therapy
- High-dose melphalan with Stem cell support is now an established myeloma therapy. Treatment of myeloma from a 30-year perspective
- High dosage therapy and autologous peripheral Stem cell transplantation in breast carcinoma
- 710. Stem cell Gene therapy: Synergizing Improved Gene Repair/Modification & Targeted Integration of Transgenes to Transient In Vivo Topical Minigene …
- The effect of preemptive therapy with intravenous ganciclovir followed by oral ganciclovir against cytomegalovirus infection after allogeneic peripheral blood Stem cell …
- Current trends in Stem cell biology and cell replacement therapy
- Dose-intensive therapy with autologous Stem cell transplantation for patients with multiple myeloma
- Current trends of Stem cell-mediated gene therapy
- Stem cell Biology and Gene therapy.: Quesenberry PJ, Stein GS, eds.(£ 65.00.) Wiley, 1998. ISBN 0 47114 656 0.
- Expansion Of Muscle-Derived Stem cells: Implications of cell therapy For Muscle Regeneration
- HEMATOPOIETIC Stem cell GENE therapy
- High-dose therapy and autologous Stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive ALK …
- Transplantation of hepatic Stem cells and potential applications for cell therapy
- 160 Importance of radiation therapy for high-risk breast cancer patients treated with high-dose chemotherapy and Stem cell transplant
- Scientific, logistical, and ethical issues related to creation of a Stem cell repository for use in experimental trials of gene therapy for AIDS
- Basic Studies Toward Hematopoietic Stem cell Gene therapy
- Integrating vector and Stem cell-based strategies for gene therapy of Duchenne muscular dystrophy
- … ANBL0032: a phase III randomized trial of chimeric anti-GD2 and GM-CSF/IL2 in high risk neuroblastoma following myeloablative therapy and autologous Stem cell …
- Human Stem cell Gene therapy
- … onset invasive pulmonary zygomycosis following allogeneic peripheral blood Stem cell transplantation in a patient with therapy-related myelodysplastic syndrome
- High-dose busulfan, VP-16 and ACNU therapy with Stem cell transplantation for the treatment of children with acute leukemia
- Delivery of a vector with vascular endothelial growth factor gene to the pluripotent Stem cell for gene therapy
- Diabetes therapy boosts Stem–cell campaign
- … -dose therapy and autologous Stem–cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy …
- cellular therapy by Non-Myeloablative Stem cell Transplantation and Immunotherapy of Minimal Residual Disease
- Pioneering Stem cell/Gene therapy Trials
- Hematopoietic Stem cell Transplantation. An Established therapy
- High Dose therapy (HDCT) with Autologous Stem cell Transplantation (ASCT) for Non-Hodgkin Lymphoma in the Elderly: Feasibility of a Patient-Tailored Treatment …
- Human embryonic Stem cells: possibilities for future cell transplantation therapy
- Cost of antibiotic therapy in neutropenic patients undergoing peripheral blood Stem cell transplantation for breast cancer
- Advances in Hematopoietic Stem cell Transplantation and Molecular therapy
- The Biology of the Stem cell and Its Environment in the Role of Effective Gene therapy
- Evaluation of leukemic contamination in peripheral blood Stem cell leukaphereses vs bone marrow after consolidation therapy in acute myeloid leukemia: not a …
- Hematopoietic Stem cell Gene therapy
- Hematopoietic Stem cell gene therapy
- Cord blood Stem and progenitor cell therapy for immunodeficiency and other disorders
- High dose therapy with autologous Stem cell support–finally a progress in myelomatosis
- High-dose therapy and peripheral blood Stem cell transplantation for patients with aggressive non-Hodgkin’s lymphoma remaining in initial remission: results of a …
- High-dose chemotherapy and autologous Stem cell transplantation for refractory and relapsing Hodgkin’s disease as first-line therapy–studies at Sheba Medical …
- Autologous hematopoietic Stem cell transplantation (AHSCT) as consolidation therapy for childhood acute myelogenous leukemia in 1st complete remission
- Prognostic factors for survival and response after high-dose therapy and autologous Stem cell transplantation in syStemic AL amyloidosis: a report on 21 patients
- Stem–cell gene therapy: problems and solutions
- Stem cell GENE therapy OR GENETIC DISEASES
- High dose therapy and autologous Stem cell transplantation (ASCT) for lymphoblastic lymphoma in adults: Results from the European Group for Bone Marrow …
- Aggressive neoplastic plasma cell growth with MLL gene rearrangement after high-dose therapy with autologous Stem cell support for multiple myeloma
- Stem cell GENE therapy OR GENETIC DISEASES
- A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with Stem cell transplantation
- Stem cell GENE therapy OR GENETIC DISEASES
- Stem cell and gene therapy approaches for skeletal disorders
- High-dose therapy and autologous hematopoietic Stem–cell transplantation for recurrent or refractory pediatric hodgkin’s disease: analysis of the stanford university …
- … Trial of Short-Course Preemptive Ganciclovir Compared with Conventional Ganciclovir therapy To Prevent Cytomegalovirus Infection after Allogeneic Stem cell …
- therapy-related acute myeloid leukemia following double autologous peripheral blood Stem cell transplantation for non-Hodgkin’s lymphoma
- Human hematopoietic Stem cell gene therapy
- Excessive Weight Gain during Mobilization Increases First Year Mortality Following High Dose therapy and Stem cell Transplantation in Patients with Primary …
- Contamination with minimal residual disease in autologous peripheral Stem cell collected from Non-Hodgkin’s lymphoma patients treated with high-dose therapy
- Leukocyte Depleted Blood Transfusion in Hematopoietic Stem cell Reconstitution therapy
- … therapy with Autologous Blood Stem cell Transplantation (Asct) for Relapsed, Follicular Lymphoma (FL) vs. De Novo, Diffuse Large B-cell (dnDLBL) vs. Transformed …
- Evaluation of human hemopoietic Stem cell assays for transplantation and gene therapy
- Stem cell gene therapy–second conference. Biology and technology. 31 May-3 June 1998, Orcas Island, WA, USA.
- High-dose therapy with peripheral Stem cell support in patients with lymphomas and breast cancer
- Supportive therapy in patients with autologous hemopoietic Stem cell transplantation
- … Predictor of Survival for Refractory and Relapsed HIV-Associated Lymphoma Enrolled in a Program of High Dose therapy and Autologous Peripheral Blood Stem cell …
- The biologic character of cancer Stem cell and targeted therapy
- CD34-positive cells as Stem cell support after high dose therapy
- … infusions is safe and effective therapy for a subgroup of relapsed acute myeloid leukaemia and myelodysplastic syndrome following allogeneic haemopoietic Stem cell …
- … (Gemcitabine, Dexamethasone, Cisplatin) Salvage therapy Results in Superior Progression Free Survival Compared to Mini-Beam Prior to Autologous Stem cell …
- Application of mesenchymal Stem cells for the regeneration of cardiomyocyte and its use for cell transplantation therapy
- Modulation of the Hematopoietic Stem cell Phenotype: Implications For Regenerative Medicine and Gene therapy
- Studies Add to Debate on High-Dose therapy & Stem cell Transplantation for NHL
- Surgical therapy for corneal epithelial Stem cell deficiency
- High dose therapy with autologous Stem cell support in malignant disorders; Hoeydosebehandling med autolog stamcellestoette ved maligne lidelser
- Studies of hematopoietic-human-Stem–cell viability in-vitro and of celocentesis in non-human primates for in-utero Stem cell gene therapy
- Mesenchymanl Stem cell Based Intradiscal Gene therapy: Therapeutic Implication in Degenerative Disc Disease
- Correction of mouse models of sickle cell disease and β-thalassemia using Stem cell and genetic-based therapy
- An investigation of murine trachea cellular kinetics: implications for Stem cell gene therapy
- … ARTHRITIS (JIA) ON LONG-TERM therapy WITH METHOTREXATEP172. THE POSITION OF AUTOLOGOUS Stem cell TRANSPLANTATION (ASTA) IN …
- Electronic data processing-assisted high dosage therapy with Stem cell transplantation at the Donauspital
- Twelve Cases of Malignant Hematopathy Treated by Combined therapy of Hematopoietic Stem cell Transplantation andChinese Herbal Medicine
- A Novel Stem cell Derived Gene therapy for HIV/AIDS
- Development of selective amplifier genes for hematopoietic Stem cell gene therapy
- Application of Risk-Adapted therapy for Acute Myeloid Leukemia to a Population. Effects of Stem cell Transplantation on Outcome.
- Correction of ADA-SCID by Stem cell gene therapy combined with nonmyeloablative conditioning
- Nonmyeloablative Allogeneic Peripheral Blood Hematopoietic Stem cell Transplantation for therapy of Hematologic Diseases
- Stem cells and cell therapy. Contribution to the ethical debate
- Stem cell Transplantation: Successful therapy for the Substitution of Unfunctional Hemato-Lymphoid SyStem
- Optimizing recovery from aplasia after high-dose therapy and hematopoietic Stem cell transplantation
- High-dose therapy with autologous Stem cell support in malignant lymphoma and breast cancer. Experiences with hematopoietic Stem cells isolate from blood
- ABCG2: A new target for cancer therapy and new marker for Stem cell screening
- Renal transplantation and immunosuppressive therapy do not contraindicate Stem–cell donation for bone-marrow transplantation
- 15-year follow-up of myeloma patients receiving 140 MG/M2 melphalan without hematopoietic Stem cell or growth factor support as initial therapy
- Twelve cases of malignant hematopathy treated by combined therapy of hematopoietic Stem cell transplantation and Chinese herbal medicine
- High-dose therapy followed by autologous haematopoietic Stem cell transplantation in multiple myeloma.
- Thirteenth Annual Meeting of Society for Biological therapy, 454 interleukin-2 expression, CTL against renal cell carcinoma, 170 CD8 T cell activity, 307 Stem cell …
- Use of Cord Blood Stem cells in cell therapy
- … phase II study of maintenance chemotherapy versus high-dose chemotherapy with autologous peripheral blood Stem cell transplantation as postremission therapy of …
- High-dose immunosuppressive therapy with Stem cell transplantation for the treatment of autoimmune disease
- High dose therapy with autologous Stem cell support in malignant disorders. Excerpt from the statement by the advisory group of the State Health Services
- Application of real-time quantitative PCR for guidance therapy of cytomegalovirus infection after allohematopoietic Stem cell transplantation
- Myeloablative therapy, Stem cell rescue and gene transfer in advanced ewing tumors (AET)
- Gene therapy for Human Immunodeficiency Virus Infection Using Stem cell Transplantation
- … -non-identical peripheral blood Stem cell transplantation (total body irradiation, etoposide, thiotepa) and interleukin 2-based experimental therapy for poor prognosis …
- cellular therapy for intensification in oncology and hematology: manipulation of peripheral blood Stem–cell products
- High-dose chemotherapy with peripheral blood Stem cell transplantation as adjuvant therapy for primary breast cancer
- 225. Phenotypic Correction of ALD Mouse after Hematopoietic cell Transplantation and Evaluation of Hematopoietic Stem cell Gene therapy with a Lentivirus Vector
- Autologous blood Stem cell transplantation as intensive consolidation therapy in hematological malignancies.
- Bone Stem cell mediated gene therapy and tissue engineering
- Dose-Intensive therapy with Autologous Blood Stem cell or Bone Marrow Transplantation for Treatment of Breast Cancer
- Etarnercept therapy for Idiopathic Pneumonia Sydrome After Allogeneic Hematopoietic Stem cell Transplantation in an Adul
- # 649 The feasibility of outpatient high dose multiagent cytoreductive rpeparative therapy (CPT) in patients undergoin autologous Stem cell transplantation (SCT) for …
- Autologous Stem cell harvesting after high dosage chemo-and/or growth factor therapy
- 1004. Integration Analyses in ADA-Deficient SCID Patients Successfully Treated with Stem cell Gene therapy
- Isolation of human mesenchymal Stem cell-like fibroblast from adipose tissue for reconstructive therapy
- … Targeted Integration of Minigenes: T Integration of Minigenes: Toward Improved Ex V oward Improved Ex V oward Improved Ex Vivo/In Vivo Stem–cell Gene-therapy
- High dose chemotherapy and autologous Stem cell transplantation as adjuvant therapy for primary breast cancer pa…
- 51. A Novel Approach to Stem cell Gene therapy: Controlling Stem cell ifferentiation with Engineered Zinc-Finger Protein Transcription Factors
- Dose intensive therapy and myeloablative chemotherapy with haematopoietic Stem cell rescue in childhood poor prognosis Ewing’s sarcoma
- Stem–cell engraftment as delayed therapy to repair organophosphate-induced brain damage
- predicts relapse of malignant lymphoma after high-dose therapy with Stem cell transplantation
- Oral valganciclovir is safe and effective as preemptive therapy for CMV infection in allogeneic hematopoietic Stem cell transplantation
- High-dose chemotherapy with peripheral blood Stem cell transplantation as adjuvant therapy for primary breast cancer with extensive lymph node involvement
- High-dose therapy and autologous peripheral blood Stem cell transplantation in patients with relapsed lymphoma
- 1125 High-dose therapy with hemopoietic Stem cell support for high risk breast cancer. A pilot study in 31 patients
- Role of Chemokine Receptor, CXCR4, Expression in Directing Neural Stem cell Vectors in Brain Tumor therapy
- Imatinib therapy for Chronic Myeloid Leukemia Patients Who Relapse after Allogeneic Stem cell Transplantation: A Molecular Analysis.
- Role of music therapy-based relaxation vs. expressive reading interventions in blood marrow Stem cell transplantation
- The Impact of Immunosuppressive therapy on an Early Quantitative Reconstitution of NK cells after Allogeneic Hematopoietic Stem cell Transplantation.
- Allogenic Peripheral Blood Stem cell Transplant Utilizing Rabbit Anti-Thymocyte Globulin as a Part of Non-Myeloablative Conditioning therapy.
- Engineered human mesenchymal Stem cells: a novel platform for skeletal cell mediated gene therapy
- 1162. Correction of the Immune and Metabolic Defect of ADA-SCID by Stem cell Gene therapy Combined with Nonmyeloablative Conditioning
- The HGFIN Gene Mediates cell Cycle Quiescence of CD34+/CD38-: Implications for Hematopoietic Stem cell Expansion and Gene therapy.
- Adenovirus-Mediated Targeted Gene therapy for Breast Cancer and for Purging Hematopoietic Stem–cell Sources
- … RESTORES THYMIC FUNCTION AND ENHANCES HEMOPOIESIS AND LYMPHOPOIESIS FOLLOWING ALLOGE-NEIC AND AUTOLOGOUS Stem cell …
- High Dose therapy with Autologous Blood Stem cell Transplantation (ASCT) for Follicular Lymphoma: Long-Term Outcome According to Histologic Grade.
- Intracerebral Mesenchymal Stem cell Gene therapy in the Niemann-Pick Disease Mouse
- First Line therapy with Reduced Intensity Conditioning Allogeneic Stem cell Transplantation for Patients with Acute Myeloblastic Leukemia in First Complete …
- … Intensity Induction therapy Followed by Early High Dose Chemotherapy (HDT) and Autologous Hematopoietic Stem cell Transplantation (AHSCT) for Mantle cell …
- GMP Compliant Expansion of Hematopoietic Stem cells (CD34+) Selected from Cord Blood for a Phase I cell therapy Trial
- Sex streoid ablation therapy restores thymic function and enhances hemopoiesis and lymphopoiesis following allogeneic and autologous Stem cell transplantation
- … RESISTANT TO CONVENTIONAL THERAPEUTIC REGIMENSV4. 2. 18 CHILDREN AFTER AUTOLOGOUS Stem cell TRANSPLANTATION FOR REFRACTORY …
- Autologous Stem cell transplantation following induction therapy with an anthracycline-based regimen including interferon-alpha for low-grade non-Hodgkin’s …
- Development of hemopoietic Stem cell gene therapy for Niemann-Pick disease using the acid sphingomyelinase knock-out mouse model
- BCCA Protocol Summary for Myeloablative Conditioning therapy Prior to Autologous and Allogeneic Hematopoietic Stem cell Transplantation for Myeloid …
- # 703 High dose mobilization chemotherapy followed by myeloblative therapy with Stem cell support for the treatment of small, round, blue cell tumors
- … blood Stem cell transplantation (allo-pbsct): changing patterns and low dose short course (ldsc) gancyclovir (gcv) as an effective nontoxic presumtive therapy (pt) …
- Intensified induction followed by high-dose therapy with autologous peripheral blood Stem cell support in poor-prognosis aggressive non-Hodgkin’s lymphoma …
- 12 Multiple courses of high-dose alkylating therapy with autologous Stem cell support
- … Followed by High-Dose therapy with Autologous Peripheral Blood Stem cell Transplantation for Advanced-Stage Follicular Lymphoma as First-Line therapy …
- Improving dosing precision in busulfan (bu)-based preparative regimens for hematopoietic Stem cell transplantation (HSCT) using parmacokinetics directed therapy …
- Gene therapy: Bone Regeneration Using Adenovirus Mediated Bone Morphogenic Protein Engineered Mesenchymal Stem cell
- … Stem cell transplantation (PBSCT) for patients with malignant lymphoma–its role in the treatment strategy for non-Hodgkin’s lymphoma, and ESHAP+ PBSCT therapy
- The Useful Individualized Assessment of Immunosuppressive therapy with Cyclosporine A (CsA) after Allogeneic Stem cell Transplantation by Simultaneous …
- … Patients Undergoing Allogeneic Hematopoietic Stem cell Transplantation: Increased Incidence in Patients Receiving Alemtuzumab (ALEM) as Conditioning therapy …
- AUTOLOGOUS Stem cell TRANSPLANTATION (ASCT) FOR THE TREATMENT OF HIV-ASSOCIATED NON-HODGKIN’S LYMPHOMA (NHL) IN THE ERA OF …
- Intensified full-dose induction therapy (HD-MACHOP+ radiotherapy) follwed dy consolidation with BAVC regimen and autologous Stem cell transplantation as fron-line …
- Symposium 7: Stem cell Research; Application of Endothelial Progenitor cells (EPC) to Vascular Medicine: Mobilized EPC by GM-CSF accelerate …
- Intensive antileukemic therapy including Stem cell transplantation (SCT) for high risk MDS and AML following MDS (SAML) in patients< 60 years. a joint study of the …
- … Versus Gene Modified Autologous Stem cell Transplantation for Severe Combined Immunodeficiencies (SCID). The Risk/Benefit Balance Is in Favor of Gene therapy …
- Denileukin diftitox (ONTAK) as targeted therapy against steroid refractory graft-versus-host disease (GVHD) after allogeneic hematopoietic Stem cell transplantation …
- Repetitive High-Dose therapy with Dose Escalated CHOP+ Etoposide Followed by Autologous Stem cell Transplantation (Mega-CHOEP) in Younger Patients with …
- … POST TRANSPLANT-Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic Stem cell …
- Fludarabine and cytosine arabinoside as salvage therapy in patients with relapsed acute and chronic leukaemia after BMT or allogenic Stem cell transplantation
- Post-remission therapy with 4 cycles of intermediate (I) or high-dose (HD) cytarabine (AC) or autologous hematopoietic Stem cell transplantation (ASCT) for acute …
- … /Disease Consisting of a Higher Cutoff Point and a Lower Initial Dose of Ganciclovir after Allogeneic Hematopoietic Stem cell Transplantation (HSCT) with an HLA …
- cell therapy Using Embryonic Stem cells
- … EXPRESSION IN SYStemIC JUVENILE IDIOPATHIC ARTHRITIS IS RESTORED BY AUTOLOGOUS Stem cell TRANSPLANTATION. AUTONOMIC NERVOUS …
- … purging of autologous hematopoietic Stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with …
- A novel sub-population of bone marrow derived myocardial Stem cells: potential autologus cell therapy in myocardial infarction
- Human neural Stem and progenitor cells: in vitro and in vivo properties, and potential for gene therapy and cell replacement in the CNS
- Autologous mesenchymal Stem cells for articular and bone cell therapy
- Potential use of T cell receptor genes to modify hematopoietic Stem cells for the gene therapy of cancer
- … of Human Neural Stem cells in a New Primate Model of Motor Neuron Degeneration: An Experimental Study of Potential cell therapy for Amyotrophic Lateral …
- Engineering mesenchymal Stem cells with hypoxia-regulated gene syStem: A promising approach for effective cell therapy
- Recovery of stromal Stem cells in bone sarcoma patients after chemotherapy: Implication for cell-based therapy in bone defect reconstruction
- … of the rate of reduction in platelet counts in recipients of hematopoietic Stem and progenitor cell transplant: clinical implications for platelet transfusion therapy
- Mesenchymal Stem cells. Potential use in cell and gene therapy of bone loss caused by aging and osteoporosis
- Use of Embryonic Stem cells to Produce Islets in cell Replacement therapy as a Treatment for Type 1 Diabetes
- 1417: Mesenchymal Stem cells Alone or Modified with ENOS Restore Erectile Function in the Aged Rat: cell-Based Gene therapy for Erectile Dysfunction
- Adult Stem cell therapy in stroke
- Potential of mesenchymal Stem cell therapy
- Stem cell therapy and the retina
- Does mesenchymal Stem cell therapy help multiple sclerosis patients? Report of a pilot study
- Role of imaging in cardiac Stem cell therapy
- Stem cell therapy enhances electrical viability in myocardial infarction
- The potential for Stem cell therapy in diabetes
- Stem cell-based cell therapy for spinal cord injury
- Comparison of imaging techniques for tracking cardiac Stem cell therapy
- cell therapy and the safety of embryonic Stem cell-derived grafts
- Adult Stem cell therapy: dream or reality?
- Stem cell therapy for autism
- Stem cell therapy for vascular disease
- The dying Stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle
- Mesenchymal Stem cell therapy to rebuild cartilage
- Stem cell therapy for ischemic heart failure
- Stem cell therapy—Present status
- Stem cell therapy for neurologic disorders: therapeutic potential of adipose-derived Stem cells
- Injectable mesenchymal Stem cell therapy for large cartilage defects—a porcine model
- Autologous in vitro expanded mesenchymal Stem cell therapy for human old myocardial infarction
- Concise review: prospects of Stem cell therapy for temporal lobe epilepsy
- Enhancing Stem cell therapy through genetic modification
- Differentiation of mesenchymal Stem cells transplanted to a rabbit degenerative disc model: potential and limitations for Stem cell therapy in disc regeneration
- Successful Stem cell therapy using umbilical cord blood‐derived multipotent Stem cells for Buerger’s disease and ischemic limb disease animal model
- Stem cell therapy: hope or hype?
- Embryonic Stem cell therapy for diabetes mellitus
- Stem cell therapy for osteonecrosis of the femoral head
- Concise review: scientific and ethical roadblocks to human embryonic Stem cell therapy
- Stem cell therapy for human brain disorders
- New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal Stem cell therapy
- Mesenchymal Stem cell therapy in equine musculoskeletal disease: scientific fact or clinical fiction?
- Lost and found: cardiac Stem cell therapy revisited
- Stem cell therapy for cardiovascular disease
- Cardiac Stem cell therapy: need for optimization of efficacy and safety monitoring
- Stem cell therapy for cardiac diseases
- Stem cell therapy in bone repair and regeneration
- The potential role of mesenchymal Stem cell therapy for intervertebral disc degeneration: a critical overview
- Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal Stem cell therapy
- Nonmyeloablative Stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease
- Practical issues in Stem cell therapy for Alzheimer’s disease
- Towards Stem–cell therapy in the endocrine pancreas
- Stem cell therapy for cardiac repair: ready for the next step
- Increase in vascular permeability and vasodilation are critical for proangiogenic effects of Stem cell therapy
- Stem cell plasticity and issues of Stem cell therapy
- Intravenous mesenchymal Stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic …
- Current concepts in adult Stem cell therapy for stroke
- Stem cell therapy for joint problems using the horse as a clinically relevant animal model
- Stem cell therapy for Parkinson’s disease
- Stem cell therapy for urinary stress incontinence
- Fetomaternal cell trafficking: a story that begins with prenatal diagnosis and may end with Stem cell therapy
- Preimplantation genetics: improving access to Stem cell therapy
- Stem cell therapy after myocardial infarction: ready for clinical application?
- Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances Stem cell therapy
- Stem cell therapy for human liver cirrhosis: a cautious analysis of the results
- Adult neural Stem cell therapy: expansion in vitro, tracking in vivo and clinical transplantation
- Stem cell therapy in postinfarction chronic coronary heart disease
- Hyalomatrix: a temporary epidermal barrier, hyaluronan delivery, and neodermis induction syStem for keratinocyte Stem cell therapy
- Stem cell therapy delivery: treading the regulatory tightrope
- In situ Stem cell therapy: novel targets, familiar challenges
- Nonmyeloablative Stem cell transplantation and cell therapy for malignant and non-malignant diseases
- Paracrine and differentiation mechanisms underlying Stem cell therapy for the damaged kidney
- Gene and Stem cell therapy
- Heparin/poly (L-lysine) nanoparticle-coated polymeric microspheres for Stem–cell therapy
- Diabetes mellitus: a potential target for Stem cell therapy
- Multipotential mesoangioblast Stem cell therapy in the mdx/utrn-/- mouse model for Duchenne muscular dystrophy
- Stem cell therapy for sickle cell disease: transplantation and gene therapy
- Stem cell therapy for ischemic heart disease: beginning or end of the road?
- Neural Stem cell therapy and gastrointestinal biology
- Therapeutic angiogenesis for peripheral artery disease: Stem cell therapy
- Stem cell therapy for myelin diseases
- The allure of Stem cell therapy for muscular dystrophy
- Bone marrow Stem cell therapy for myocardial angiogenesis
- Gene and Stem cell therapy for erectile dysfunction
- The use of Stem cell therapy for cardiovascular disease
- Limbal epithelial Stem cell therapy
- Which place for Stem cell therapy in the treatment of acute radiation syndrome?
- cellular multiparametric MRI of neural Stem cell therapy in a rat glioma model
- Pharmacologic management of ischemic stroke: relevance to Stem cell therapy
- Stem cell therapy for myocardial repair
- Advances in the understanding of sress urinary incontinence and the promise of Stem–cell therapy
- Artificial cells: biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, and cell/Stem cell therapy
- Stem cells and their applications in skin-cell therapy
- The potential of cardiac Stem cell therapy for heart failure
- Contemplating the bright future of Stem cell therapy for cardiovascular disease
- Stem cell therapy: a hope for dying hearts
- Neural Stem cell therapy for neuropsychiatric disorders
- Stem cell therapy or snake oil?
- Novel therapies for the treatment of cystic fibrosis: new developments in gene and Stem cell therapy
- G‐CSF‐based Stem cell therapy for the heart—unresolved issues part A: Paracrine actions, mobilization, and delivery
- Stem cell therapy for the treatment of heart failure
- … -colony-stimulating factor mobilization of Stem cells in patients with acute or chronic ischaemic heart disease: a non-invasive alternative for clinical Stem cell therapy?
- Mesenchymal Stem cell-based HLA-independent cell therapy for tissue engineering of bone and cartilage
- Stem–cell therapy: hope and hype
- Gene and Stem cell therapy of the hair follicle
- Cardiac Stem cell therapy for myocardial regeneration. A clinical perspective.
- Embryonic Stem cell therapy.
- Isolation of amniotic Stem cell lines with potential for therapy
- … donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and cell therapy
- Stem cell therapy in the aging hearts of Fisher 344 rats: synergistic effects on myogenesis and angiogenesis
- Sources of cardiomyocytes for Stem cell therapy: an update
- The Netherlands bans private Stem cell therapy
- Adult Stem cell therapy beyond haemopoietic Stem cell transplantation? An update
- Gene therapy and Stem cell therapy for cardiovascular diseases today: a model for translational research
- The origin of deoxynucleosides in brain: implications for the study of neurogenesis and Stem cell therapy
- Stem cell therapy for central nervous syStem demyelinating disease
- Stem cell therapy for cardiac arrhythmias
- Cardiac Stem cell therapy: present and future
- Cancer Stem cell: target for anti‐cancer therapy
- T-cell therapy after hematopoietic Stem cell transplantation
- A method for quantitative cell tracking using SPECT for the evaluation of myocardial Stem cell therapy
- Umbilical cord Stem cell therapy for cerebral palsy
- Stem cell therapy for Parkinson’s disease
- Tubular regeneration and the role of bone marrow cells:’Stem cell therapy‘–a panacea?
- The promise of Stem cell therapy to restore urethral sphincter function
- The role of high-dose therapy and Stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study
- Bone-marrow-derived cells for cardiac Stem cell therapy: safe or still under scrutiny?
- Cancer Stem cell and cancer Stemloids: from biology to therapy
- Clinical applications of Stem cell therapy–the pros and cons of Stem cell sources
- … and sustain hematopoietic reconstitution after coculture and cografting in lethally irradiated baboons: is autologous Stem cell therapy in nuclear accident …
- Safety of intramyocardial Stem cell therapy for the ischemic myocardium: results of the Rostock trial after 5-year follow-up
- Functional considerations of Stem cell transplantation therapy for spinal cord repair
- Insertional mutagenesis in gene therapy and Stem cell biology
- Bone marrow Stem cell therapy for cardiac repair: challenges and perspectives.
- Stem–cell therapy for diabetes cure: how close are we?
- Platelet lysates promote mesenchymal Stem cell expansion: A safety substitute for animal serum in cell‐based therapy applications
- Stem cell therapy for retinal degeneration: retinal neurons from heterologous sources
- How does human Stem cell therapy influence gene expression after liver injury?: Microarray evaluation on a rat model
- … leukocyte antigen matching estimations in a hypothetical bank of human embryonic Stem cell lines in the Japanese population for use in cell transplantation therapy
- Stem cell‐based therapy for Parkinson’s disease
- Stem cell therapy for neuropathic pain treatment
- Stem cell therapy-Hope and scope in pediatric surgery
- Phenotypic characterization and preclinical production of human lineage‐negative cells for regenerative Stem cell therapy
- Stem cell therapy for acute myocardial infarction
- Stem cell therapy improves myocardial perfusion and cardiac synchronicity: new application for echocardiography
- 50th anniversary of artificial cells: their role in biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/Stem cell therapy …
- Stem cell strategies for Alzheimer’s disease therapy.
- Stem cell therapy and tissue engineering for cardiovascular repair: from basic research to clinical applications.
- Stem cell transplantation: a promising therapy for Parkinson’s disease
- The role of noninvasive imaging techniques in the assessment of Stem cell therapy after acute myocardial infarction
- From bench to bedside? Biomedical scientists’ expectations of Stem cell science as a future therapy for diabetes
- In vivo tracking in cardiac Stem cell-based therapy
- Hematopoietic Stem cell therapy for malignant diseases
- Gene therapy progress and prospects: Stem cell plasticity
- Preemptive therapy of EBV‐related lymphoproliferative disease after pediatric haploidentical Stem cell transplantation
- Stem cell therapy-A panacea for all ills?
- Bone marrow-derived Stem cell therapy in ischemic heart disease
- Survival of the fittest: in vivo selection and Stem cell gene therapy
- Cardiovascular MRI for Stem cell therapy
- Stem cell therapy for hearing loss: Math1 overexpression in VOT-E36 cells
- Impact of lenalidomide therapy on Stem cell mobilization and engraftment post-peripheral blood Stem cell transplantation in patients with newly diagnosed …
- REVIEW ARTILCE: cell therapy and Stem cells in animal models of motor neuron disorders
- Stem cell therapy for glomerular disease
- Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic Stem–cell transplantation: an international case-control study
- A look to the future: prediction, prevention, and cure including islet transplantation and Stem cell therapy
- Remaking the body? Scientists’ genetic discourses and practices as examples of changing expectations on embryonic Stem cell therapy for diabetes
- The impact of Stem cell therapy in hematology and oncology
- Youthful prospects for human Stem‐cell therapy: In another few decades, revised attitudes towards Stem cells could lead to disease prevention and life extension
- A natural Stem cell therapy? How novel findings and biotechnology clarify the ethics of Stem cell research
- Dutch clinic is ordered to stop giving Stem cell therapy
- Stem cell therapy in stroke: strategies in basic study and clinical application
- Hematopoietic Stem cell mobilization therapy accelerates recovery of renal function independent of Stem cell contribution
- Evaluation of the functional assessment of cancer therapy cognitive scale with hematopoetic Stem cell transplant patients
- Development of human umbilical cord matrix Stem cell-based gene therapy for experimental lung tumors
- Celocentesis for in utero Stem cell therapy: where we now stand and future directions
- Clinical trials in Stem cell therapy: pitfalls and lessons for the future
- Stem cell therapy of acute spinal cord injury in dogs
- G‐CSF‐Based Stem cell therapy for the Heart—Unresolved Issues Part B: Stem cells, Engraftment, Transdifferentiation, and Bioengineering
- The challenge for Stem cell therapy
- … Renal Failure by Stem cell therapy—Paracrine Secretion Versus Transdifferentiation into Resident cells: Administered Mesenchymal Stem cells Protect against …
- Nonmyeloablative Stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative …
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review
- High-dose therapy and autologous blood Stem–cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term …
- Stem cell therapy in patients with multiple sclerosis
- Embryonic Stem cells: prospects for developmental biology and cell therapy
- Cardiac Stem cell therapy from bench to bedside
- Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with Stem cell gene therapy
- Stem cell and gene-based therapy
- A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic Stem cell transplantation
- Stem cell therapy for diabetes mellitus: progress, prospects and challenges
- Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic Stem cell transplantation: risk factors analysis and outcome
- Promises and pitfalls of Stem cell therapy for promotion of bone healing
- Quantitative assessment of molecular remission after high-dose therapy with autologous Stem cell transplantation predicts long-term remission in mantle cell …
- Launching a clinical program of Stem cell therapy for cardiovascular repair
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review
- Potential of Stem cell based therapy and tissue engineering in the regeneration of the central nervous syStem
- Allogeneic hematopoietic Stem cell transplantation as part of postremission therapy improves survival for adult patients with high‐risk acute lymphoblastic leukemia: a …
- … of the left ventricular myocardial contraction with Stem cell therapy: new insights into the therapeutic implication of Stem cell therapy in myocardial infarction
- Allogeneic Stem–cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma
- Embryonic Stem cells: meeting the needs for cell therapy
- Successful reconstitution of immunity in ADA-SCID by Stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning
- High-dose therapy followed by autologous purged Stem–cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a …
- Stem–cell therapy for hepatobiliary pancreatic disease
- Safety and efficacy of enzyme replacement therapy in combination with hematopoietic Stem cell transplantation in Hurler syndrome
- Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic Stem–cell transplantation results in favorable outcomes
- Stem cell therapy in cardiovascular diseases
- Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous Stem cell transplantation in untreated patients with …
- Mesenchymal Stem cell therapy for multiple sclerosis
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based …
- … With Myeloablative Chemotherapy and Autologous Stem–cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma therapy …
- High-dose chemotherapy with autologous Stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a …
- Autologous Stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis
- Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic Stem cell transplantation
- Stem cell transplantation and gene therapy for hemoglobinopathies.
- The effect of first-line imatinib interim therapy on the outcome of allogeneic Stem cell transplantation in adults with newly diagnosed Philadelphia chromosome …
- Stem cell therapy in the heart and vasculature
- Perspectives of gene therapy in Stem cell tissue engineering
- Correction of murine hemophilia A by hematopoietic Stem cell gene therapy
- Stem cell therapy
- Stem cell migration: a quintessential stepping stone to successful therapy
- Dendritic cell therapy for tolerance induction to Stem cell transplants
- Integration of genomics, proteomics, and imaging for cardiac Stem cell therapy
- … in the peripheral blood after allogeneic Stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy
- Induction of neurotrophin expression via human adult mesenchymal Stem cells: implication for cell therapy in neurodegenerative diseases
- … syStem-based comparison between human dental pulp Stem cells (hDPSCs) and human mesenchymal Stem cells (hMSCs) for tissue engineering cell therapy
- Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic Stem cell transplant recipients
- Low‐energy laser therapy for prevention of oral mucositis in hematopoietic Stem cell transplantation
- New era of cardiac Stem cell therapy in heart failure
- Cripto as a Target for Improving Embryonic Stem cell–Based therapy in Parkinson’s Disease
- Gene and Stem cell therapy in the treatment of erectile dysfunction and pulmonary hypertension; potential treatments for the common problem of endothelial …
- Stem cell therapy in Iran
- Current practice and future perspectives of myocardial Stem cell therapy
- Current status and concepts of Stem cell therapy
- Rituximab and DHAP followed by intensive therapy with autologous Stem–cell transplantation as first-line therapy for mantle cell lymphoma
- Stem cell therapy in acute myocardial infarction
- Stem cell therapy for myocardial regeneration: creating hype ignoring reality
- The safety of interferon‐γ‐1b therapy for invasive fungal infections after hematopoietic Stem cell transplantation
- Targeting, imaging, and therapy using a humanized antiprostate Stem cell antigen (PSCA) antibody
- Mesenchymal Stem cell therapy of brain ischemic stroke in rats
- Stem cell-based therapy for the treatment of Type 1 diabetes mellitus
- Novel tyrosine kinase inhibitor therapy before allogeneic Stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant …
- Cardiovascular therapeutic aspects of cell therapy and Stem cells
- Neuropsychological function in high-risk breast cancer survivors after Stem–cell supported high-dose therapy versus standard-dose chemotherapy: evaluation …
- Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic Stem–cell transplant
- Effectiveness of prophylactic anti‐HBV therapy in allogeneic hematopoietic Stem cell transplantation with HBsAg positive donors
- … , dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous Stem cell …
- Stem cell therapy in chronic heart failure
- Tumorigenesis and embryonic Stem cell-derived therapy
- Imatinib therapy prior to myeloablative allogeneic Stem cell transplantation
- Stem cell therapy in heart failure: where do we stand and where are we heading?
- Development of hematopoietic Stem cell gene therapy for Wiskott-Aldrich syndrome.
- Neural Stem cells as biological minipumps: a faster route to cell therapy for the CNS?
- High-dose therapy with autologous Stem cell transplantation in first response in mantle cell lymphoma
- Stem cell pharmacogenomics: a reality check on Stem cell therapy.
- cell therapy using allogeneic bone marrow mesenchymal Stem cells prevents tissue damage in collagen‐induced arthritis
- Stem cell research: cloning, therapy and scientific fraud
- Stem cell therapy. Biology of hematopoietic Stem cells
- Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic Stem cell …
- Hematopoietic Stem–cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens
- Myogenic Stem cells: regeneration and cell therapy in human skeletal muscle
- Lessons for the Stem cell discourse from the gene therapy experience
- Targeting the most critical cells: approaching leukemia therapy as a problem in Stem cell biology
- “Stealth immune tolerance” in Stem cell transplantation: potential for “universal donors” in myocardial regenerative therapy
- Ethical legal and social issues in Stem cell research and therapy
- Stem cell therapy for demyelinating disorders
- Hematopoietic Stem cell–targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice
- Stem cells engineering for cell-based therapy
- … veno-occlusive disease in pediatric Stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy
- … conditioning allogeneic Stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and cellular therapy …
- Value of Stem cell therapy for the treatment of stress incontinence. Current status and perspectives
- The role of high-dose therapy and autologous Stem cell transplantation for pediatric bone and soft tissue sarcomas
- … -occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood Stem cell transplantation in multiple …
- Application of liver Stem cells for cell therapy
- Stem cell therapy: a new perspective for the treatment of ischemic heart failure
- Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic Stem cell transplantation
- Estrogen-progestin therapy in women after Stem cell transplant: our experience and literature review
- Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic Stem cell recipients
- Extended lamivudine therapy against hepatitis B virus infection in hematopoietic Stem cell transplant recipients
- Mesenchymal Stem cell therapy for the injured heart
- Hematopoietic Stem cell gene therapy: dead or alive?
- The promise of Stem cell therapy for eye disorders
- Towards the generation of patient-specific pluripotent Stem cells for combined gene and cell therapy of hematologic disorders
- Use of bortezomib as induction therapy prior to Stem cell transplantation in frontline treatment of multiple myeloma: impact on Stem cell harvesting and engraftment
- Good manufacturing practice-compliant expansion of marrow-derived Stem and progenitor cells for cell therapy
- Salvage therapy for CLL and the role of Stem cell transplantation
- Chemotherapy with rituximab followed by high‐dose therapy and autologous Stem cell transplantation in patients with mantle cell lymphoma
- Short intensive sequential therapy followed by autologous Stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma
- Haematopoietic Stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma
- Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood Stem cell transplantation
- Stem cell therapy for intervertebral disc degeneration: In vitro study
- Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load⩾ 10000 copies/ml: a safe and effective strategy for allogeneic Stem cell …
- High-dose therapy and autologous hematopoietic Stem cell transplantation for patients with primary syStemic amyloidosis: a Center for International Blood and Marrow …
- A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic Stem cell transplantation
- Stem cell controversy to stall European tissue and cell therapy rules
- cell therapy, Stem cells and brain repair
- Outcome of hematopoietic Stem cell transplantation for pediatric patients with therapy‐related acute myeloid leukemia or myelodysplastic syndrome
- New strategies of antifungal therapy in hematopoietic Stem cell transplant recipients and patients with hematological malignancies
- Stem cell Transplantation: Biology, Processes, therapy
- Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with Stem cell transplant: review and consensus statement
- therapy of Duchenne muscular dystrophy with umbilical cord blood Stem cell transplantation
- Human embryonic Stem cell therapy for Parkinson’s disease
- Autologous Stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome
- Motor function recovery after adipose tissue derived mesenchymal Stem cell therapy in rats with cerebral infarction
- Efficacy of high‐dose therapy and hematopoietic Stem cell transplantation for mantle cell lymphoma
- Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic Stem cell gene therapy
- High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic Stem cell transplantation
- Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic Stem cell mobilization
- Cardiac effects within 3 months of BEAC high‐dose therapy in non‐Hodgkin’s lymphoma patients undergoing autologous Stem cell transplantation
- High dose chemotherapy and autologous Stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes …
- … intensity conditioning and allogeneic Stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non …
- High-dose chemotherapy with Stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up
- Thalidomide salvage therapy following allogeneic Stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du …
- Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human Stem cell and gene therapy
- Hematopoietic Stem cell gene therapy with drug resistance genes: an update
- Stem cell therapy in end-stage ischaemic heart failure: a catheter-based therapeutic strategy targeting myocardial viability
- … therapy with ICE Followed by High Dose therapy and Autologous Stem cell Transplantation for Relapsed/Refractory Peripheral T-cell Lymphomas: Minimal Benefit …
- Preclinical trials for Stem cell therapy
- Complexity of the human acute myeloid leukemia Stem cell compartment: implications for therapy
- Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic Stem cell …
- Catheter-based Stem cell and gene therapy for refractory myocardial ischemia
- Stem cell and Stem cell therapy in Thailand
- Reduced intensity conditioning allows for up-front allogeneic hematopoietic Stem cell transplantation after cytoreductive induction therapy in newly-diagnosed …
- Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic Stem cell transplantation
- Posaconazole salvage therapy allows successful allogeneic hematopoietic Stem cell transplantation in patients with refractory invasive mold infections
- Characterization of BioSafe SEPAX Manufactured Stem cell Intended for Cardiac cell therapy.
- Low-dose methotrexate as salvage therapy for refractory graft-versus-host disease after reduced-intensity conditioning allogeneic Stem cell transplantation
- The role of high-dose therapy and autologous Stem cell transplantation in patients with primary refractory Hodgkin’s lymphoma: a report from the Gruppo …
- Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic Stem cell recipients receiving immunosuppressive therapy or with acute graft …
- Medium-term survival without haematopoietic Stem cell transplantation in a case of IPEX: insights into nutritional and immunosuppressive therapy
- The effect of neural embryonic Stem cell therapy in a rat model of cavernosal nerve injury
- Review: Mesenchymal Stem cells: cell–Based Reconstructive therapy in Orthopedics
- Initial therapy of multiple myeloma patients who are not candidates for Stem cell transplantation
- Mantle cell lymphoma (MCL): induction therapy with HyperCVAD/High-dose methotrexate and cytarabine (MC)(±rituximab) improves results of autologous Stem cell …
- High-dose chemotherapy and autologous hematopoietic Stem cell transplantation for metastatic breast cancer: a therapy whose time has passed
- Melphalan 200 mg/m2 with blood Stem cell support as first-line myeloma therapy: impact of glomerular filtration rate on engraftment, transplantation-related …
- Human embryonic Stem cell therapy, what is the attitude of the public?
- Progress and clashes in Stem cell therapy research
- The role of Stem–cell transplantation in chronic lympocytic leukemia risk-adapted therapy
- Haematopoietic Stem cell gene therapy to treat autoimmune disease
- Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic Stem cell transplant recipients
- Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic Stem cell transplantation: a single-center experience in Korea
- … Stem–cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant imatinib therapy
- Effect of prior rituximab on high-dose therapy and autologous Stem cell transplantation in follicular lymphoma
- Stem cell therapy in ischemic heart disease
- High-dose therapy and autologous Stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma
- Stem cell transplantation for patients with Fanconi anemia with low-dose cyclophosphamide and antithymocyte globulins without the use of radiation therapy
- Stem cell therapy for chronic cardiac insufficiency–therapy of the future?
- Outcome of Allogeneic Stem cell Transplantation after Hypomethylating therapy with 2′-Deoxy-5 Azacytidine for Patients with Myelodysplastic Syndrome.
- Rituximab long-term maintenance therapy after autologous Stem cell transplantation in patients with B-cell non-Hodgkin’s lymphoma
- First-line thalidomide–dexamethasone therapy in preparation for autologous Stem cell transplantation in young patients (< 61 years) with symptomatic multiple …
- Long-term event-free survivors after high-dose therapy and autologous Stem–cell transplantation for low-grade follicular lymphoma
- … staging syStems can predict prognosis of multiple myeloma patients undergoing autologous peripheral blood Stem cell transplantation as first-line therapy
- Human cordonal Stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats
- Stem cell therapy still not here
- … in a multicenter observational database: relevance for design of a clinical trial for high dose immunosuppressive therapy with autologous hematopoietic Stem cell …
- Collection of fetal blood for Stem cell research and therapy
- Umbilical Cord Stem cell therapy: The Gift of Healing from Healthy Newborns
- Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic Stem cell transplantation during childhood
- … therapy for Treatment of Autoimmune Diseases, Basic Science and Clinical Studies, Including New Developments in Hematopoietic and Mesenchymal Stem cell …
- Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic Stem cell transplantation: a molecular analysis
- Current concepts of Stem cell therapy
- Diabetic cardiomyopathy: a “cardiac Stem cell disease” involving p66Shc, an attractive novel molecular target for heart failure therapy
- The yin and yang of Stem cell gene therapy: insights into hematopoiesis, leukemogenesis, and gene therapy safety
- Autologous Stem cell Transplantation as First-Line therapy in Peripheral T-cell Lymphomas. A Prospective Multicenter Study.
- Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous Stem cell support
- Recent View of Stem cell Plasticity and Stem cell therapy
- Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous Stem–cell transplantation as first-line treatment in …
- The therapeutic potential of mesenchymal Stem cells: cell-& tissue-based therapy
- Regulating Stem cell research & therapy
- Embryonic Stem cell-based diabetes therapy—a long road to travel
- Etanercept therapy for late-onset idiopathic pneumonia syndrome after nonmyeloablative allogeneic hematopoietic Stem cell transplantation
- Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous Stem cell …
- Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic Stem cell transplantation
- Stem and progenitor cell–based therapy of the human central nervous syStem
- Immobilization of mesenchymal Stem cells and monocytes in biocompatible microcapsules to cell therapy
- T cell suicide gene therapy to aid haematopoietic Stem cell transplantation
- … therapy between chemotherapeutic cycles and in vivo purging prior to autologous Stem cell transplantation, followed by maintenance therapy is a feasible …
- Suppressive anti-HCV therapy for prevention of donor to recipient transmission in Stem cell transplantation
- Frontline therapy with early intensification and autologous Stem cell transplantation versus conventional chemotherapy in unselected high-risk, aggressive non …
- Mechanistic insights into cardiac Stem cell therapy from a histopathologic perspective
- Modified total body irradiation as a planned second high-dose therapy with Stem cell infusion for patients with bone-based malignancies
- Early Stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide
- Successful therapy with whole‐lung lavage and autologous peripheral blood Stem cell transplantation for pulmonary alveolar proteinosis complicating acute …
- … during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent Stem cell …
- The shady side of embryonic Stem cell therapy
- … of In Vitro Irradiated CD34+ cells in the Presence of SCF, FLT3 Ligand, TPO and IL3: Potential Application to Autologous cell therapy in Accidentally Irradiated …
- The KIDStem European research training network: Developing a Stem cell based therapy to replace nephrons lost through reflux nephropathy
- Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic Stem cell transplantation outcome
- Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic Stem cell transplantation
- Successful interim therapy with imatinib prior to allogeneic Stem cell transplantation in Philadelphia chromosome‐positive acute myeloid leukemia
- rHuEpo before high-dose therapy allows autologous peripheral Stem–cell transplantation without red blood cell transfusion: a pilot study
- Stem cells, Stem cell therapy, and ethical problems of medicine
- The World of Stem cell therapy: Anonymity is not an Option
- The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic Stem cell transplant patients
- Mesenchymal Stem cells characteristics, niches, and applications for cell therapy
- Gene and cell therapy involving hematopoietic Stem cell
- Cardiovascular regeneration and Stem cell therapy
- Autologous Stem cell gene therapy: toward a universal platform for personalized therapy
- Embryonic Stem cell–derived astrocytes: a novel gene therapy vector for brain tumors
- The impact of histologic grade on the outcome of high-dose therapy and autologous Stem cell transplantation for follicular lymphoma
- A novel intensive induction therapy for high‐risk neuroblastoma utilizing sequential peripheral blood Stem cell collection and infusion as hematopoietic support
- Use of iron oxide MR contrast agents for monitoring Stem cell therapy
- Potentials and limitations of Stem cell therapy in myocardial disease
- Stem cell based cell therapy for muscular dystrophy
- Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: role of rituximab, high-dose therapy, and allogeneic Stem cell …
- High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous Stem cell transplantation
- Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood Stem cell transplantation
- cell transplant and regenerative therapy with Stem cells
- Potential application of embryonic Stem cells in Parkinson’s disease: drug screening and cell therapy
- 328: Transurethral Ultrasound Guided Stem cell therapy of Urinary Incontinence
- … International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin’s lymphomas treated with high-dose BEAM therapy and autologous Stem cell …
- Effect of neurotrophic factor and Stem cell therapy on axonal regeneration after spinal cord injury: Overseas progress in basic and clinical researches
- A randomized, double-blinded, pilot trial of aprepitant added to standard antiemetics during conditioning therapy for hematopoietic Stem cell transplant (HSCT)
- Can Basic Fibroblast Growth Factor Pre-Treatment Enhance Mesenchymal Stem cell therapy in Undecorticated Posterior Spinal Fusion?
- Dog leukocyte antigen-haploidentical Stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model
- The Impact of Disease Status on the Outcome of High-Dose therapy (HDT) and Autologous Stem cell Transplantation (ASCT) for Peripheral T-cell …
- High‐dose therapy and autologous Stem‐cell transplantation can improve event‐free survival for indolent lymphoma: a study using patients as their own controls
- 230. In Vivo Fluorescence Tracking SyStem for Cardiac Stem cell therapy
- Autologous bone marrow Stem cell or peripheral blood endothelial progenitor cell therapy in patients with peripheral limb ischaemia
- Stem cells and plasticity of skeletal muscle cell differentiation: potential application to cell therapy for degenerative muscular diseases
- Initial therapy of multiple myeloma in patients who are candidates for Stem cell transplantation
- Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic Stem–cell transplant recipients?
- The future of allogeneic hematopoietic Stem cell transplantation for metastatic renal cell carcinoma in the era of target-specific therapy
- … therapy for myeloma: Thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high‐dose melphalan with autologous Stem cell …
- Lenalidomide as induction therapy before allogeneic Stem cell transplantation in a patient with proliferative CMML-2 and del (5q) not involving the EGR1 locus
- IMVP-16/Pd followed by high-dose chemotherapy and autologous Stem cell transplantation as a salvage therapy for refractory or relapsed peripheral T-cell …
- Embryo Stem cells from parthenotes and embryos produced by nuclear transfer: the distinction between them and their potential value in cell therapy
- Evaluation of the therapeutic responses of Stem cell therapy after myocardial infarction: Comparison of Thallium-201 gated-SPECT with 18F-FDG metabolism imaging
- cell therapy for heart failure—muscle, bone marrow, blood, and cardiac-derived Stem cells
- Mechanisms and applications of Stem cell gene therapy in autoimmunity
- CD34+ selected haematopoietic Stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment for graft failure
- … circulation with localized transplantation in situ at the site of tissue/organ damage: a possible strategy to optimize the efficacy of Stem cell transplantation therapy
- Neural Stem cell therapy in lysosomal storage disorders
- Embryonic Stem cell-based therapy for the treatment of diabetes mellitus: a work in progress
- Pre‐Stem cell transplantation enzyme replacement therapy in Hurler syndrome does not lead to significant antibody formation or delayed recovery of the endogenous …
- Triple antifungal therapy for severe syStemic candidiasis allowed performance of allogeneic Stem cell transplantation
- Gene and Stem cell therapy for autoimmune demyelination
- High‐dose therapy and autologous Stem cell transplantation for children with HIV‐associated non‐Hodgkin lymphoma
- Stability of colon Stem cell methylation after neo-adjuvant therapy in a patient with attenuated familial adenomatous polyposis
- Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous Stem cell transplant in multiple myeloma patients
- … recurred hemophagocytic syndrome in remission state of anaplastic large cell lymphoma following high‐dose therapy and autologous peripheral blood Stem cell …
- Successful therapy of patients in therapy-resistant cardiogenic shock with intracoronary, autologous bone marrow Stem cell transplantation
- Salvage therapy of refractory chronic disseminated candidiasis in a patient with acute myeloid leukaemia and secondary prophylaxis during allogeneic Stem cell …
- 568. Ex Vivo Mesenchymal Stem cell therapy with rAAV2 Encoding BMP-2 Enhances Bone Regeneration in Ovariectomized Mouse Model
- Peripheral blood Stem cell mobilization and harvesting after fludarabine therapy for low-grade lymphoma and chronic lymphocytic leukemia
- Molecular imaging is indispensable for the development of Stem cell-based myocardial regenerative therapy
- Cancer Stem cells–new and potentially important targets for the therapy of oral squamous cell carcinoma
- Stem cell therapy of IBD
- The effect of induction therapy with novel agents on Stem cell mobilization in multiple myeloma
- Stem cell therapy: an emerging science
- Stem cell therapy: An Emerging Science
- … amphotericin B and combined syStemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic Stem cell transplant for a …
- Stem cell therapy ahead
- Autologous bone marrow Stem cell therapy for an ischemic ulcer of the lower limb in a diabetic patient
- Febrile neutropenia in paediatric peripheral blood Stem cell transplantation, in-vitro sensitivity data and clinical response to empirical antibiotic therapy
- … Complete Responses (CR/nCR) after Initial therapy with Bortezomib (Velcade®), Doxil®, and Dexamethasone (VDD) Is Further Increased after Autologous Stem cell …
- Stem cell Biotechnology for cell therapy
- Maintenance therapy by Glivec® and Pegasys® in Patients with Philadelphia Positive Acute Lymphocytic Leukemia Not Eligible for Hematopoietic Stem cell …
- Planning time for peripheral blood Stem cell infusion after high-dose targeted radionuclide therapy using dosimetry
- An International Conversation on Stem cell Gene therapy: 4th Stem cell Conference on Stem cell Gene therapy Thessaloniki, Greece, 13–17 September …
- Hematopoietic Stem cell Gene therapy for Wiskott-Aldrich Syndrome.
- Investigation progress of imaging techniques monitoring Stem cell therapy
- KINETIC CONSIDERATIONS FOR. Stem cell therapy
- cellular therapy can be affected by the sex of the Stem cell used
- Biological modifiers as cytoreductive therapy before Stem cell transplant in previously untreated patientswith multiple myeloma
- Resistance to pretransplant imatinib therapy may adversely affect the outcome of allogeneic Stem cell transplantation in CML
- Stem cell therapy for Liver Disease
- Stem cell therapy for myocardial infarction
- 360. Transmitochondrial Stem cells: Toward Autologous Cybrid Stem cell therapy and Synergistic Transient Regenerative Gene therapy for Mitochondrial (mt) DNA …
- Second Autologous Stem cell Transplant (ASCT) as Salvage therapy in Patients with Relapsed Multiple Myeloma: Improved Outcomes in Patients with Longer …
- Autologous or allogeneic Stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy
- Gene and Stem cell therapy
- Stem cell therapy in heart disease
- Hematopoietic Stem cell Transplantation, StemCells, and Gene therapy
- … Reduces the Cytotoxic Effects of In Vitro Expanded NK cells: Implications for Adoptive NK cell therapy in the Setting of Allogeneic Hematopoietic Stem cell …
- A PETHEMA study of high-dose therapy/Stem cell support (HDT), including tandem transplant, in primary refractory multiple myeloma (MM): Identification of two …
- Nuclear cloning, embryonic Stem cells and cell therapy: Promise, problems, reality
- Stem cell therapy of AD: Which way to go?
- Concerns Regarding Stem cell therapy from the Clinical Perspective
- therapy-related myelodysplastic syndrome following acute promyelocytic leukemia and biphenotypic acute leukemia following Stem cell transplantation in the …
- Durable remissions are rare following high dose therapy with autologous Stem cell transplantation for adults with” paediatric” bone and soft tissue sarcomas
- Neural Stem cells and cell replacement therapy: making the right cells
- Stem cell therapy in Liver Disease
- Stem cell therapy for myocardial infarction
- … Schedule Finding Study of Maintenance therapy with Low-Dose 5-Azacitidine (AZA) after Allogeneic Hematopoietic Stem cell Transplantation (HSCT) for …
- Stem cell therapy: Moving towards reality
- … : ARTIFICIAL cells: Biotechnology, Nanomedicine, Regenerative Medicine, Blood Substitutes, Bioencapsulation, and cell/Stem cell therapy. By Thomas Ming Swi …
- Stem–cell therapy for type 1 diabetes
- The Role of Pet Scan in Stem cell therapy
- Developmental aberrations of permanent teeth after high-dose anticancer therapy in childhood: A study on Stem cell transplant recipients
- Stem cell therapy in Acute Coronary Syndrome
- … PCR detection method for preemptive therapy of cytomegalovirus infection in patients after allogeneic hematopoietic Stem cell transplantation–single-centre …
- Development of Adult Stem cell therapy Products
- Is Regulation of Stem cell therapy and Therapeutic Cloning Needed?
- New developments in Stem cell biology and therapy. meeting report from the working group of the German Society for Hematology and Oncology
- Hope to the cancer therapy: cancer Stem cell
- Stem cell therapy in endocrinology: reality and challenges
- New Approach in Ischemic Stroke Treatment: Stem cell therapy
- Adult Stem cell therapy–an option for the brain?
- Stem cell therapy for Erectile Dysfunction
- The Basics of Pathologic Assessment in Experimental Models of Stem cell therapy
- Understanding the Basics of Clinical Imaging for Assessing Stem cell therapy in the Heart
- Stem cell therapy for Patients with Myocardial Infarction
- Intensive multimodality therapy including paclitaxel and reduced-intensity allogeneic hematopoietic Stem cell transplantation in the treatment of adrenal cancer with …
- Clinical Utilization of Stem cell therapy in Acute Myocardial Infarction
- Stem cell therapy In Endocrinology-Scope And Limitations
- Stem cell transplantation as consolidation therapy for children in first-remission AML: a single-center report
- Second autologous Stem cell transplantation as salvage therapy in patients with relapsed multiple myeloma: Improved outcomes in patients with longer disease free …
- Embryonic Stem cell therapy for diabetes mellitus
- Mechanisms of myocardium repairing by Stem cell therapy
- Stem cell therapy FOR MYOCARDIAL REGENERATION
- Stem cell therapy-role in corneal diseases: mini review
- 1088. Stem cell Gene therapy with No Pre-Conditioning for the ADA-Deficiency Patients Leads to Generalized Detoxification and Delayed, but Steady Hematological …
- Hearing loss treatment through Stem cell therapy
- Exploring Stem cell therapy Potentials: A Q&A with Anthony G. Payne, Ph.D.
- Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic Stem cell transplantation: a single-center experience in Korea
- Current Status of G-CSF Based Stem cell therapy for Patients with Myocardial Infarction
- Future of Stem–cell therapy for neuromuscular diseases
- Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood Stem cell transplantation
- Stem cell therapy for failing hearts: there is something else beyond the cells
- Cardiac Stem cell therapy research in China
- The Role of Non-invasive Imaging and cell Labelling Techniques in the Clinical Assessment of Stem cell therapy
- Bringing cardiac Stem cell therapy into the clinic
- A comparative review of legal and ethical issues arising from Stem cell therapy and therapeutic cloning
- Myocardium repair with Stem cell therapy
- Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic Stem cell transplantation
- Guided cardiogenesis for safe Stem cell‐based therapy
- Stem cell therapy of Intractable Human Diseases; Potentials and Pitfalls
- Efficacy of High-Dose therapy and Autologous Stem cell Transplantation for Chemoresistant Hodgkin’s Lymphoma.
- Stem cell therapy jumps another ethical hurdle
- Adult neural Stem cell therapy for the brain
- Stem cell therapy using Umbilical Cord Blood in Liver Disease
- Pre-Transplant Rituximab therapy Is Associated with Improved Progression-Free and Overall Survival in Patients Undergoing Autologous Hematopoietic Stem cell …
- Stem cell therapy in animal models of inherited metabolic diseases
- Growth and differentiation of human embryonic Stem cells for cardiac cell replacement therapy
- Drug evaluation: ADA-transduced hematopoietic Stem cell therapy for ADA-SCID.
- In Vitro Model SyStem for Cardiac Stem cell therapy
- Efficacy of posaconazole (POS) vs standard therapy and safety of POS in hematopoietic Stem cell transplant (HSCT) recipients vs other patients with aspergillosis
- Does mesenchymal Stem cell therapy help multiple sclerosis patients? report of a pilot study
- Evaluation of Magnetic Nanoparticles for Stem cell therapy Using a Microfluidic SyStem
- The Role of High Dose therapy and Stem cell Rescue in the Management of T-cell Malignant Lymphomas (TCL): A BSBMT and ABMTRR Study.
- Hematopoietic AC133+ Stem cell therapy for patients with severe peripheral vascular disease
- Increasing importance of Stem cell gene therapy in adenosine deaminase deficiency?
- Dendritic cell therapy for Tolerance Induction to Stem cell Transplantation
- Regenerative medicine and cardiovascular diseases: Stem cell therapy
- Stem cell therapy FOR DEGENERATIVE DISC DISEASE: IN VITRO AND IN VIVO STUDY
- Complete remission upon bortezomib–dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic Stem cell …
- … -retinoic acid+ dexamethasone+ alpha interferon as maintenance therapy following high-dose chemotherapy and autologous Stem cell transplant for multiple …
- Stem cell therapy, smoking and obesity: getting the priorities right for reducing cardiovascular diseases
- The Application of Mesenchymal Stem cell therapy on Multiple SyStem Atrophy
- … High Dose Chemotherapy (HDC) Prior to Autologous Stem cell Transplantation (ASCT) as First Line therapy in Stage III-IV Diffuse Large B-cell Lymphoma (B-DLCL …
- Cancer Stem cell targeted therapy: Removing the sword of Damocles
- Does Stem cell therapy for ischemic cardiomyopathy result in the improvemnt of congestive heart failure: A prospective randomized study
- The effects of music therapy on anxiety, nausea and vomiting in patients receiving total body irradiation for hematopoietic Stem cell transplantation
- Stem cell therapy after irradiation of a malignant asecretory pheochromocytoma–a case report
- Indications for hematopoietic Stem cell therapy for patients with diagnosis of myelodysplastic syndromes
- Stem cell therapy FOR INTERVERTEBRAL DISC DEGENERATION IN-VITRO AND IN-VIVO FEASIBILITY STUDY
- Stem cell therapy in rat hind limb ischemic injury
- … Large B-cell Lymphoma (DLBCL) Does Not Affect Disease-Free (DFS) or Overall Survival (OS) Following High Dose therapy (HDT) and Autologous Stem cell …
- CD34+ Stem cell therapy in Chronic Stroke Patients
- Safety and Efficacy of Enzyme Replacement therapy (ERT) in Combination with Haematopoietic Stem cell Transplantation (HSCT) for Hurler’s Syndrome …
- Molecular imaging of cardiac Stem cell mediated angiogenic gene therapy
- Heart rate variability and cardiac rhythm alterations associated with Stem cell therapy in cardiovascular disease
- … Use of Palifermin and Pegfilgrastim Significantly Reduces Toxicity of High-Dose therapy and Autologous Blood Stem cell Transplantation in Patients with …
- … of Prevention of Severe Oral Mucositis Using Single Dose Velafermin in Patients Receiving Myeloablative therapy and Autologous Hematopoietic Stem cell …
- Restoration of the left ventricular synchronous contraction after acute myocardial infarction by Stem cell therapy
- Rostock Confocal Image Analysis of Patients Treated With Cultured Limbal Epithelial Stem cell therapy
- Bone marrow derived adult Stem cells: characterization and application in cell therapy
- Production, Transplantation and Outcome of Good Manufacturing Practice Compliant Limbal Epithelial Stem cell therapy
- Muscle Derived Stem cell/Alginate/Polycaprolactone/Injection therapy in Rats with Denervated Urethral Sphincter
- High-dose chemotherapy with autologous hematopoietic Stem cell transplantation for non-Hodgkin’s lymphoma in complete response as consolidation therapy …
- Engineering a New Insulin-Like Growth Factor-1 Protein for Embryonic Stem cell therapy
- The effect of cell therapy using a human mesenchymal Stem cell injection on left ventricular systolic function in rat myocardial infarction model
- 90Y-Ibritumomab Tiuxetan (Zevalin®) in Combination with High-Dose therapy (HDT) Followed by Autologous Stem cell Transplant (ASCT) May Improve …
- Human Mesenchymal Stem cell therapy: Platelet Lysate Supports Efficient Preclinical Expansion.
- … of a minimally invasive bone marrow harvest device and method for the rapid extraction of bone marrow for use in bone marrow transplantation and Stem cell therapy
- ENGINEERED MESENCHYMAL Stem cell therapy PROLONGED CARDIAC ALLOGRAFT SURVIVAL.
- Autologous Bone Marrow-Derived Stem cell therapy in Patients with Severe Peripheral Arterial Disorders: A Pilot Study.
- Mesenchymal Stem cell therapy Prevents Ischemia/Reperfusion Injury and Promotes Tissue Regeneration
- Update of melphalan 280 mg/m2 plus amifostine cytoprotection before autologous Stem cell transplantation as part of initial therapy in multiple myeloma patients
- … Correlates with Less Acute Graft-Versus-Host Disease and Better Survival in B-cell Lymphoma Patients Who Received Allogeneic Peripheral Blood Stem cell …
- Bone marrow Stem cell therapy for renal regeneration after acute tubular necrosis: A dream or a reality?
- Autologous Bone Marrow Stem cell Infusion (AMBI) therapy for Chronic Liver Diseases
- Patients with End-Stage Ischemic Heart Failure: a Growing Target Population for Cardiac Stem cell therapy
- … Stem cell therapy for Incurable and Intractable Disease: More than 700 Stem cell Panels are Stored and Umbilical Cord Blood Derived Stem cell Bank will be …
- … effects of hematopoietic Stem cells on cancer (gliosarcoma spheroids) and normal tissues: towards developing hematopoietic Stem cell therapy for astronauts’ cancer
- Molecular Level of Minimal Residual Disease in Bone Marrow Before High-Dose therapy and Autologous Stem cell Transplantation Is a Prognostic …
- Prolonged Clinical and Molecular Remissions Following High-Dose therapy/Autologous Stem cell Transplantation (HDT/ASCT) and Rituximab and …
- Gene therapy and Stem cell therapy for cardiovascular diseases today: a model for translational research Cancer regression in patients after transfer of genetically …
- First trial in a case of Fibrocarcilaginous embolism by dorsolaminectomy and Stem cell therapy in a cocker spaniel dog
- 13N-NH3 PET: The assessment of myocardial perfusion in patients with AMI and Stem cell therapy
- … chemotherapy and autologous hematopoietic Stem cell mobilization, collection and transplantation with simultaneous Imatinib therapy in patients with blast …
- Stem cell therapy with G-CSF Did Not Aggravate Neointimal Growth, but Induced Positive Remodeling in Patients with Myocardial Infarction who Underwent Drug …
- Novel tyrosine kinase inhibitor therapy (NTKI) prior to allogeneic Stem cell transplantation (ASCT) in patients (pts) with chronic myeloid leukemia (CML): No evidence …
- High-Dose therapy and Autologous Stem cell Transplantation for Chemoresistant Diffuse Large B cell Lymphoma: The Seattle Experience.
- Bringing cardiac cell therapy with bone marrow Stem cells to the clinic: where are we now?
- 1018. Stem cell Gene therapy: Toward a Universal Platform Relying on Custom Endonuclease-Boosted Gene Targeting, Cybridization, Transient Regenerative …
- Treosulfan-Based Tandem High-Dose Chemo-Immuno-therapy with Autologous Stem cell Transplantation for Relapsed and Refractory Aggressive B-cell …
- Idiotype (Id) immunotherapy (IT) following high dose therapy and autologous Stem cell transplant (HDT/ASCT) in mantle cell (MC) and indolent lymphoma (IL): cellular …
- Smoothened peptides inhibit prostate and gastric cancer cells by targeting the Hedgehog pathway: a potential cancer Stem cell therapy
- Treatment of AL amyloidosis with high dose therapy and autologous Stem cell transplantation
- Intervertebral disc cell therapy for regeneration: mesenchymal Stem cell cultivation in vitro and intervention in TGF-? 1 implantation in rabbit intervertebral discs
- Fetal Stem–cell and gene therapy
- Allogeneic Hematopoietic Stem cell Transplantation (Allo-SCT) Versus Conventional Postremission therapy (PRT) for AML in First Complete Remission …
- Protein A column therapy for a patient refractory to platelet transfusions undergoing allogeneic hematopoietic Stem cell transplantation
- Treosulfan high dose therapy with autologous Stem cell rescue in high-risk Ewing tumors
- Tandem high-dose therapy with autologous Stem cell support for small-cell lung cancer (SCLC)
- … VTD (VELCADE®, Thalidomide, Dexamethasone) Induction Followed by High-Dose therapy with Autologous Stem cell Transplantation and Maintenance …
- Air Leak Syndrome (ALS) Following Allogeneic Stem cell Transplantation (SCT): A Report of 22 Patients from Kanto Study Group for cell therapy (KSGCT) in Japan.
- High dose therapy with autologous Stem cell transplantation in patients with Hodgkin’s lymphoma: long-term follow-up in patients treated in one center
- Effects of injection therapy using muscle derived Stem cell/chitosan/hydroapatite composite gel in a rat model of urinary incontinence
- Stem cells as Targets for Gene and cell therapy
- … bone marrow mononuclear cells labeled with Tc-99m hexamethylpropylene amine oxime scintigraphy after intracoronary Stem cell therapy in acute myocardial
- Immunomodulatory therapy for SSc: Will high-intensity immunosuppression with Stem cell rescue improve outcome?
- Stem–cell transplant for Hodgkin’s lymphoma: does choice of therapy prior to high-dose treatment matter?
- Bortezomib (BTZ) prior to and as maintenance therapy after autologous Stem cell transplant (ASCT) in multiple myeloma (MM): Long-term follow-up of a phase II study
- Potential of Stem cell based therapy and tissue engineering in the regeneration of the central nervous syStem
- Stem cells a Hope for cell therapy and Regenerative Medicine
- Maintenance therapy with 5-Azacytidine (5-AC) after Allogeneic Stem cell Transplantation (allo-SCT) for Acute Myelogenous Leukemia (AML) and High-Risk …
- Dual-gene transfer and vector targeting for hematopoietic Stem cell gene therapy
- … therapy (ECP) with UVADEX® for the prevention of acute GVHD in patients (pts) undergoing standard myeloablative conditioning and allogeneic hematopoietic Stem …
- Gene therapy and Stem cell activation against stroke
- Directed differentiation of adult neural Stem cells for cell therapy in the nervous syStem
- Stem cell potential for type 1 diabetes therapy
- The Impact of Histologic Grade on the Outcome of High-Dose therapy and Autologous Stem cell Transplantation for Follicular Lymphoma.
- Reply to ‘Autologous Stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome’
- High Dose therapy and Autologous Peripheral Blood Stem cell Transplantation as Salvage therapy for HIV-Associated Lymphoma: Result of the GICAT Study.
- Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous Stem cell transplantation
- Clonal Analyses of Retroviral Vector Integrations in ADA-SCID Patients Treated with Stem cell Gene therapy.
- Prognostic Factors for CMV Reactivation/Infection after Stem cell Transplantation and Value of Oral Valganciclovir for Preemptive therapy.
- Haematopoietic Stem cell Based Gene therapy as a Strategy to Treat Autoimmune Disease
- Functional Comparison of Bone Marrow–Derived Liver Stem cells: Selection Strategy for cell-Based therapy
- Efficacy of Azacytidine (5-AC) Given as Maintenance or Salvage therapy for Patients (pts) with Acute Leukemia Post Allogeneic Stem cell Transplantation (HSCT).
- … Preparative Regimens on the Incidence of therapy Related Myelodysplasia (t-MDS) or AML (t-AML) Following Autologous Stem cell Transplant (ASCT) for …
- High-dose cyclophosphamide as an effective therapy for a patient with refractory multiple myeloma relapsing after autologous Stem cell transplantation
- 1: Cytotoxic T lymphocyte therapy for the treatment and prevention of adenovirus infection after Stem cell transplant
- Preliminary Results of therapy with AM3 in Patients Undergoing Hematopoietic Stem cell Transplantation.
- The role of high-dose therapy and Stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and…
- Stem cell replacement therapy in type 1 diabetes
- 2520: Involved Field Radiation therapy Following Autologous Stem cell Rescue for Hodgkin and Non-Hodgkin Lymphoma-Is it Efficacious?
- … -Adapted therapy of Adult Acute Myeloid Leukemia (AML): Safety and Efficacy of Repetitive HD-ARA-C Courses with Low-Dose Autologous Blood Stem cell …
- The experimental study on bone marrow Stem cell transplantition combinated with bushen fang therapy for DMD
- Phase II trial of GM-CSF as maintenance therapy post–autologous peripheral blood Stem cell transplantation in multiple myeloma
- … after autologous peripheral blood Stem cell transplantation does not add any benefit regarding hematological engraftment and supportive therapy …
- … Incidence in Patients with Hematological Malignancies Receiving Myelotoxic therapy Requiring Hematopoietic Stem cell Support-Palifermin Experience.
- … of Interferon Versus Thalidomide Versus RIC Allotransplant for Maintenance/Consolidation therapy after Autologous Stem cell Transplantation in Patients …
- Stem cell transplantation therapy for diabetes mellitus
- Rituximab maintenance following high dose therapy and autologous Stem cell rescue after RICE cytoreduction improves event free and overall survival
- Posaconazole (POS) salvage therapy allows successful allogeneic hematopoietic Stem cell transplantation (HSCT) in patients with refractory invasive mold infections
- High dose therapy followed by autologous purged Stem cell
- High-Dose therapy/Stem cell Support (HDT), Including Tandem Transplant, for Primary Refractory Multiple Myeloma (MM): Results from the Spanish Myeloma Group …
- Study Progress of Hematopioetic Stem cell Transplantation therapy on Acute Leukemia in Children
- … -CHOP, Based on CT and Gallium 67 Scan (G67S) with or without IFE Salvage therapy Followed by Peripheral Autologous Stem cell Transplant (PBSCT) in …
- … CsA, MTX, MMF and ATG and Triple therapy with CsA, MTX and ATG for Preventing Graft-Versus-Host Disease in Unrelated Donor Hematopoietic Stem cell …
- … Associated with Engraftment of Gene-Corrected Repopulating cells Achieved in ADA-SCID Patients by Stem cell Gene therapy without Myelopreparative Pre …
- Isolation of amniotic Stem cell lines with potential for therapy.
- … WITH LOW DOSE PARATHYROID HORMONE PULSE therapy INCREASES ALLOGENEIC HEMATOPOIETIC Stem cell ENGRAFTMENT IN NON-HUMAN …
- … Stem cells may be uniquely suited for combined gene therapy and cell replacement: evidence from engraftment of neurotrophin-3-expressing Stem cells in hypoxic …
- … neurectodermal tumors (SPNET) treated with risk-adapted craniospinal (CSI) radiation (RT) therapy followed by 4 cycles of high-dose chemotherapy and Stem cell …
- Allogeneic Stem cell Transplantation for therapy-Related Myelodysplastic Syndrome (t-MDS) and Acute Myeloid Leukemia. A Report from the MDS …
- Reply to ‘Promotion of neurogenesis by human Stem cells in high-risk breast cancer survivals after Stem–cell supported high-dose therapy‘by K. Altundag et al.(Ann …
- Gene therapy and Stem cell transplantation in PAD
- Stem cell: From Bone Marrow Transplantation for the Treatment of Hematological Diseases to therapy for Other SyStemic Disorders
- EPIGENETIC INSTABILITY OF HUMAN EMBRYONIC Stem cell LINES: IMPLICATIONS FOR therapy
- Neural Stem cell can mediate immune therapy for brain tumor
- Osteosarcoma target therapy with Stem cell transplant: A case review
- Impact of intensive Stem cell mobilization therapy on outcomes following autologous Stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL)
- Immunoablative therapy with Autologous Stem cell Transplantation in the Treatment of Poor Risk Multiple Sclerosis.
- Embryonic Stem cells and cardiac cell therapy
- Which Strategy of Immunoablative therapy with Autologous Stem cell Transplantation (ASCT) Is Preferable in Multiple Sclerosis (MS) Patients?.
- Combination therapy with mesenchymal Stem cell and erythropoietin in patients with ALS
- Experimental substantiation of embryonic Stem cell application in therapy of patients with extrapyramidal hyperkinesis
- therapy of Heart Failure Rats with Mesenchymal Stem cell Transplantation
- Long-term safety and efficacy of Stem cell gene therapy for ADA-SCID.
- Differentiation of Human Embryonic Stem cells; Prospects for Development Biology and cell therapy
- Autologous Stem cell Transplantation Provides Additional Cytoreduction Following Induction therapy in Multiple Myeloma.
- Correction of Murine Hemophilia A by Hematopoietic Stem cell Gene therapy.
- Experimental investigation on therapy of intravenous transplantation of neural Stem cell for spinal cord injury
- Are RIC allogeneic Stem cell transplants ready for prime time in CLL therapy?
- High-dose therapy with autologous Stem cell rescue in patients with breast cancer at high risk for relapse
- Regenerative cellular therapy: How To Enrich The Mesenchymal Stem cell Content In The Periinfarction Zone After Myocardial Infarction
- Bone marrow Stem cells: possible source for cell therapy in Parkinson’s disease
- Second Autologous Stem cell Transplant (ASCT) as Salvage therapy for Relapsed Multiple Myeloma.
- Tacrolimus therapy for Severe Recurrent Crohn’s Disease after Stem cell Transplant: 844
- Improved Survival in Patients with Peripheral T cell Lymphoma, Unspecified Following High-Dose therapy and Stem cell Transplantation: A Retrospective …
- Plasmid transfection of rat bone marrow mesenchymal Stem cells by cationic lipid for gene-modified cell transplantation therapy
- 1672: Early Phase I/II Clinical Trial Results for Human Cord Blood Stem cell Injection therapy for Stress Urinary Incontinence
- Thalidomide salvage therapy following allogeneic Stem cell transplantation for multiple myeloma: A…
- Conditioning therapy with intravenous busulfanum and cyclophosphamide for allogeneic hematopoietic Stem cell transplantation: A report of 19 cases☆
- 433 EVALUATION OF Stem cell POPULATIONS IN THE BLOOD OF PATIENTS UNDERGOING EXTRACORPOREAL MEMBRANE OXYGENATION therapy.
- Estrogen-progestin therapy in women after Stem cell transplant: our experience and literature review.
- Gemtuzumab Ozogamicin as Maintenance therapy after Autologous Stem cell Transplantation (ASCT) in Patients with Acute Myeloid Leukemia (AML).
- Biological modifiers as cytoreductive therapy before Stem cell transplant in previously untreated patientswith m…
- Early Goal Directed therapy for Septic Shock Is Feasible and Safe in Hematopoietic Stem cell Transplant Patients.
- Sca-1+ Progenitors Derived from Stem cells Differentiate into Endothelial cells: Implications for Stem cell-Based therapy in the Injured Artery
- Limbal Stem cell autotansplantation in therapy of recurrent pterygium and ophthalmoherpes
- Characteristics of patients with false positive FDG-PET findings after high dose therapy and autologous Stem cell transplantation (HDT/ASCT)
- Comment on ‘CD34+ selected hematopoietic Stem cell (HSC) not preceded by any immunosuppressive therapy as effective treatment of graft failure’–G Milone et al
- Allogeneic hematopoietic Stem cell transplantation as consolidation therapy for adult T cell Leukemia/Lymphoma patients: A single-center experience in 35 patients.
- … therapy for Thymic Insufficiency after Hematopoietic Stem cell Transplantation: Generation of MTS24 Positive Definitive Endoderm from Murine Embryonic Stem …
- … results of risk adapted pre-emptive therapy of CMV infection with ganciclovir in 169 patients, after allogeneic hematopoietic Stem cell transplantation in Hematology …
- Voriconazole (VOR) is safe and effective as prophylactic antifungal therapy for allogeneic Stem cell transplantation (AT)
- Effects of Prior therapy on the in Vitro Proliferative Potential of Stem cell Factor Plus Filgrastim-mobilized CD34-positive Progenitor cells1
- Hematopoietc Stem cell Targeted Neonatal Gene therapy Cures oc/oc Mice from Osteopetrosis.
- Interferon-α therapy for patients with molecular relapse in leukemia after allogeneic Stem cell transplantation
- NOVEL METHODS IN THE DIAGNOSTICS AND therapy Intracoronary, autologous bone marrow Stem cell transplantation for treatment of postinfarction left …
- Involved Field Radiation therapy Following Autologous Stem cell Rescue for Hodgkin and Non-Hodgkin Lymphoma-Is It Efficacious?.
- Determining the Appropriate PCR Trigger for Pre-Emptive Anti-CMV therapy in Allogeneic Stem cell Transplant Recipients.
- FDG-PET for the prediction of therapy outcome in patients with high risk soft tissue sarcomas receiving high dose chemotherapy with Stem cell rescue
- … initial therapy may be associated with a poorer outcome in young patients subsequently treated with Stem cell transplantation for relapsed chemosensitive large B-cell …
- Clinical Prognostic Factors in Chemosensitive Multiple Myeloma (MM) Patients Intensified with High Dose therapy/Stem cell Support (HDT/SCS): Results of …
- High-dose therapy and autologous Stem cell transplantation for Hodgkin’s lymphoma in relapse or failure after initial chemotherapy: results of the Centre National de …
- … of Patients with Refractory/Relapsed Hodgkin’s Disease (HD) Treated with IGEV Chemotherapy (CT) and High Dose Consolidation therapy (HDT) with Stem cell …
- Gene therapy and neural Stem cell transplantation in rodent models of Huntington’s disease
- Poor Prognosis for Patients after Myelo-and Non-Myeloablative Conditioning therapy Followed by Allogeneic Peripheral Blood Stem cell Transplantation Admitted to …
- … Followed by Early High-Dose therapy and Hematopoietic Stem cell Transplantation Results in Improved Outcome for Patients with Hepatosplenic T-cell …
- High dose chemotherapy with autologous Stem cell rescue as a part of combined modality therapy in stage IIIB inflammatory breast cancer
- … I/II-Study on PCR-Based Pre-Emptive therapy with Valganciclovir or Ganciclovir for Active CMV Infection Following Reduced Intensity Allogeneic Stem cell …
- 248: Novel tyrosine kinase inhibitor therapy (NTKI) prior to allogeneic Stem cell transplantation (ASCT) in patients with chronic myeloid leukemia (CML): No evidence …
- 442. LV Expressing MR Reporter Genes Allows In Vivo Monitoring of Stem cell Gene therapy
- High-Dose therapy (HDT) with Autologous Hematopoietic Stem cell Transplantation (HSCT) in Patients with Poor Prognosis Ewing Family Tumors (EFT).
- Busulfan and melphalan as preparative therapy for Stem cell transplantation in pediatric patients with acute myelogenous leukemia (AML) and myelodysplasia (MDS)
- … chemotherapy and autologous Stem cell transplantation in poor prognosis patients with advanced follicular lymphoma—effective therapy in first complete or partial …
- Administration of Virus-Specific Cytotoxic T-Lymphocytes for the Prophylaxis and therapy of Adenovirus Infection post Allogeneic Stem cell Transplant
- Modified Thalidomide, Cyclophosphamide and Dexamethasone (TCD) to Patients with Multiple Myeloma as Primary therapy Prior to Peripheral Blood Stem cell …
- Hematopoietic Stem cell Transplantation (HSCT) as Curative therapy for Fanconi Anemia (FA) Patients with Acute Leukemia or Advanced Myelodysplasia (MDS).
- Steroid therapy Increase Only Adenovirus Infection but Not Cytomegalovirus Infection in Dose Dependent Manner after Hematopoietic Stem cell Transplantation.
- Stem cell Transplantation (SCT) in Conjunction With Enzyme Replacement therapy (ERT) for a Child With Hurler Syndrome (MPS IH): 42
- Characterization of an Immunodeficient Mucopolysaccharidosis Type I (MPS-I) Mouse Model Suitable for Preclinical Testing of Human Stem cell and Gene therapy.
- … treatment for thrombocytopenia after salvage therapy with arsenic trioxide therapy followed by autologous hematopoietic Stem cell transplantation in acute …
- Comparison of HLA-Identical Sibling Hematopoietic Stem cell Transplant (HCT) Versus Chemotherapy as Postremission therapy in t (8; 21) Acute Myeloid Leukemia …
- Allogeneic Hematopoietic Stem cell Transplantation after Combination therapy with Imatinib and Intensive Chemotherapy for Newly Diagnosed Philadelphia …
- Zoledronic Acid Plus Thalidomide Is Safe and Well Tolerated When Used as Post-Autologous Stem cell Transplant Maintenance therapy in Patients with …
- 1055. High Levels of Human Factor IX Expression in Hemophilia B Mice after Adult Stem cell-Based Gene therapy Combined with Non-Myeloablative Conditioning
- Bortezomib therapy for Multiple Myeloma in Relapse after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem cell Transplantation (RICT).
- Maintenance therapy with Thalidomide/Prednisone Post Autologous Stem–cell Transplant for Patients with Multiple Myeloma Elevates D-Dimer and Possibly …
- Directed differentiation of pancreatic islets from human embryonic Stem cells and cell therapy of diabetes mellitus
- … a Phase II Study of Post-Transplant Maintenance therapy in Patients with Multiple Myeloma Following High-Dose Chemotherapy and Autologous Stem cell …
- … -Rituximab (DC-R) Plus GM-CSF as a Salvage therapy in B-Diffuse Large cell Lymphoma (B-DLCL) after Autologous Stem cell Transplantation (ASCT) Failure.
- Allogeneic Myelo-Ablative Stem cell Transplant (SCT) as Salvage therapy of Reduced-Intensity Conditioned (RIC) SCT: Toxicity and Outcome.
- Molecular mechanisms of immune deficiency in adenosine deaminase (ADA)-deficient SCID patients: implications for Stem cell gene therapy
- … Memory B cell Population with Persistent Hypogammaglobulinemia after Rituximab Administration as an Adjuvant therapy after Autologous Stem cell …
- 347: Intentional induction of mixed hematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic Stem cell transplantation in childhood …
- Corticosteroid therapy Does Not Increase Relapse Rate after Allogeneic Hematopoietic Stem cell Transplantation for Acute Myelogeneous Leukemia and …
- Tandem high-dose chemotherapy (HDC) with peripheral blood Stem cell rescue (PBSCR) as consolidation therapy for high-risk (primary unresectable pelvic tumors or …
- … -Based Maintenance therapy in Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukaemia (Ph+ ALL) Ineligible for Allogeneic Stem cell …
- … Field Radiation Treatment (IFRT) in Patients With Bulky Non-Hodgkin Lymphoma (NHL) Undergoing High-Dose therapy and Autologous Bone Marrow/Stem cell …
- 131I-Metaiodobenzylguanidine (131I-MIBG) double infusion with autologous Stem cell transplant for neuroblastoma: A New Approaches to Neuroblastoma therapy …
- Allogeneic Stem cell Transplantation (AlloSCT) for the Treatment of therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid Leukemia (tAML): Results …
- … (Cp) and C. guillermondii (Cg) Blood Stream Infections in Allogeneic Hematopoetic Stem cell (HSC) Recipients Receiving Long Term Caspofungin (C) therapy.
- Gleevec as therapy for CML Relapsed after Allogeneic Stem cell Transplantation: High Rate of BCR-ABL PCR Negativity and Donor Graft Reconstitution.
- Successful Engraftment Using Varied Stem cell Sources, Low Toxicity, and Long-Term Survival Using a Bu/Flu/ATG Reduced Intensity Allogeneic Transplantation in …
- Does Highly Active Anti-Retroviral therapy (HAART) Delay Myeloid Engraftment after Autologous Stem cell Transplant (ASCT) in HIV Associated Lymphoma (HIV+ Ly …
- Low-Dose Methotrexate as Salvage therapy for Refractory Graft-Versus-Host Disease (GVHD) after Reduced-Intensity Conditioning (RIC) for Allogeneic Stem cell …
- 65. Long-Term Effects of Hematopoietic Stem cell Gene therapy in the Murine Model of Wiskott-Aldrich Syndrome: Persistence of Functional Correction of T cells and …
- 263: Non-myeloablative conditioning therapy with fludarabine, cyclophosphamide and ATG allogeneic hematopoietic Stem cell transplantation from HLA-identical …
- … , Etoposide, Cyclophosphamide and Autologous Peripheral Blood Stem cell Transplantation Followed by Randomization to therapy with Interleukin-2 Versus …
- Combined Stem cell Mobilization via CXCR4 Antagonist Augments Recruitment of EPCs Following Sonic Hedgehog Gene therapy via Increased Local Expression of …
- … Graft-Versus-Host Disease (GVHD) Following Bortezomib as Salvage therapy after Reduced Intensity Conditioning Allogeneic Stem cell Transplantation (RIC allo …
- DLA-Haploidentical Stem cell Allografts after Anti-CD44 therapy and Nonmyeloablative Conditioning: The Impact of Donor Lymphocyte Infusion (DLI) …
- Sustained effect of first line sequential therapy with intensive consolidation chemotherapy and allogeneic hematopoietic Stem cell transplantation (ASCT) after reduced …
- 356: First line sequential therapy with intensive consolidation chemotherapy and allogeneic hematopoietic Stem cell transplantation (ASCT) after reduced intensity …
- COMBINATION cell AND GENE therapy FOR PERIPHERAL ISCHEMIA USING MYOBLASTS AND Stem cells ENGINEERED WITH CONDITIONALLY …
- Stem cells and cell-based therapy in neurodegenerative disease
- Mobilis in Mobile–Human Embryonic Stem cells and Other Sources for cell therapy
- Stem cells and islet engineering for cell replacement therapy in diabetes
- Investigation into the application of adult human Mueller Stem cells in retinal ganglion cell replacement therapy
- Proliferation of bone marrow mesenchymal Stem cells, skeletal muscle cells and co-culture of both for cell myocardium therapy in Wistar rats
- Mesenchymal Stem cells: Differentiation, hematopoietic support and possible application in cell and gene therapy for osteoarthritis
- Neural Stem cells for cell replacement therapy in Huntington’s disease
- cell and gene therapy via human neural Stem cells (hNSCs) in transgenic SOD1 (G93A) ALS (amyotrophic lateral sclerosis) mice
- cell transplantation for periodontal diseases. A novel periodontal tissue regenerative therapy using bone marrow mesenchymal Stem cells
- Microencapsulation of Mesenchymal Stem cells (MSCs) for cell Based therapy
- Improvement of musculoskeletal function by cell-based therapy using mesenchymal Stem cells with a prolonged life span
- … Stem cells together with differentiated derivatives of human embryonic Stem cells. A novel strategy to enhance the efficacy of autologous cell-transplantation therapy …
- Discovery of a Novel Paracrine Angiogenic Factor from Akt-Transduced Mesenchymal Stem cells for cell/Protein-based therapy in angiogenesis
- Introduction to Stem cell therapy
- Stem–cell therapy for cardiac disease
- Stem cell‐based cell therapy in neurological diseases: a review
- Stem cell therapy in stroke
- Stem cell therapy–Hype or hope? A review
- Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal Stem cells
- Mesenchymal Stem cells: Stem cell therapy perspectives for type 1 diabetes
- Stem cell therapy is proarrhythmic
- The changing face of neural Stem cell therapy in neurologic diseases
- Feasibility of a Stem cell therapy for intervertebral disc degeneration
- A review of gene and Stem cell therapy in cutaneous wound healing
- Stem cell therapy for cardiac repair: benefits and barriers
- Stem cell therapy: MRI guidance and monitoring
- Intravenous mesenchymal Stem cell therapy for traumatic brain injury
- Stem cell therapy restores transparency to defective murine corneas
- Adult Stem cell therapy of female stress urinary incontinence
- Stem cell therapy for heart failure: are arrhythmias a real safety concern?
- Emerging hurdles in Stem cell therapy for peripheral vascular disease
- cellular MRI and its role in Stem cell therapy
- Mesenchymal Stem cell therapy for diabetes through paracrine mechanisms
- Critical issues of clinical human embryonic Stem cell therapy for brain repair
- Current status of Stem cell therapy for liver diseases
- Subacute neural Stem cell therapy for traumatic brain injury
- Mesenchymal Stem cell therapy for equine tendinopathy
- Prospects of Stem cell therapy for replacing dopamine neurons in Parkinson’s disease
- Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal Stem cell therapy
- Stem cell therapy and regenerative medicine
- Olfactory mucosa is a potential source for autologous Stem cell therapy for Parkinson’s disease
- Bone-marrow-derived mesenchymal Stem cell therapy for neurodegenerative diseases
- Stem–cell therapy in retinal disease
- Overview of Stem cell therapy for Crohn’s disease
- Combining growth factor and Stem cell therapy for amyotrophic lateral sclerosis
- Capillary regeneration in scleroderma: Stem cell therapy reverses phenotype?
- Current and future regenerative medicine—principles, concepts, and therapeutic use of Stem cell therapy and tissue engineering in equine medicine
- Cardiac regeneration and Stem cell therapy
- Proinflammatory cytokine effects on mesenchymal Stem cell therapy for the ischemic heart
- Embryonic Stem cell therapy of heart failure in genetic cardiomyopathy
- Mesenchymal Stem cell therapy for nonmusculoskeletal diseases: emerging applications
- Prospects for pluripotent Stem cell‐derived cardiomyocytes in cardiac cell therapy and as disease models
- Autologous mesenchymal Stem cell therapy delays the progression of neurological deficits in patients with multiple syStem atrophy
- Stem cell therapy for cartilage regeneration in osteoarthritis
- Bionetworking: experimental Stem cell therapy and patient recruitment in India
- Stem cell therapy: the great promise in lung disease
- Paracrine mechanisms in adult Stem cell signaling and therapy
- Muscle derived Stem cell therapy for stress urinary incontinence
- Stem cell therapy for cardiac repair
- Mesenchymal Stem cell therapy for protection and repair of injured vital organs
- Stem cell therapy for the kidney?
- Allogenic Stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension
- Potencial role of Stem cell therapy in type 1 diabetes mellitus
- Translational development of mesenchymal Stem cell therapy for cardiovascular diseases
- Stem cell‐based cell therapy for Huntington disease: a review
- Gene and Stem cell therapy in peripheral arterial occlusive disease
- Stem–cell therapy faces more scrutiny in China; but regulations remain unclear for companies that supply treatments
- Stem cell therapy to reduce radiation-induced normal tissue damage
- Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model
- Immunogenicity and allogenicity: a challenge of Stem cell therapy
- Differential destruction of Stem cells: implications for targeted cancer Stem cell therapy
- Comparison of different culture conditions for human mesenchymal stromal cells for clinical Stem cell therapy
- Cytokines as the major mechanism of mesenchymal Stem cell clinical activity: expanding the spectrum of cell therapy.
- Choosing between Stem cell therapy and drugs in myelofibrosis
- Stem cell therapy for ischemic heart disease: where are we?
- Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials
- Tracking Stem cell therapy in the myocardium: applications of positron emission tomography
- Stem cell therapy for end-stage heart failure: indispensable role for the cell?
- Placental mesenchymal and cord blood Stem cell therapy for dilated cardiomyopathy
- Long-term outcome of Stem cell therapy for acute myocardial infarction: right results, wrong reasons
- A new dawn for Stem–cell therapy
- Stem cell therapy in myocardial repair and remodeling
- Stem cell therapy to treat diabetes mellitus
- Stem–cell-based therapy and lessons from the heart
- Stem cell therapy for Alport syndrome: the hope beyond the hype
- Gene and Stem cell therapy in ischemic stroke
- Stem cell therapy: a primer for interventionalists and imagers
- Drawbacks to Stem cell therapy in cardiovascular diseases
- Stem cell therapy for chronic liver disease—choosing the right tools for the job
- Bone marrow-derived mesenchymal Stem cell therapy as a candidate disease-modifying strategy in Parkinson’s disease and multiple syStem atrophy
- Stem cell therapy for heart failure
- Human amnion‐derived mesenchymal Stem cells are a potential source for uterine Stem cell therapy
- Prospects for Stem cell-based therapy
- Mesenchymal Stem cell therapy for degenerative inflammatory disorders
- Isolation of Stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease
- Mesenchymal Stem cell-based therapy for cartilage repair: a review
- Stem cell therapy for urethral sphincter regeneration.
- Adult Stem cell therapy for acute brain injury in children
- Histocompatibility testing of cultivated human bone marrow stromal cells–A promising step towards pre-clinical screening for allogeneic Stem cell therapy
- Stem cell therapy in multiple sclerosis: promise and controversy
- T cell therapy of Epstein–Barr virus and adenovirus infections after hemopoietic Stem cell transplant
- … into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis—a novel approach in Stem cell therapy
- Inflammatory mediators: parallels between cancer biology and Stem cell therapy
- Strategies for future histocompatible Stem cell therapy
- Establishment of a rat model of myocardial infarction with a high survival rate: A suitable model for evaluation of efficacy of Stem cell therapy
- Cardiovascular regeneration and Stem cell therapy
- Stem cell therapy for cystic fibrosis: current status and future prospects
- What are the prospects of Stem cell therapy for neurology?
- Neuroimaging as a basis for rational Stem cell therapy
- Potential of Stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic
- Mesenchymal Stem cell‐based therapy: a new paradigm in regenerative medicine
- T cell therapy in allogeneic Stem cell transplantation
- Immunological considerations for cell therapy using human embryonic Stem cell derivatives
- Stem cell therapy for the broken heart: mini-organ transplantation
- Prostate cancer Stem cell therapy: hype or hope?
- Promise of blood-and bone marrow-derived Stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy
- … synchronous contraction after acute myocardial infarction by Stem cell therapy: new insights into the therapeutic implication of Stem cell therapy for acute myocardial …
- Stem cell therapy in orthopaedic surgery: Current status and ethical considerations
- Microenvironment at tissue injury, a key focus for efficient Stem cell therapy: A discussion of mesenchymal Stem cells
- cell therapy generates a favourable chemokine gradient for Stem cell recruitment into the infarcted heart in rabbits
- Implications of the cancer Stem–cell hypothesis for breast cancer prevention and therapy
- Stem cell therapy for heart failure: the science and current progress
- A review of current progress in gene and Stem cell therapy for erectile dysfunction
- Adipose Stem cells as a clinically available and effective source of adult Stem cell therapy
- Measurement of oxygenation at the site of Stem cell therapy in a murine model of myocardial infarction
- Autologous Stem–cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study
- cell therapy for the diseased liver: from Stem cell biology to novel models for hepatotropic human pathogens
- Stem cell therapy: a promising and prospective approach in the treatment of patients with severe Buerger’s disease
- Adult Stem cell therapy for autoimmune disease
- Physical exercise as adjuvant therapy for patients undergoing hematopoietic Stem cell transplantation
- cell therapy with autologous bone marrow mononuclear Stem cells is associated with superior cardiac recovery compared with use of nonmodified …
- Targeting the leukemic Stem cell: the Holy Grail of leukemia therapy
- Reduced-intensity allogeneic hematopoietic Stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European …
- Stem cell therapy for critical limb ischaemia—a review
- Immunostimulatory effects of mesenchymal Stem cell‐derived neurons: implications for Stem cell therapy in allogeneic transplantations
- Stem cell therapy for inherited metabolic disorders of the liver
- Placenta-derived Stem cells: new hope for cell therapy?
- Inflammatory bowel disease: moving toward a Stem cell-based therapy
- Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial Stem cell therapy
- Twisting immune responses for allogeneic Stem cell therapy
- Hematopoietic Stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy
- Human parthenogenetic embryonic Stem cells: one potential resource for cell therapy
- Another new “super muscle Stem cell” leaves unaddressed the real problems of cell therapy for duchenne muscular dystrophy
- Stem cell research and therapy for liver disease
- Stem cell‐based therapy in gastroenterology and hepatology
- Effects of Stem cell therapy with G-CSF on coronary artery after drug-eluting stent implantation in patients with acute myocardial infarction
- cell therapy for ischaemic heart disease: focus on the role of resident cardiac Stem cells
- Stem cell therapy: past, present, and future
- Neural commitment of embryonic Stem cells: molecules, pathways and potential for cell therapy
- Gene therapy and Stem cell transplantation: strategies for hearing restoration
- Genetic basis of inherited macular dystrophies and implications for Stem cell therapy
- A combined artificial chromosome-Stem cell therapy method in a model experiment aimed at the treatment of Krabbe’s disease in the Twitcher mouse
- Stem cell therapy and coordination dynamics therapy to improve spinal cord injury
- Rewiring the heart: Stem cell therapy to restore normal cardiac excitability and conduction
- Immunosuppressive therapy mitigates immunological rejection of human embryonic Stem cell xenografts
- Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf
- Stem cell therapy for hereditary breast cancer
- Clinical trials update from the American Heart Association 2007: CORONA, RethinQ, MASCOT, AF‐CHF, HART, MASTER, POISE and Stem cell therapy
- Cancer Stem cell: implications in cancer biology and therapy with special reference to lung cancer
- Adoptive precursor cell therapy to enhance immune reconstitution after hematopoietic Stem cell transplantation in mouse and man
- cell therapy for diabetes mellitus: an opportunity for Stem cells?
- Combination of enzyme replacement and hematopoietic Stem cell transplantation as therapy for Hurler syndrome
- Unproven Stem–cell therapy ban
- … of invasive fungal infection in adult hematopoietic Stem cell transplant recipients: analysis of Multicenter Prospective Antifungal therapy (PATH) Alliance registry
- Stem cell therapy trials: a call for standardization
- Stem cell therapy for myocardial regeneration: mechanisms and current clinical applications
- Functional outcome of bone marrow Stem cells (CD45+/CD34−) after cell therapy in acute spinal cord injury: In Exercise training and in sedentary rats
- Continuous renal replacement therapy (CRRT) after Stem cell transplantation. A report from the prospective pediatric CRRT Registry Group
- Rehabilitation of therapy-related cognitive deficits in patients after hematopoietic Stem cell transplantation
- Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on Stem cell collection in multiple myeloma
- Compromised Stem cell mobilization following induction therapy with lenalidomide in myeloma
- Is Stem cell-based therapy going on or out for cardiac disease?
- Stem cell and cellular therapy developments
- How to approach Alzheimer’s disease therapy using Stem cell technologies
- High-dose immunosuppressive therapy with autologous hematopoietic Stem cell transplantation as a treatment option in multiple sclerosis
- … working group (IMWG) consensus statement and guidelines regarding the current status of Stem cell collection and high-dose therapy for multiple myeloma …
- Stem cell biology and cell transplantation therapy in the retina
- Cardiac Stem cell therapy: Advances from 2008
- Handbook of cardiac Stem cell therapy
- Stem cell therapy for tendon and ligament injuries in the horse-technique and outcome
- High incidence of leukemia in large animals after Stem cell gene therapy with a HOXB4-expressing retroviral vector
- Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic Stem cell transplant compared with enzyme replacement therapy
- Stem–cell therapy in China draws foreign patients
- The cancer Stem cell microenvironment and anti-cancer therapy
- The potential of biophotonic techniques in Stem cell tracking and monitoring of tissue regeneration applied to cardiac Stem cell therapy
- High-dose therapy and autologous peripheral blood Stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian …
- Neuroprotective therapy for ischemic stroke with free radical scavenger and gene-Stem cell therapy
- Bone marrow mesenchymal Stem cell therapy on diabetic nephropathy in rats
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of acute myelogenous leukemia in adults: an evidence-based review
- A pilot study with autologous bone marrow-derived Stem cell therapy in patients with severe peripheral arterial disorder
- Mobilization in myeloma revisited: IMWG consensus perspectives on Stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib …
- Functional outcome of bone marrow Stem cells (CD45+/CD34−) after cell therapy in chronic spinal cord injury in wistar rats
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review
- Translating Stem cell therapy to the clinic: déjà vu all over again
- Stem cell therapy in the treatment of stress urinary incontinence: a significant step in the right direction?
- Stem cell based therapy for skeletal muscle diseases
- Mesenchymal Stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model
- Mesenchymal Stem cell‐based angiopoietin‐1 gene therapy for acute lung injury induced by lipopolysaccharide in mice
- … T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated Stem cell …
- Stem cell therapy in acute myocardial infarction
- Gene therapy approaches for Stem cell protection
- Can radionuclide imaging predict future response to Stem cell therapy?
- Stem cell therapy: The eventual future
- Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic Stem cell transplantation
- Adoptive cellular therapy for cytomegalovirus infection following allogeneic Stem cell transplantation using virus-specific T cells
- Toward a Stem cell gene therapy for breast cancer
- A decision analysis: the dental management of patients prior to hematology cytotoxic therapy or hematopoietic Stem cell transplantation
- cell therapy for Parkinson’s disease: III. Neonatal, fetal and embryonic Stem cell-based applications
- Use of enzyme replacement therapy (Laronidase) before hematopoietic Stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients
- Vascular endothelial growth factor in astroglioma Stem cell biology and response to therapy
- High-dose therapy followed by autologous purged Stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a …
- Prospective multicenter trial comparing repeated immunosuppressive therapy with Stem–cell transplantation from an alternative donor as second-line treatment for …
- Autologous bone marrow Stem cell therapy for the ischemic myocardium during coronary artery bypass grafting
- Expansion of antileukaemia CTL lines and clones for adoptive cell therapy in paediatric patients given allogeneic haematopoietic Stem cell transplantation
- Issues and ethical problems of Stem cell therapy–where is hippocrates?
- Protection of Stem cell-derived lymphocytes in a primate AIDS gene therapy model after in vivo selection
- Prenatal Stem cell transplantation and gene therapy
- Emerging Stem cell concepts for imatinib‐resistant chronic myeloid leukaemia: Implications for the biology, management, and therapy of the disease
- … —metaiodobenzylguanidine double infusion with autologous Stem–cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study
- Proof-of-concept trials for lung Stem cell therapy
- High‐dose therapy and autologous Stem cell transplantation for chemoresistant Hodgkin lymphoma: The Seattle experience
- Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, Stem cell transplantation and rituximab: a Cancer and Leukemia …
- Single autologous Stem–cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma …
- … PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic Stem cell …
- … factor (GM-CSF)–secreting cellular immunotherapy in combination with autologous Stem cell transplantation (ASCT) as postremission therapy for acute myeloid …
- Casting doubt on the safety of “off-the-shelf” mesenchymal Stem cells for cell therapy
- The biological and ethical basis of the use of human embryonic Stem cells for in vitro test syStems or cell therapy
- cell and gene therapy using mesenchymal Stem cells (MSCs)
- Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic Stem cell transplant recipients
- Parthenogenetic embryonic Stem cells derived from cryopreserved newborn mouse ovaries: a new approach to autologous Stem cell therapy
- Pfizer acquires a Stem cell therapy
- Bevacizumab therapy before autologous Stem–cell transplantation for POEMS syndrome
- Endothelium‐specific gene and Stem cell‐based therapy for erectile dysfunction
- Perinatal Stem–cell and gene therapy for hemoglobinopathies
- Adipose‐derived Stem cells are a source for cell therapy of the corneal stroma
- Embryonic Stem (ES) cell-derived cardiomyocytes: a good candidate for cell therapy applications
- Regeneration of irradiated salivary glands by Stem cell therapy
- The new challenge of Stem cell: brain tumour therapy
- Stem cell therapy: how should nurses respond?
- … therapy and autologous Stem cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy …
- Involved-field radiotherapy before high-dose therapy and autologous Stem–cell rescue in diffuse large-cell lymphoma: long-term disease control and toxicity
- The extent of minimal residual disease reduction after the first 4‐week imatinib therapy determines outcome of allogeneic Stem cell transplantation in adults with …
- Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin’s lymphoma patients receiving autologous hematopoietic Stem cell …
- … Stem cell transplantation: the national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy
- Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic Stem cell transplantation: a prospective evaluation
- Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic Stem cell transplantation
- Mesenchymal Stem cell-based gene therapy with prostacyclin synthase enhanced neovascularization in hindlimb ischemia
- High prevalence of early-onset osteopenia/osteoporosis after allogeneic Stem cell transplantation and improvement after bisphosphonate therapy
- Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic Stem cell transplantation: single‐center …
- Loss of enterocyte mass is accompanied by diminished turnover of enterocytes after myeloablative therapy in haematopoietic Stem–cell transplant recipients
- Treating autoimmune diseases: is Stem cell therapy the future?
- Dental regenerative therapy: Stem cell transplantation and bioengineered tooth replacement
- Manufacturing neurons from human embryonic Stem cells: biological and regulatory aspects to develop a safe cellular product for stroke cell therapy
- Stem cell niches as clinical targets: the future of anti-ischemic therapy?
- Multilevel targeting of hematopoietic Stem cell self-renewal, differentiation and apoptosis for leukemia therapy
- Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic Stem cell transplantation: implications for the emergence of drug-resistant …
- Myeloablative therapy with autologous Stem cell rescue for patients with Ewing sarcoma
- Nausea and vomiting with high-dose chemotherapy and Stem cell rescue therapy: a review of antiemetic regimens
- Porcine embryonic Stem cells: a possible source for cell replacement therapy
- Hematopoietic Stem cell gene therapy for adenosine deaminase deficient-SCID
- Stem cells to pancreatic β-cells: new sources for diabetes cell therapy
- … graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic Stem cell transplantation for multiple …
- Mesenchymal Stem cells—Stem cell therapy perspectives for type 1 diabetes
- Combination treatment of human umbilical cord matrix Stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic …
- Gene-Stem cell therapy for ischemic stroke
- Hematopoietic Stem cell gene therapy in Hurler syndrome, globoid cell leukodystrophy, metachromatic leukodystrophy and X-adrenoleukodystrophy.
- The role of high-dose therapy with autologous Stem cell support in the era of novel agents
- Stem cell-based therapy in central nervous syStem diseases
- Vaccinations in children treated with standard-dose cancer therapy or hematopoietic Stem cell transplantation
- Human cord blood Stem cell applications in cell therapy.
- Antifungal therapy for invasive fungal diseases in allogeneic Stem cell transplant recipients: an update
- High‐dose therapy and autologous Stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B‐cell lymphoma
- Progress in researches on Stem cell therapy for erectile dysfunction
- Establishment of medakafish as a model for Stem cell-based gene therapy: Efficient gene delivery and potential chromosomal integration by baculoviral vectors
- Mathematical modelling of the impact of haematopoietic Stem cell‐delivered gene therapy for HIV
- Embryonic Stem cells and Parkinson’s disease: cell transplantation to cell therapy
- Gene therapy and bone marrow Stem–cell transfer to treat autoimmune disease
- cell therapy for Parkinson’s disease: II. Somatic Stem cell-based applications
- … parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic Stem cell transplant recipients receiving long-term caspofungin therapy
- Differentiation-chronology specific function of DNMT1 and selective anti-leukemia Stem–cell therapy
- Stem cell therapy: an update
- High-dose therapy with hematopoietic Stem cell rescue in patients with poor prognosis Ewing family tumors
- Can patient-specific Stem cell therapy enhance renal repair?
- Stem cell therapy: A “magic bullet” for cardiomyopathies?
- Stem cell therapy for spinal cord injury: A plea for rationality
- therapy for older AML patients: the role of novel agents and allogeneic Stem cell transplant
- The effect of human umbilical cord blood derived mesenchymal Stem cell therapy in rat model of cavernosal nerve injury
- High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic Stem cell transplantation as consolidation or salvage therapy
- Cord blood Stem cell therapy for acquired immune deficiency syndrome
- cell transplant and regenerative Stem cell therapy
- Primed for lethal battle: a step forward to enhance the efficacy and efficiency of Stem cell transplantation therapy
- Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous Stem cell …
- Childhood spinal muscular atrophy and Stem cell research: Is cellular replacement therapy the answer?
- Neural Stem cell-mediated therapy of primary and metastatic solid tumors
- … varicella-zoster virus infection preceding cutaneous manifestations after hematopoietic Stem cell transplantation: utility of PCR for early recognition and therapy
- Does High-Dose therapy and Autologous Hematopoietic Stem cell Transplantation Have a Role in the Primary Treatment of Peripheral T-cell Lymphomas?
- Ethical issues in Stem cell research, therapy, and public policy
- Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic Stem cell transplant recipients
- Comparison of ex vivo expansion culture conditions of mesenchymal Stem cells for human cell therapy
- Radiation therapy Oncology Group translational research program Stem cell symposium: incorporating Stem cell hypotheses into clinical trials
- Stem–cell biology and cancer therapy: the more things change.
- Stem cell therapy in chronic spinal cord injuries
- Stem cell therapy in acute respiratory distress syndrome
- Human cytomegalovirus load measurement and its applications for pre‐emptive therapy in patients undergoing hematopoietic Stem cell transplantation
- Patients with mature T-cell lymphoma show high relapse rates after high dose therapy and autologous Stem cell transplantation
- Reduced-toxicity conditioning therapy with allogeneic Stem cell transplantation for acute leukemia
- Genetic engineering and Stem cells: combinatorial approaches for cardiac cell therapy [cellular/Tissue Engineering]
- Autologous hematopoietic Stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia
- Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic Stem cell gene transfer of α‐glucosidase in Pompe …
- … node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous Stem cell …
- Therapeutic window of Stem cell potential for targeting pediatric malignant brain tumors: an opportunity for Stem cell therapy
- Stem cell therapy in Neurodegenerative
- Stem cell therapy FOR BRAIN TUMORS
- Stem cell–Based therapy for Glomerular Diseases: An Evolving Concept
- Cardiac Stem cells: at the heart of cell therapy
- Viral diagnostics and antiviral therapy in hematopoietic Stem cell transplantation
- Is allogeneic Stem cell transplantation for transformed follicular lymphoma anti-lymphoma Stem cell therapy?
- Treatment options for impaired spermatogenesis: germ cell transplantation and Stem–cell based therapy.
- The moral status of human embryos with special regard to Stem cell research and therapy
- Outcome assessment measures for evaluating clinical effectiveness of canine adipose derived Stem cell therapy of osteoarthritis
- Novel cancer Stem cell therapy on the horizon
- Surgical Stem cell therapy for the Treatment of Heart Failure
- Macrophage subpopulations are essential for infarct repair with and without Stem cell therapy
- Hypervitaminosis A in pediatric hematopoietic Stem cell patients requiring renal replacement therapy
- Principles of Stem cell therapy in the horse-the science behind the technology
- Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered Stem cells in a murine model of airway injury
- Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic Stem cell transplantation as preemptive therapy for severe graft-versus …
- Sex of muscle Stem cells does not influence potency for cardiac cell therapy
- Properties of mesenchymal Stem cells to consider for cancer cell therapy
- … body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood Stem–cell transplantation followed by randomization to therapy with interleukin-2 …
- Use of the cytomegalovirus pp65 antigenemia assay for preemptive therapy in allogeneic hematopoietic Stem cell transplantation: a real‐world review
- Future of Stem cell therapy for neuronal regeneration
- Novel and immortalization-based protocols for the generation of neural CNS Stem cell lines for gene therapy approaches
- Translational perspectives—transient epigenetic gene therapy: hazard-free cell reprogramming approach and rising arm of a universal Stem cell gene therapy platform
- Impact of initial cytomegalovirus viral load on efficacy of preemptive therapy with ganciclovir in allogeneic Stem cell transplant recipients
- Stem cell therapy for Acute Myocardial Infarction and Heart Failure-Past, Present and Future
- Stem cell therapy: Numerical simulation of In Vivo Nutrient Transport and cells Growth
- Newly diagnosed multiple myeloma in Taiwan: the evolution of therapy, Stem cell transplantation and new treatment agents
- Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral Stem cell transplantation
- Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA‐matched allogeneic Stem cell transplantation in childhood …
- Post‐translational modifications of orphan nuclear receptor TR2–new insights into drug targets for Stem cell therapy and the effect of retinoic acid
- Autologous Stem cell transplantation is superior to myeloablative allogeneic SCT as a salvage therapy for patients with refractory/relapsed transformed …
- Mesenchymal Stem cells and their use as cell replacement therapy and disease modelling tool
- The role of cardiac ultrasound in Stem cell therapy
- Stem cells for cardiac regeneration by cell therapy and myocardial tissue engineering
- … on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic Stem cell …
- Structural and functional improvement of injured brain after severe acute carbon monoxide poisoning by Stem cell-based therapy in rats.
- Generation of insulin-producing beta cells from Stem cells-perspectives for cell therapy in type 1 diabetes
- Adult Stem cell therapy for acute renal failure: the hope beyond the hype
- The prospect of pluripotent Stem cell-based therapy
- Mesenchymal Stem cell therapy in a Rat Model for GvHD
- Iodine‐131‐metaiodobenzylguanidine therapy with reduced‐intensity allogeneic Stem cell transplantation in recurrent neuroblastoma
- Stem cell therapy
- … , epirubicin and etoposide) is a more effective Stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for …
- Human cardiac Stem cell therapy for heart failure
- Adult human Stem cell therapy for ischaemic stroke
- Antifungal therapy strategies in hematopoietic Stem–cell transplant recipients: early treatment options for improving outcomes
- Preemptive therapy for cytomegalovirus disease in allogeneic Stem cell transplant recipients
- Haploidentical allogeneic bone marrow Stem cell transplantation combined with peripheral blood Stem cells for therapy of leukemia
- Review of Stem cell-based therapy for the treatment of cardiovascular disease
- A long-term durable remission with high-dose therapy and autologous Stem cell transplant for stage IVB HIV-associated Hodgkins disease
- Adult Mesenchymal Stem cells for cell therapy in Clinical Application.
- Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous Stem cell transplantation: results of a Spanish …
- Comparison of adult versus embryonic Stem cell therapy for cardiovascular disease: insights from molecular imaging studies
- Counterpoint: cord blood Stem cell therapy for acquired immune deficiency syndrome
- Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance therapy Following Single Autologous Stem cell Transplant for Multiple …
- Specific Detection of Aberrant and Normal Stem cells in Acute Myeloid Leukemia Patients Opens the Way for Defining Highly Specific Targets for Stem cell therapy.
- Counterpoint: cord blood Stem cell therapy for acquired immune deficiency syndrome
- Cardiac Stem cell therapy and arrhythmogenicity: Prometheus and the arrows of Apollo and Artemis
- Embryonic Stem cells: overcoming the immunological barriers to cell replacement therapy
- Comparison of mesenchymal tissues-derived Stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit
- A microfabricated 3-D Stem cell delivery scaffold for retinal regenerative therapy
- Bispecific antibody targeted Stem cell therapy for myocardial repair
- Tissue Engineering for the Respiratory Epithelium: Is There a Future for Stem cell therapy in the Lung?
- Novel Tyrosine Kinase Inhibitor therapy Before Allogeneic Stem cell Transplantation in Patients with Chronic Myeloid Leukemia.
- Role of biomechanical force in Stem cell-based therapy for cartilage repair
- Autologous Stem cell transplantation using MEAM regimen for relapsed AIDS-related lymphoma patients who received highly active anti-retroviral therapy: a report of …
- R-CHOP, Followed by High Dose therapy and Autologous Stem cell Rescue (HDT/ASCR), and R-Hypercvad Have Equivalent Progression-Free Survival and Are …
- Stem cell therapy-An update
- Tweaking the immune syStem: gene therapy-assisted autologous haematopoietic Stem cell transplantation as a treatment for autoimmune disease
- Characterization and genetic manipulation of human umbilical cord vein mesenchymal Stem cells: potential application in cell-based gene therapy
- High-dose therapy and autologous Stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
- … Stem cell transplantation after myeloablative therapy in first remission may be beneficial in patients with advanced stage follicular lymphoma after front-line therapy …
- Stem cell transplantation and MBL replacement therapy
- Autologous Stem cell transplantation (autoSCT) as first-line therapy in peripheral T cell lymphomas (PTCL): results of a prospective multicenter study
- Adult and Embryonic Stem cell therapy
- New strategy of treatment for POEMS syndrome–autologous peripheral blood Stem cell transplantation and thalidomide therapy
- cell therapy using induced pluripotent Stem (iPS) cells meets next-next generation DNA sequencing technology
- Impact of lenalidomide therapy on Stem cell mobilization in myeloma
- Wnt5a-treated midbrain neural Stem cells improve dopamine cell replacement therapy in parkinsonian mice
- Plasma cell leukemia maintaining complete remission by syngeneic Stem cell transplantation combined with low-dose thalidomide maintenance therapy
- … Ibritumumab Tiuxetan (Zevalin®)-BEAM/C with Autologous Stem cell Support as Frontline therapy for Advanced Mantle cell Lymphoma.–Preliminary Results …
- Stem and progenitor cell-mediated tumor selective gene therapy
- Stem cell therapy in cardiovascular diseases
- Parkinson’s disease: Role of molecular imaging in monitoring the effectiveness of Stem cell therapy
- Effects of Embryonic Neural Stem cell therapy on Oxidative and Nitrosative Stress Biomarkers in Acute and Chronic Spinal Cord Injured Rats
- Ethical Issues in Stem cell therapy
- Induced pluripotent Stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases
- Treatment of refractory severe autoimmune disease by combined therapy with Chinese drug and autohemopoietic Stem cell transplantation
- Second Autologous Stem cell Transplant (ASCT) as Salvage therapy in Patients with Relapsed Multiple Myeloma.
- Stem cell therapy× ETHICS AND RELIGION
- Islet cell therapy and pancreatic Stem cells
- … molecular response in the absence of any antileukaemic therapy after dasatinib treatment and autologous peripheral blood Stem cell transplantation in a …
- Minimally invasive Stem cell therapy
- Stem cell therapy-emerging new field of medicine.
- Hematopoietic Stem cell gene therapy trial with lentiviral vector in X-linked adrenoleukodystrophy
- … does not adversely affect the Stem cell mobilization and engraftment after high-dose therapy and autologous transplantation in patients with diffuse large B-cell …
- Fetal Stem cell therapy
- In vivo MRI of mouse heart at 11.7 t: monitoring of Stem–cell therapy for myocardial infarction and evaluation of cardiac hypertrophy
- INTERLEUKIN-10 ENGINEERED MESENCHYMAL Stem cell therapy TO PREVENT ISCHEMIA-REPERFUSION INJURY IN LUNG TRANSPLANTS: 167
- Stem cell therapy: Hype or Hope?
- Effects of Mesenchymal Stem cell therapy in BPD
- Exposing gaps in our knowledge of Stem cell therapy
- Brazilian experience using high-dose sequential therapy (HDS) followed by autologous hematopoietic Stem cell transplantation (ASCT) for malignant lymphomas
- Stem cell Transplant (SCT) and Pralatrexate therapy: Outcome of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma Who Received SCT …
- … Monoclonal Gammopathy: pulmonary hemorrhage during Stem cell mobilization and complete hematological response with bortezomib and dexamethasone therapy
- Fibrin microthreads promote Stem cell growth for localized delivery in regenerative therapy
- Stem cell Gene therapy for ADA-Deficiency without Myelopreparative Conditioning
- Progress in Stem cell therapy for Alzheimer’s disease
- cell therapy in Hematopoietic Stem cell Transplantation
- Stem cell therapy for Alzheimer’s
- Ethical aspects of Stem cell therapy and gene therapy
- A possible approach for Stem cell gene therapy of Fanconi anemia
- Outcomes with High Dose therapy and Peripheral Blood Stem cell Transplantation for Light Chain (AL) Amyloidosis with Cardiac Involvement.
- Cardiovascular Regeneration and Stem cell therapy
- Stem–cell therapy is the last option for cardiac disease?
- Second Autologous Stem cell Transplantation Is Effective Salvage therapy for Relapsed Multiple Myeloma.
- Stem cell therapy for corneal defects
- Potential applications of combined Stem cell and gene therapy for the treatment of infarcted heart
- Handbook Of Cardiac Stem cell therapy
- Cardiac regenerative therapy integrated via human autologous cardiac Stem cell and biodegradable bFGF-incorporating gelatin hydrogel
- 237. Stem cell therapy: Neuroplasticity as a novel cellular mechanism for regeneration
- Future Implementation of Adult Stem cell therapy in the Current Standards of Care for Myocardial Infarction
- Experience of Hanyang ALS Clinic for Autologous BM Stem cell therapy in the Patients with ALS
- Stem cell-targeted therapy–a new strategy for cancer treatment
- Red Fluorescent Protein as a Marker for Stem cell therapy
- … , pegylated-lyposomal-doxorubicin and dexamethasone (PAD) as induction therapy prior to reduced intensity autologous Stem cell transplant (ASCT) followed by …
- Microencapsulated Stem cells for tissue repairing: implications in cell-based myocardial therapy
- Involved field radiation therapy and donor lymphocyte infusion for relapsed or refractory non-Hodgkin lymphoma after allogeneic hematopoietic Stem cell …
- Liver Stem cell therapy: current and near future
- Maintenance therapy with Low-Dose Azacitidine (AZA) after Allogeneic Hematopoietic Stem cell Transplantation (HSCT) for Relapsed or Refractory AML or …
- Selection of Optimal M esenchymal Stem cells for Stem cell therapy in Amyotrophic Lateral Sclerosis Patients
- Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic Stem cell transplantation in acute myeloid leukemia: influence of karyotype
- Autologous and Cancer Stem cell Gene therapy
- MO‐FF‐A2‐01: Neural Stem cell Sparing Radiation therapy—A Feasibility Study
- Stem cell mobilization following initial therapy with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma
- Experimental Stem cell therapy in acquired neurological illnesses: Current status
- Gene and Stem cell therapy in pulmonary arterial hypertension
- Research progress of traditional Chinese medicine for Stem cell therapy of ischemic heart disease
- The evaluation of acute renal failure models for the study of Stem cell therapy
- Clinical Trials in Cardiac Stem cell therapy: An Update
- Low level laser therapy and phototherapy assisted hydrogel dressing in burn wound healing: light guided epithelial Stem cell biomodulation
- Stem cell therapy following acute myocardial infarction: Comparative studies with adipose tissue-derived Stem cells and bone marrow-derived Stem cells
- Cardiac Stem cell therapy, from bench to bedside
- Stem cell therapy to Promotor Functional Recovery Following Injury to the Nervous SyStem
- Mesenchymal Stem cell therapy Prevents Ischemia/Reperfusion Injury
- Impact of Allogeneic Stem cell Transplantation as Salvage therapy After T315I Mutation Detection in Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic …
- Chondroitin sulfate, a major niche substance of neural Stem cells, and cell transplantation therapy of neurodegeneration combined with niche modification
- Characterization and optimization of in vitro culture conditions of adult Stem cells for clinical cell therapy
- Noninvasive methods for monitoring cardiac Stem cell therapy
- Effectiveness of Mesenchymal Stem cell therapy in Patients With Amyotrophic Lateral Sclerosis
- Stem cell therapy for age-related retinal disease
- Analysis of Umbilical Cord Blood Stem cell therapy for Regenerative Medicine Applications
- Cardiac resynchronization and Stem cell therapy: do associative benefits exist?
- Difficulty of peripheral blood Stem cell collection after multiple consolidation therapy in acute myeloid leukemia
- Cytoprotective Actions of Mesenchymal Stem cell therapy After Acute Myocardial Infarction
- Muscle‐derived Stem cell therapy for Stress Urinary Incontinence
- Autologous in vitro expanded mesenchymal Stem cell therapy for human old myocardial infarction
- 2 Overview of Adult Stem cell therapy in Cardiac Disease
- Autologous Stem cell therapy with surgical myocardial revascularization/Otolog kok hucre tedavisi ve cerrahi miyokardiyal revaskularizasyon
- Panoramic View of The Fifth International Symposium on Stem cell therapy and Applied Cardiovascular Biotechnology, April 2008, Madrid (Spain)
- Engineering Cardiac Tissue Using Stem cell therapy to Mend the Broken Heart
- Adult Stem cell therapy for acute and subacute spinal cord injury: Early clinical results and combined therapy strategy
- ADIPOSE-TISSUE DERIVED MESENCHYMAL Stem cell (ASC) AS ALTERNATIVE SOURCE FOR AUTOLOGOUS cell therapy
- Allay the ailing hearts-promising Stem cell therapy through apheresis: An experience of a tertiary care hospital in South India, ie SVIMS, Tirupati, Andhra Pradesh.
- Long term follow-up after intramyocardial Stem cell therapy with AC133+ bone marrow cells
- cell therapy for Diabetes Mellitus: An Opportunity for Stem cells?
- Baylor’s contribution to thoracic surgery and cardiac Stem cell therapy for heart failure
- SyStemic and Gene Modified Mesenchymal Stem cell therapy for Metastatic Prostate Cancer
- G-CSF Based Peripheral Blood Stem cell therapy in Myocardial Infarction: Results of MAGIC cell Clinical Trial
- UMBILICAL CORD BLOOD DERIVED MESENCHYMAL Stem cell therapy IN NOVEL CORONA VIRUS INFECTION–A REVIEW
- Aspects of Embryonic Stem cell Derived Somatic cell therapy of Degenerative Diseases
- (90) y-Ibritumumab Tiuxetan (Zevalin (R))-BEAM/C with Autologous Stem cell Support as Frontline therapy for Advanced Mantle cell Lymphoma.-Preliminary Results …
- Cardiac regeneration by intramyocardial Stem cell therapy: clinical development
- … and VTD (Bortezomib, Thalidomide, Dexamethasone) Induction Followed by High-Dose therapy with Autologous Stem cell Transplantation and Maintenance …
- Mesenchymal Stem cell therapy for traumatic brain injury: Implications for intracranial inflammation
- Value of MRI and iron oxide particle labeling in Stem cell therapy of brain ischemic rats
- R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous Stem–cell transplantation on outcome
- Results from functional and cellular studies using an ovine model to assess response to mesenchymal Stem cell therapy after induction of myocardial infarction
- Human Embryonic Stem cell‐Derived Cardiomyocytes for cell therapy and Drug Discovery
- Stem cell therapy for myocardial infarction: Overcoming the hypoxic impediment to enhance cell-survival and engraftment
- Two Patients with Sporadic Late-Onset Nemaline Myopathy Respond to Stem cell therapy
- Single Versus Tandem High Dose therapy (HDT) Supported with Autologous Blood Stem cell (ABSC) Transplantation Using Unselected or CD34-Enriched ABSC …
- Adoptive Immune cell therapy for the Control of Fungal Infections in Hematopoietic Stem cell Transplant Patients
- … Expression on Human CD34+ cells During Murine Leukemia Virus-Derived Retroviral Transduction with Recombinant Fibronectin for Stem cell Gene therapy
- Hedgehog Signaling Pathway Is a New Target of Cancer Stem cell therapy for Breast Cancer Patients.
- Placental mesenchymal and cord blood Stem cell therapy for dilated cardiomyopathy
- Autologous bone marrow-derived Stem cell therapy in patients with Buerger’s disease
- Intracoronary autologous bone marrow Stem cell therapy in diastolic heart failure
- Serendipity—Methotrexate and 6-mercaptopurine for Continuation therapy for Patients With Acute Lymphoblastic Leukemia: The Leukemic Stem cell and Beyond?
- … ®), Doxil®, and dexamethasone (VDD) is superior to thalidomide and dexamethasone (TD) as initial therapy prior to autologous Stem cell transplantation (ASCT) for …
- RESCUE OF LUMICAN NULL CORNEAL PHENOTYPE USING Stem cell therapy
- Autologous Bone Marrow-Derived Stem cell therapy: A Promising and Prospective Approach in the Treatment of Patients with Severe Buerger’s Disease.
- 100. Subacute Neural Stem cell therapy for Traumatic Brain Injury
- Lenalidomide as Salvage therapy after Allogeneic Stem′ cell Transplantation in Multiple Myeloma
- Sci—Thurs AM: YIS—11: A Hybrid SPECT and Contrast Enhanced CT Platform: Application in Stem cell therapy
- Rituximab based therapy followed by autologous Stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell …
- The role of allogeneic Stem cell transplantation in the therapy of adult acute lymphoblastic leukemia (ALL)
- Laboratory of Neurogenesis and cell therapy, Wallenberg Neuroscience Center, and Lund Stem cell Center, University Hospital, SE-221 84 Lund, Sweden. 2 …
- Defibrotide therapy for patients with sinusoidal obstruction syndrome after hematopoietic Stem cell transplantation
- … by granulocyte colony-stimulating factor on myocardial perfusion and viability: Improvement of myocardial perfusion as a plausible mechanism of Stem cell therapy
- Advance of researches on thyroid tissues autotransplantation and embryonic Stem cell transplantation in therapy of hypothyroidism
- Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. An open gate towards endogenous Stem cell therapy in diabetes.
- Multipotent Progenitor cells: A New Era In Stem cell-Mediated Gene therapy?
- Mesenchymal Stem cell therapy increases proinflammatory cytokine production via NFkB activation independent of the PI3 kinase pathway
- Early evaluation of genetically engineered mesenchymal stromal Stem cell therapy for prevention of left ventricular dysfunction in pigs
- Stem cell Transplantation: Biology, Processes, therapy
- … Mononuclear cell Transfer Is Associated with Superior Cardiac Recovery and Neovascularization as Compared to Nonmodified Mesenchymal Stem cell therapy in …
- 2.5 Mesenchymal Stem cell therapy has significant clinical effect in proteoglycan induced arthritis
- Effects of Bone Marrow-Derived Stem cell therapy on Airway and Lung Parenchyma Remodeling in a Murine Model of Chronic Allergic Asthma.
- Allogeneic Stem cell transplantation (SCT) in advanced chronic myeloid leukemia (CML) patients after tyrosine kinase inhibitor (TKI) therapy
- 78. Genetically Modified Mesenchymal Stem cell therapy for Prostate Cancer Bone Metastasis
- Locally induced neural Stem cells/pluripotent Stem cells for in vivo cell replacement therapy
- Treatment failure due to intracerebral Stem cell-like behavior of glioblastoma (GBM) cells: A reason for targeted maintenance therapy with imatinib (I) and hydroxyurea …
- Corneal epithelial Stem cell deficiency and its therapy with transplantation of in vitro cultivated limbal Stem cells
- Allogeneic Hematopoietic Stem cell Transplantation (HSCT) as a Curative therapy in Primary and Secondary Myelofibrosis (MF): A 14-Year Period …
- … II Study of Sequential Velcade/Thalidomide/Dexamethasone (VTD) as Maintenance therapy Post Single Autologous Peripheral Stem cell (PSCT) in Patients …
- Salvage therapy with Allogeneic Stem cell Transplantation Results in Better Outcome for Patients with Relapsed/Refractory Follicular Lymphoma Compared …
- Endonuclease-Boosted Gene Targeting and Cybridization for Long-Term Stem cell Gene therapy
- Stem cell based therapy for the treatment of prion diseases
- Stem cell-based therapy in Parkinson disease
- Stem–cell collection before high-dose therapy for multiple myeloma: time has come to raise the standards!
- … Phase II Study Using Dexamethasone Induction therapy and High-Dose Melphalan Chemotherapy Followed by Autologous Stem cell Transplantation in 30 …
- Novel Stem/Progenitor Populations: Implications for cell therapy
- … Reduces the Cytotoxic Effects of in vitro Expanded NK cells: Implications for Adoptive NK cell therapy in the Setting of Allogeneic Hematopoietic Stem cell (HCT) …
- Application potential of human fetal Stem/progenitor cells in cell therapy
- Feasibility and Monitorization of Stem–cell Replacement therapy
- Sequential Chemotherapy Followed by High Dose therapy and Autologous Stem cell Rescue for Mantle cell Lymphoma: Impact of MIB-1 on Outcome
- Is the era of the therapy by tailor-made Stem cell coming?
- Stem cell based therapy to restore nearly normal hearing
- Mesenchymal Stem cell Based therapy in Liver Disease
- Stem cell research and therapy: A preliminary theological-ethical evaluation
- Bortezomib therapy followed by autologous Stem cell transplantation in POEMS syndrome
- Stem cell research and therapy: An overview of its feasibility with accompanying ethical implications
- Yasuo Takeuchi, Makoto Otsu, Akihiro Kume, 2 Masafumi Onodera, 3 Tadatoshi Kuratsuji, 4 Hiromitsu Nakauchi. 1Lab of Stem cell therapy, Center for Experimental …
- Prospective Study of Oral Valganciclovir for Pre-Emptive therapy of Cytomegalovirus After Allogeneic Stem cell Transplantation.
- High-Dose therapy with Peripheral Blood Stem cell Transplantation for Patients with Multiple Myeloma: Prognostic Impact of Chromosomal Aberrations and …
- Cancer Stem cell theory and cancer therapy
- Autologous haematopoietic Stem cell transplantation followed by thalidomide therapy in poems syndrome
- Outcomes of Allogeneic Stem cell Transplant in Patients with Myeloid Leukemias Over 65 Years of Age. Rationale for Aggressive therapy with Curative Intent.
- Hodgkin-lymphoma with relapsed or progressive disease after autologous Stem cell transplantation: efficacy of salvage radiation therapy
- Adipose derived Stem cells for regenerative cell therapy in peripheral vascular disease
- Rituximab combined with autologous hematopoietic Stem cell transplantation for therapy of CD_ (20), positive B-cell lymphoma
- DEVELOPING THE TOOLS FOR A Stem cell-BASED therapy FOR DEAFNESS: ISOLATION AND ANALYSIS OF HUMAN AUDITORY Stem cells
- 236: Busulfan and Single-Dose Melphalan as Preparative therapy for Infants and Young Children Undergoing Stem cell Transplantation for Leukemia: A Single …
- Caspofungin as secondary prophylaxis or therapy in patients undergoing allogeneic Stem cell transplantation with a prior or ongoing history of syStemic or …
- Bortezomib-based induction therapy induces better responses and outcomes of autologous Stem cell transplantation in newly diagnosed patients with multiple …
- Engineering embryonic Stem cells for myelin cell therapy
- Newly diagnosed multiple myeloma in Taiwan: the evolution of therapy, Stem cell transplantation and new treatment agents
- High Dose Chemotherapy and Autologous Stem cell Transplantation in the Primary therapy of Advanced Follicular Lymphoma in Adults: A SyStematic …
- Role of autologous Stem cell transplant after induction therapy with bortezomib-lenolidomide or bortezomib-thalidomide in newly diagnosed multiple myeloma patients
- Characterisation of neural Stem cells for oestrogen in vitro: potential for improving Stem cell based therapy for stroke
- Stem cell based therapy of malignant brain tumors
- … Interferon-Alpha Maintenance therapy for Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Ineligible for Allogeneic Stem cell …
- Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived Stem cell…
- Stem cell therapy for Vascular Disease
- Regenerative therapy and mesenchymal Stem cell for veterinary medicine.
- … Stem cell Transplantation in the therapy of Acute Myeloid Leukemia in Adults Evidence-Based Review 137 The Role of Cytotoxic therapy with Hematopoietic Stem …
- … , Melphalan (RBEAM) and Autologous Stem cell Transplantation (ASCT) for Poor Prognosis Diffuse Large B-cell Lymphoma (DLBCL). ClinicalTrials. Gov …
- Allogeneic Stem cell Transplantation (Allo-SCT) For Relapsed, Refractory Myeloid Leukemia and Mds Using Clofarabine (Clo)±Fludarabine (Flu) with IV Busulfan (Bu …
- Evaluation of Selected Human Embryonic Stem cell Lines for Differentiation to Retinal cells and for cell-Based therapy
- Muscular dystrophy cell therapy: an in utero approach using human fetal mesenchymal Stem cells
- Role of high-dose therapy and autologous Stem cell transplantation in treatment of chemotherapy-efractory Hodgkin lymphoma
- Development of new human Stem cell-derived cellular vehicles for glioma gene therapy
- Generation of cells for cell Replacement therapy: Specification of Neural Precursors in Vivo and in Neural Stem cell Cultures
- Stem cell-based therapy of ocular surface diseases: novel approaches to expansion of adult epithelial Stem cells in culture
- Optimization of suicide gene therapy in Stem cell transplantation with special reference to the selection marker OuaSelect
- Feasibility and Efficacy of Autologous Stem cell Transplantation as First-Line therapy for Peripheral T-cell Lymphoma: a Single Center Experience
- High dose immunosuppressive therapy with autologous hematopoietic Stem cell transplantation in secondary progressive multiple sclerosis: Case report
- Adult Stem cell-based gene therapy for alpha 1-antitrypsin deficiency
- Long-Term Follow-up of HCV Infected Stem cell Transplant Patients and Effects of Antiviral therapy.
- The Effect of SyStemic Steroid therapy on Dry Eye in Hematopoietic Stem cell Transplantated Patients
- … of DNA Methylation Changes in a Phase I Clinical Trial of Low-dose 5-azacitidine (AZA) given as Maintenance therapy after Allogeneic Hematopoietic Stem cell …
- Protection of Stem cell-Derived Lymphocytes in a Primate AIDS Gene therapy Model
- A comparative study of the curative effects of cytomegalovirus preemptive therapy in various kinds of hematopoietic Stem–cell transplantation
- … outcome in transformed follicular lymphoma compared to de novo aggressive B-cell lymphoma treated with high-dose therapy and autologous Stem–cell …
- Hematopoietic Stem cell based gene therapy for the treatment of metachromatic leukodystrophy: towards clinical testing
- Preemptive therapy of HHV-6 Encephalitis with Foscarnet Sodium for High Risk Patients After Hematopoietic Stem cell Transplantation.
- Gemtuzumab-ozogamicin as maintenance therapy after autologous Stem cell transplantation in elderly patients with acute myeloid leukaemia
- Successful autologous Stem cell transplantation in a woman with Severe SyStemic Sclerosis, refractory to immunosuppressive therapy
- CML: Is Allogeneic Stem cell Transplantation the Second-Line therapy of Choice following Resistance to Imatinib?
- Bortezomib-Based therapy, without Stem cell Transplantation, for Newly Diagnosed Multiple Myeloma Patients with t (4; 14).
- Gemtuzumab Ozogamicin as Induction therapy Followed by Post-Remission Hematopoietic Stem cell Transplantation in Elderly Patients with Acute Myeloid …
- Prognostic Value of Bone Marrow Angiogenesis in Patients with Multiple Myeloma Undergoing High-Dose therapy and Autologous Stem cell Transplantation …
- The rate of cytomegalovirus infection and disease in correlation with the type of haematopoietic Stem cell transplantation in the era of pre-emptive antiviral therapy
- … of Prior Radiation therapy Predicts Poor Progression Free Survival and Overall Survival in African Americans with Multiple Myeloma after Autologous Stem cell …
- Biological quantification of murine osteoarticular joints following treatment using Stem cell-based gene therapy
- High-Dose therapy with Peripheral Blood Stem cell Transplantation for Patients with Relapsed or Refractory Hodgkin’s Disease: A Single-Institution 20-Year …
- Treatment of diabetes by cell therapy: new insights on Stem cells and precursors
- “Hiper CVAD Followed by Rituximab Purging Previous to Autologous Stem–cell Transplantation as therapy of Mantle cell Lymphoma. Results of Manto 2000 …
- Epithelial to mesenchymal transition in breast cancer is associated with resistance to therapy and a cancer Stem cell-like phenotype
- Autologous Stem cell Transplant in Recurrent Diffuse Large B-cell Lymphoma: Prior Rituximab therapy Has No Impact On Early Lymphocyte Recovery and …
- Adoptive therapy with T-cell Precursors for Immune Reconstitution After Allogeneic Hematopoietic Stem cell Transplantation.
- Case Closed (If There Was Still Any Doubt): High-Dose Chemotherapy & Autologous Stem–cell Transplant As Adjuvant therapy for Breast Cancer
- 267. Targeted therapy of Metastatic Melanoma Using Neural Stem cell-Based Drug Delivery
- Mechanism of Action of Prostate Stem cell Antigen Targeted Antibody therapy and Its Relevance to Clinical Application in Prostate Cancer
- 90y-Ibritumumab Tiuxetan (Zevalin®-BEAM/C with Autologous Stem cell Support as therapy for Advanced Mantle cell Lymphoma.-Preliminary Results From …
- … of Cytomegalovirus Infection and Disease in Correlation with the Type of Hematopoietic Stem cell Transplantation in the Era of Preemptive Antiviral therapy
- Hyperbaric oxygen therapy for post-Stem cell transplant haemorrhagic cystitis in children and adolescents
- Stem cell Mobilization In Patients With Newly Diagnosed Multiple Myeloma Following therapy With Lenalidomide and Dexamethasone
- Comparative study of allogeneic peripheral blood Stem cell transplantation and immunosuppressive therapy for severe aplastic anemia
- … Seropositivity Does Not Affect the Outcome of Allogeneic Hematopoietic Stem cell Transplantation with Intensive Monitoring and Modern Anti-Viral therapy
- Adding Fludarabine to Cyclophophamide-dexamethason induction therapy impair Stem cell harvest in MM: Report from an interim analysis of the NMSG 13/03 …
- The effect of rituximab in first line therapy to results of autologus haematopoietic Stem cell transplantation in relapsed non-Hodgkin’s lymphoma patients
- Allogeneic haematopoietic Stem cell transplantation as a curative therapy in primary and secondary myelofibrosis
- Allogeneic Stem cell transplantation after sequential therapy using high-dose melphalan and myeloablative conditioning in patients with refractory acute myeloid …
- cell death of colorectal cancer Stem-like cell was induced by photodynamic therapy with protoporphyrin IX
- In the article entitled ”The Role of Cytotoxic therapy with Hematopoietic Stem cell Transplantation in the therapy of Myelodysplastic Syndromes: An Evidence-Based …
- Allogeneic haematopoietic Stem cell transplantation as front line therapy for patients with” de novo” or secondary myelodysplastic syndrome: a single-centre …
- Frequency of Allogeneic Stem cell Transplant (SCT) in Patients Presenting with Newly-Diagnosed AML or AML at Time of First Salvage therapy.
- The Combination of Cyclophosphamide and Thalidomide During Induction therapy for Multiple Myeloma Results in a High Rate of Stem cell Mobilization Failure.
- Future advances in glaucoma therapy: today’s research–gene therapy, Stem cell transplants, neuroprotective drugs and’real-time’pressure monitoring–will help …
- Gauging the response of circulating epithelial tumor cells (CETC) and tumor Stem cell subpopulations to therapy of early-stage cancer in the individual patient
- Immunosuppressive therapy and Future Response to Androgens or Survival After Hematopoietic Stem cell Transplantation in Fanconi Anemia.
- Peripheral Blood Stem cell (PBSC) Harvest Is More Expensive Following Bortezomib-Based therapy in Multiple Myeloma (MM), Related to Increase Number …
- Up-front allogeneic Stem cell transplantation as part of induction or salvage therapy in primary high-risk and relapsed acute myeloid leukaemia
- Resolution of pure red cell aplasia after reduced-intensity allogenic Stem cell transplantation with major ABO mismatch during therapy with lenalidomide
- Achievement of CR and nCR Before and After First High-Dose therapy Followed by Autologous Stem cell Transplantation Is a Major Marker for Long-Term …
- Combination Of Ifn-α/GM-CSF as Maintenance therapy for Multiple Myeloma Patients After Autologous Stem cell Transplantation (ASCT): Results of a Prospective …
- 902. Mucopolysaccharidosis Type I Ex Vivo Gene therapy Based on MLV-Mesenchymal Stem cell Transduction: Is There a Way To Be Attenuated When Older?
- Double Reduced-Intensity Allogeneic Hematopoietic Stem cell Transplantation: French Society of Bone Marrow Graft Transplantation and cellular therapy …
- Hypogammaglobulinemia Following Rituximab and High-Dose therapy and Autologous Stem–cell Transplant: Incidence and Predictors of Prolonged …
- Early allogeneic Stem cell transplantation for peripheral T-cell lymphoma results in a lower relapse rate and a higher non-relapse mortality than high-dose therapy …
- No benefit of autologous Stem cell transplantation as consolidation for high and high-intermediate risk diffuse large B-cell lymphoma in 1. CR after R-CHOP therapy–a …
- PAD Induction therapy Followed by Autologous Peripheral Blood Stem cell Transplant (APBSCT) as Upfront Treatment for Myeloma (MM) in Chinese Patients.
- … (Ph+) Leukemia cells in the Primitive (CD34posCD38neg) Stem cell Fraction in Chronic Myeloid Leukemia (CML) Patients during Tyrosine Kinase Inhibitor therapy.
- … of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human Stem cell and gene therapy“[Brain. Res. Bull 74 (2007) …
- Translation and validation of the Functional Assessment of Cancer therapy-Bone Marrow Transplant (FACT-BMT) Version 4 quality of life instrument into Arabic …
- Neural Stem cell-mediated enhanced gene therapy of malignant gliomas using a novel plant thymidine kinase
- … of Second-Line therapy in Multiple Myeloma Patients Relapsing After Uniform Front-Line Treatment with High-Dose Melphalan and Autologous Stem cell …
- … targeted therapy into conditioning regimen for patients undergoing autologous Stem cell transplant (ASCT) for aggressive CD20 positive B-cell lymphoma has altered …
- Thiotepa-cyclophosphamide high-dose immunosuppressive therapy with autologous haematopoietic Stem cell transplantation in aggressive forms of multiple sclerosis …
- Post Tandem Autologous Stem cell Transplant Maintenance therapy with Bortezomib Improves Remission Duration and Quality of Response in Multiple …
- BCCA Protocol Summary for Myeloablative Conditioning therapy Prior to Autologous and Allogeneic Hematopoietic Stem cell Transplantation for Myeloid …
- Effect of prior therapy with Nilotinib or Dasatinib on the outcome after allogeneic Stem cell transplantation for patients with chronic myeloid leukaemia
- Evaluating the Safety and Efficacy of Anti-HIV Transgenic cells in a Humanized Mouse Model (NOD/SCIDγc−/−) for HIV Stem cell Gene therapy.
- Abstract# 1071: Tumor Stem cell targeted therapy with mTOR inhibitor RAD001 and hedgehog signalling inhibitor Cyclopamine reverts chemoresistance towards 5 …
- … proliferative index in mantle cell lymphoma (MCL) treated with sequential chemotherapy followed by high-dose therapy and autologous Stem cell rescue (HDT/ASCR)
- Thalidomide-Dexamethasone as Induction therapy Prior to Autologous Stem–cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma and …
- Steroid Refractoriness, but Not Rapidity of Response, to Induction therapy Predicts for Outcome Post-Autologous Stem cell Transplant (ASCT) in Patients …
- Ganciclovir and Leflunomide Combination therapy for a Patient with Cytomegalovirus Pneumonia after Unrelated Allogenic Stem cell Transplantation
- … factors in relapsed acute myeloid leukaemia patients receiving an allogeneic haematopoetic Stem cell transplantation as salvage therapy: a retrospective analysis on …
- TI 4 Potential of muscle Stem cells and cell therapy for Duchenne muscular dystrophy
- … (MFAC) regimen as induction therapy in relapsed or refractory CD33+ acute myeloid leukaemia prior to allogeneic haematopoetic Stem cell transplantation: a single …
- … Haematopoietic Stem cell Transplantation for Myeloid Malignancies Can Be Effectively Salvaged with Intensive Chemotherapy Followed by cellular therapy …
- Sequential therapy With Nonablative Allogeneic Stem cell Transplantation, Post Transplant Imatinib and Donor Lymphocyte Infusion for Chronic Myeloid Leukemia
- … Is No Longer An Adverse Prognostic Factor for Patients with Relapsed HL Undergoing High Dose therapy and Autologous Stem cell Transplant: Results of a …
- … with Multiple Myeloma Who Have Undergone High-Dose Melphalan therapy Followed by Autologous Peripheral Blood Stem cell Transplantation and Failed …
- 1007. Factor VIII Transgene Tolerance Is Induced by Nonmyeloablative Hematopoietic Stem cell Gene therapy for Hemophilia A
- … Trial of Pre-Emptive therapy with Oral Valganciclovir Compared with IV Ganciclovir for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem cell …
- 340: Response to Steroids as Primary therapy for Acute Graft-Versus-Host Disease (GVHD) in 280 Hematopoietic Stem cell Transplant (HSCT) Recipients …
- Antitumor Effects of Canine Adipose Tissue-Derived Mesenchymal Stem cell Based IFN- Gene therapy and Cisplatin in a Mouse Melanoma Model
- … (VD) or Bortezomib, Adriamycine and Dexamethasone (PAD) Followed by High Dose therapy and Peripheral Blood Stem cell Transplantation in First-Line Treatment …
- 13: The Outcome of Allogeneic Stem cell Transplantation (alloSCT) for the Treatment of therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid …
- … A, on behalf of the Tunisian Multiple Myeloma Study Group. Single autologous Stem–cell transplantation followed by maintenance therapy with thalidomide is superior …
- Mesenchymal Stem cells: Applications in cell and gene therapy
- … without Preceding Remission Induction therapy Induces Durable Remission in Patients with Relapsed Acute Leukemia After the First Allogeneic Stem cell …
- … with hematological malignancy and hematopoietic Stem cell transplant (HSCT) recipients in the absence of active immunization and approved therapy: The role of …
- Clofarabine [+ or-] fludarabine with IV busulfan as reduced-toxicity conditioning therapy for allogeneic Stem cell transplantation (Allo-SCT) in advanced myeloid …
- Islet neogenesis potential of human adult Stem cells and its applications in cell replacement therapy for diabetes
- High-dose therapy/autologous Stem cell transplantation increases complete remission rate in multiple myeloma irrespective of the induction regimen used: TD …
- The Effect of Mesenchymal Stem cells as a cell therapy in Renal Ischemia
- Stem cells and cell replacement therapy for Parkinson’s disease
- Developing cell therapy techniques for respiratory disease: Intratracheal delivery of genetically engineered Stem cells in a murine model of airway injury
- Bioluminescence Imaging of X-Ray Visible Microencapsulated Mesenchymal Stem cells for cell Based therapy of Peripheral Arterial Disease
- … Transduction of the Human Purine Nucleoside Phosphorylase (PNP) Gene in Murine Hematopoietic Stem cells: An In Vivo Model of Gene therapy for PNP-T-cell …
- … AND GENETIC MANIPULATION OF HUMAN UMBILICAL CORD VEIN MESENCHYMAL Stem cells: POTENTIAL APPLICATION IN cell-BASED GENE therapy
- Development of real-time MR cell tracking for human neural Stem/progenitor cell-mediated brain tumor therapy
- Lymphatic Reprogramming of Adult Endothelial Stem cells for a cell-Based therapy for Lymphedema in Breast Cancer Patients
- WITHDRAWN: Treatment of combining antiangiogenic therapy and cytotoxic chemotherapy reduce the cancer Stem-like cell fraction in hepatocarcinoma xenografts
- Evaluation of human fetal neural Stem/progenitor cells as a source for cell replacement therapy for neurological disorders: Properties and tumorigenicity after long …
- 323: Immunosuppressive therapy Mitigates Murine T-cell Mediated Rejection of Human Embryonic Stem cells Following Transplantation
- Hematopoietic Stem and progenitor cells and potentials for application in fetal cell replacement therapy
- Stem cells and Genetic therapy for Hair cell–Related Hearing Loss
- Molecular Characterization, Safety and Feasibility of Induced Pluripotent Stem (iPS) cell Derived Cardiomyocytes for Heart Regenerative therapy
- The effect of angiotensin (1-7) on bone marrow Stem cells: adjunctive pharmacological therapy for cell transplantation in heart failure
- Risk factors in the development of Stem cell therapy
- Embryonic and adult Stem cell therapy
- Mesenchymal Stem cell therapy: Two steps forward, one step back
- Angiomyeloproliferative lesions following autologous Stem cell therapy
- Stem cell therapy as an emerging paradigm for stroke (STEPS) II
- Stem cell therapy for type 1 diabetes mellitus
- Mesenchymal Stem cell therapy for knee osteoarthritis. Preliminary report of four patients
- Limbal Stem–cell therapy and long-term corneal regeneration
- Stem cell and progenitor cell therapy in peripheral artery disease
- Translation of Stem cell therapy for neurological diseases
- Stem cell therapy for heart diseases
- Autologous Stem cell therapy for peripheral arterial disease: meta-analysis and syStematic review of the literature
- Stem cell therapy for neonatal brain injury: perspectives and challenges
- Mesenchymal Stem cell therapy for nonhealing cutaneous wounds
- Stem cell therapy: A challenge to periodontist
- Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent Stem cells
- Mesenchymal Stem cell therapy for cardiac repair
- Combination Stem cell therapy for heart failure
- Feasibility of combination allogeneic Stem cell therapy for spinal cord injury: a case report
- Stem cell therapy: a new treatment for burns?
- Challenges of Stem cell therapy for spinal cord injury: human embryonic Stem cells, endogenous neural Stem cells, or induced pluripotent Stem cells?
- Stem cell therapy in acute myocardial infarction: a review of clinical trials
- Experimental Stem cell therapy: Biohierarchies and bionetworking in Japan and India
- Intestinal myofibroblasts: targets for Stem cell therapy
- Stem cell therapy in PAD
- Stem cell therapy for Alzheimer’s disease
- Prospects of Stem cell therapy in osteoarthritis
- Human Stem cell therapy in ischaemic stroke: a review
- cellular antioxidant levels influence muscle Stem cell therapy
- Update on Stem cell therapy for cerebral palsy
- Combination Stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis
- Congenic mesenchymal Stem cell therapy reverses hyperglycemia in experimental type 1 diabetes
- Recent advances in liver Stem cell therapy
- Stem cell therapy: pieces of the puzzle
- Stem cell separation: a bottleneck in Stem cell therapy
- What Have I Got to Lose?: An Analysis of Stem cell therapy Patients’ Blogs
- Mesenchymal Stem cell therapy modulates the inflammatory response in experimental traumatic brain injury
- Allogeneic periodontal ligament Stem cell therapy for periodontitis in swine
- The Stem cell niche should be a key issue for cell therapy in regenerative medicine
- Results of intracoronary Stem cell therapy after acute myocardial infarction
- Chemokines in mesenchymal Stem cell therapy for bone repair: a novel concept of recruiting mesenchymal Stem cells and the possible cell sources
- Mesenchymal Stem cell therapy for the treatment of chronic obstructive pulmonary disease
- Combined gene and Stem cell therapy for cutaneous wound healing
- Non-invasive Stem cell therapy in a rat model for retinal degeneration and vascular pathology
- Successful clinical implementation of corneal epithelial Stem cell therapy for treatment of unilateral limbal Stem cell deficiency
- Concise review: limbal epithelial Stem cell therapy: controversies and challenges
- Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications
- Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal
- Stem cell therapy for retinal diseases: update
- Imaging: guiding the clinical translation of cardiac Stem cell therapy
- Stem cell therapy in pulmonary fibrosis
- Stem cell therapy for cardiac disease
- The regenerative medicine laboratory: facilitating Stem cell therapy for equine disease
- Stem cell therapy improves the outcome of liver resection in cirrhotics
- Human cord blood Stem cell therapy for treatment of stress urinary incontinence
- Mesenchymal Stem cell therapy for chronic renal failure
- Mesenchymal Stem cell therapy for treatment of cardiovascular disease: helping people sooner or later
- Human relevance of pre-clinical studies in Stem cell therapy: syStematic review and meta-analysis of large animal models of ischaemic heart disease
- Advancement of mesenchymal Stem cell therapy in solid organ transplantation (MISOT)
- Selection of optimal passage of bone marrow-derived mesenchymal Stem cells for Stem cell therapy in patients with amyotrophic lateral sclerosis
- Human placenta-derived mesenchymal Stem cells and islet-like cell clusters generated from these cells as a novel source for Stem cell therapy in diabetes
- Dental Stem cell therapy with calcium hydroxide in dental pulp capping
- Stem cell therapy in cardiovascular disorders
- Advances in Stem cell therapy for the lower urinary tract
- Case control series of intrathecal autologous bone marrow mesenchymal Stem cell therapy for chronic spinal cord injury
- Mesenchymal Stem cell therapy for cutaneous radiation syndrome
- Promises of Stem cell therapy for retinal degenerative diseases
- Stem cell therapy for spinal cord injury
- Animal models of cardiac disease and Stem cell therapy
- Mesenchymal Stem cell therapy regenerates the native bone-tendon junction after surgical repair in a degenerative rat model
- G-CSF for Stem cell therapy in acute myocardial infarction: friend or foe?
- Dual Stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis
- Effects of adipose tissue-derived Stem cell therapy after myocardial infarction: impact of the route of administration
- Terminal differentiation is not a major determinant for the success of Stem cell therapy-cross-talk between muscle-derived Stem cells and host cells
- Can HIV be cured with Stem cell therapy?
- Mesenchymal Stem cell therapy in necrotizing enterocolitis: a rat study
- Intracoronary autologous CD34+ Stem cell therapy for intractable angina
- Extinction models for cancer Stem cell therapy
- Potential and pitfalls of Stem cell therapy in old age
- Stem cell therapy for glaucoma: possibilities and practicalities
- Stem cell therapy for digestive tract diseases: current state and future perspectives
- Stem cell therapy for the kidney: a cautionary tale
- 10 years of intracoronary and intramyocardial bone marrow Stem cell therapy of the heart: from the methodological origin to clinical practice
- Regenerative medicine in the field of pain medicine: Prolotherapy, platelet-rich plasma therapy, and Stem cell therapy—Theory and evidence
- Mesenchymal Stem cell therapy and delivery syStems in nonhealing wounds
- Safety and efficacy of bone marrow-derived autologous CD133+ Stem cell therapy
- cell delivery and tracking in post-myocardial infarction cardiac Stem cell therapy: an introduction for clinical researchers
- In vivo imaging of embryonic Stem cell therapy
- Cervical multilevel intraspinal Stem cell therapy: assessment of surgical risks in Gottingen minipigs
- Gene and Stem cell therapy: alone or in combination?
- Stem cell therapy for myocardial infarction: are we missing time?
- Imaging cardiac Stem cell therapy: translations to human clinical studies
- Stem–cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process
- Stem cell therapy: a future treatment of stress urinary incontinence
- Oxygen and oxygenation in Stem–cell therapy for myocardial infarction
- Dermal substitute-assisted healing: enhancing Stem cell therapy with novel biomaterial design
- Stem cell therapy for incontinence: where are we now? What is the realistic potential?
- Stem cell therapy in stroke: designing clinical trials
- Combination Stem cell therapy for the treatment of medically refractory coronary ischemia: a Phase I study
- FOXP3 gene expression in multiple sclerosis patients pre-and post mesenchymal Stem cell therapy
- Recruiter-patients as ambiguous symbols of health: bionetworking and Stem cell therapy in India
- Stem cell therapy for dermal wound healing
- Stem cell therapy for ischemic heart disease
- Stem cell therapy in acute myocardial infarction: a pot of gold or Pandora’s box
- Autologous Stem cell therapy maintains vertebral blood flow and contrast diffusion through the endplate in experimental intervertebral disc degeneration
- Allogeneic haematopoietic Stem cell transplantation: individualized Stem cell and immune therapy of cancer
- Current perspectives on imaging cardiac Stem cell therapy
- A new paradigm for Stem cell therapy: substance-P as a Stem cell-stimulating agent
- Advances in cardiovascular molecular imaging for tracking Stem cell therapy
- Cardiac Stem cell therapy: progress from the bench to bedside
- Stem cell therapy for chronic heart failure. Lessons from a 15-year experience
- Human umbilical cord blood as an emerging Stem cell therapy for diabetes mellitus
- Progenitors for the corneal endothelium and trabecular meshwork: a potential source for personalized Stem cell therapy in corneal endothelial diseases and …
- Effects of Stem cell therapy on Left Ventricular Remodeling After Acute Myocardial Infarction: A Meta‐Analysis
- Neural crest regionalisation for enteric nervous syStem formation: implications for Hirschsprung’s disease and Stem cell therapy
- Surgical approaches to gene and Stem cell therapy for retinal disease
- Current status of Stem cell therapy in heart failure
- Synergistic effect of adipose-derived Stem cell therapy and bone marrow progenitor recruitment in ischemic heart
- Stem cell therapy for neuromuscular diseases
- Stem cell therapy for the heart: a perspective
- Effect of oxygenation on Stem–cell therapy for myocardial infarction
- Evidence-based medicine and Stem cell therapy: how do we know such technologies are safe and efficacious?
- Host tissue response in Stem cell therapy
- Stem cell therapy for stress urinary incontinence
- Mesenchymal Stem cell therapy of intestinal disease: are their effects syStemic or localized?
- Stem cell therapy for chronic lung diseases: hope and reality
- Stem cell therapy for the treatment of myocardial infarction
- Regenerative stromal cell therapy in allogeneic hematopoietic Stem cell transplantation: current impact and future directions
- GRNOPC1: the world’s first embryonic Stem cell-derived therapy
- Stem–cell therapy for peripheral arterial occlusive disease
- Bone marrow Stem cell therapy for recessive dystrophic epidermolysis bullosa
- The bioethics of Stem cell research and therapy
- Neural tube defects: review of experimental evidence on Stem cell therapy and newer treatment options
- Stem cell therapy in cardiology
- Evaluation of 28 human embryonic Stem cell lines for use as unrelated donors in Stem cell therapy: implications of HLA and ABO genotypes
- Clinical applications of Stem cell therapy for regenerating the heart
- Human pluripotent Stem cell therapy for Huntington’s disease: technical, immunological, and safety challenges
- Mesenchymal Stem cell exosome: a novel Stem cell-based therapy for cardiovascular disease
- From bone to brain: human skeletal Stem cell therapy for stroke
- Current and future status of Stem cell therapy in heart failure
- In vivo imaging for Stem cell therapy: new developments and future challenges
- Potential clinical applications of adult human mesenchymal Stem cell (Prochymal®) therapy
- Allogeneic human mesenchymal Stem cell therapy (Prochymal®) as a rescue agent for severe treatment resistant GVHD in pediatric patients
- Stem cell therapy for Parkinson’s disease: a road map for a successful future
- Stem cell therapy and research status in Iran: at A glance
- In sickness and in health: corneal epithelial Stem cell biology, pathology and therapy
- Stem cell therapy in patients with thromboangiitis obliterans: assessment of the long-term clinical outcome and analysis of the prognostic factors
- Mesenchymal Stem cell therapy in the Treatment of Acute and Chronic Graft Versus Host Disease
- Stem cell therapy for the bladder: where do we stand?
- ABCG2: a potential marker of Stem cells and novel target in Stem cell and cancer therapy
- … of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear Stem cell administration on left …
- Bionetworking: between guidelines and practice in Stem cell therapy enterprise in India
- Emerging therapy for improving wound repair of severe radiation burns using local bone marrow‐derived Stem cell administrations
- Stem cell therapy extends incubation and survival time in prion-infected mice in a time window–dependant manner
- Stem cell based cancer gene therapy
- Stem cell therapy for chronic myocardial infarction
- Stem–cell gene therapy for the Wiskott–Aldrich syndrome
- Cultured and freshly isolated adipose tissue-derived cells: fat years for cardiac Stem cell therapy
- Adult Stem cell therapy for periodontal disease
- Hematopoietic Stem cell transplantation and implications for cell therapy reimbursement
- … of Mesenchymal and hematopoietic Stem cells derived from Peripheral blood of Acute Lymphocytic Leukemia patients for regenerative Stem cell therapy
- Cardiac Stem cell therapy
- PET molecular imaging in Stem cell therapy for neurological diseases
- Stem cell therapy for diabetes mellitus
- cell therapy for spinal cord injury by neural Stem/progenitor cells derived from iPS/ES cells
- A controlled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic Stem cell transplantation
- Early increase in myocardial perfusion after Stem cell therapy in patients undergoing incomplete coronary artery bypass surgery
- Practical barriers to delivering autologous bone marrow Stem cell therapy as an adjunct to liver resection
- Stem cell therapy for the treatment of acute myocardial infarction
- The role of cardiac electrophysiology in myocardial regenerative Stem cell therapy
- Mesenchymal Stem cells for cardiac cell therapy
- Hematopoietic Stem cell transplantation and hematopoietic Stem cell gene therapy in X‐linked adrenoleukodystrophy
- Neural Stem cell-based gene therapy for brain tumors
- Identification of hematopoietic Stem cell–specific miRNAs enables gene therapy of globoid cell leukodystrophy
- The cardiomyocyte lineage is critical for optimization of Stem cell therapy in a mouse model of myocardial infarction
- New concepts in cardiac Stem cell therapy
- Treatment of peripheral arterial disease using Stem and progenitor cell therapy
- Advances in mesenchymal Stem cell-mediated gene therapy for cancer
- Stem cell therapy for cardiac disease: what can be learned from oncology
- Effect of Stem cell therapy on amiodarone induced fibrosing interstitial lung disease in albino rat
- Current developments in the use of Stem cell for therapeutic neovascularisation: is the future therapy” cell-free”?
- cell therapy of congenital corneal diseases with umbilical mesenchymal Stem cells: lumican null mice
- ATP‐Sensitive K+ Channel‐Deficient Dilated Cardiomyopathy Proteome Remodeled by Embryonic Stem cell therapy
- Stem cell therapy for diabetes
- … combined granulocyte colony stimulating factor and erythropoetin based-Stem cell therapy using intracoronary infusion of peripheral blood Stem cells in patients …
- Allogeneic Stem–cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin’s lymphoma relapsing after an autologous Stem–cell …
- An increase in cancer Stem cell population after primary syStemic therapy is a poor prognostic factor in breast cancer
- A case study of experimental Stem cell therapy and the risks of over-regulation
- Stem cell therapy for articular cartilage defects
- Targeting Stem cell niches and trafficking for cardiovascular therapy
- Toward an ideal animal model to trace donor cell fates after Stem cell therapy: production of stably labeled multipotent mesenchymal Stem cells from bone marrow of …
- Mesenchymal Stem cell therapy of Crohn’s disease: are the far-away hills getting closer?
- Stem cell-based anti-HIV gene therapy
- Stem cells and cell therapy approaches in lung biology and diseases
- Interview: Affordability at the cutting edge: Stem cell therapy for ocular surface reconstruction
- … to requests of families for unproven interventions in neurodevelopmental disorders: Hyperbaric oxygen “treatment” and Stem cell “therapy” in Cerebral Palsy
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based …
- Stem cells from human exfoliated deciduous teeth (SHED) enhance wound healing and the possibility of novel cell therapy
- Nodal/Activin signaling: a novel target for pancreatic cancer Stem cell therapy
- Stem cell therapy for peripheral arterial disease: a review of clinical trials
- Human gingiva-derived mesenchymal Stem cells are superior to bone marrow-derived mesenchymal Stem cells for cell therapy in regenerative medicine
- Which is the most suitable and effective route of administration for mesenchymal Stem cell-based immunomodulation therapy in experimental kidney transplantation …
- Clinical impact of suicide gene therapy in allogeneic hematopoietic Stem cell transplantation
- Maintenance therapy with low‐dose azacitidine after allogeneic hematopoietic Stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic …
- … compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous Stem–cell transplantation in newly …
- Eyes open to Stem cells: safety trial may pave the way for cell therapy to treat retinal disease in patients
- Enzyme replacement therapy and/or hematopoietic Stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European …
- Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity
- Combination of Stem cell mobilized by granulocyte-colony stimulating factor and human umbilical cord matrix Stem cell: therapy of traumatic brain injury in rats
- Neural Stem cell therapy
- A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of Stem cell‐based therapy
- Getting to the heart of myocardial Stem cells and cell therapy
- Hematopoietic Stem cell gene therapy for adenosine deaminase–deficient severe combined immunodeficiency leads to long-term immunological recovery and …
- Stroke patients take part in “milestone” UK trial of Stem cell therapy
- A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after Stem cell transplantation
- Hypoxia-inducible factor 1-alpha release after intracoronary versus intramyocardial Stem cell therapy in myocardial infarction
- High-dose chemotherapy with autologous Stem–cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials
- Pluripotent Stem cell-derived natural killer cells for cancer therapy
- Maladaptive hypertrophy after acute myocardial infarction positive effect of bone marrow-derived Stem cell therapy on regional remodeling measured by cardiac MRI
- Concerns and hopes for Stem cell therapy in cardiology: focus on endothelial progenitor cells
- Glioma gene therapy using induced pluripotent Stem cell derived neural Stem cells
- Republished review: cardiac Stem cell therapy: progress from the bench to bedside
- Mesenchymal Stem cell infusion therapy in a carbon tetrachloride‐induced liver fibrosis model affects matrix metalloproteinase expression
- Stem cell labeling for noninvasive delivery and tracking in cardiovascular regenerative therapy
- Neural Stem cell-based therapy for ischemic stroke
- How to measure the effects of the intracoronary Stem cell therapy?
- Stem cells and cell therapy
- Human embryonic Stem cell-derived mesenchymal Stem cells as cellular delivery vehicles for prodrug gene therapy of glioblastoma
- High-dose therapy and autologous Stem–cell transplantation in Waldenström macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and …
- … trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic Stem–cell …
- Advances in Stem cell therapy: application to veterinary medicine.
- Shedding new light on the mechanism underlying Stem cell therapy for the heart
- Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic Stem cell transplantation for BCR–ABL-positive acute lymphoblastic …
- Intracoronary administration of cardiac Stem cells in mice: a new, improved technique for cell therapy in murine models
- Amniotic fluid Stem cell migration after intraperitoneal injection in pup rats: implication for therapy
- Large animal models of hematopoietic Stem cell gene therapy
- Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic Stem cell transplant patients: an European Organisation for Research and …
- … connexin channel-dependent intercellular communication in human adult hematopoietic progenitor/Stem cells: probing mechanisms of autologous Stem cell therapy
- Neural Stem cell gene therapy ameliorates pathology and function in a mouse model of globoid cell leukodystrophy
- B-cell function in severe combined immunodeficiency after Stem cell or gene therapy: a review
- Mesenchymal Stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats
- Stem cell therapy for cardiovascular regeneration: the beginning or the end of all hearts’ hopes
- Hematopoietic Stem cell expansion and gene therapy
- Stem cell therapy for islet regeneration
- Nanoscaffold based Stem cell regeneration therapy: recent advancement and future potential
- The role of cytotoxic therapy with hematopoietic Stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review
- … remains the most important determinant of CMV reactivation after allogeneic hematopoietic Stem cell transplantation in the era of surveillance and preemptive therapy
- Clinical application of adult Stem cell therapy in neurological disorders
- Development of novel efficient SIN vectors with improved safety features for Wiskott–Aldrich syndrome Stem cell based gene therapy
- Predifferentiated adult Stem cells and matrices for cardiac cell therapy
- Mesenchymal Stem cell-mediated cancer therapy: A dual-targeted strategy of personalized medicine
- Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting
- Stem cell-based therapy and regenerative approaches to d
